[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_d65952f5-bb89-41af-82bb-17e91c9a5606":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:d65952f5-bb89-41af-82bb-17e91c9a5606,\"}":766},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":661,"relativeEntities":662,"slug":663,"properties":664,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":669,"manageAffiliations":702,"indexDatabases":723,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"d65952f5-bb89-41af-82bb-17e91c9a5606","2023-12-05T05:51:08.058+00:00","2025-11-21T10:05:45.027+00:00",[],"Cytokine-Growth-Factor-Reviews",{"issn":665,"title":667},{"VOID":666},"13596101",{"EN":668},"Cytokine & Growth Factor Reviews",[670,678,686,694],{"id":671,"createTime":672,"updateTime":673,"relativeEntities":674,"label":675,"description":677,"parentId":26,"standard":26,"scholarHubFieldId":26},"6dc081f7-79a9-45f6-8ed3-54ef5518db41","2023-05-29T10:24:14.547+00:00","2023-11-21T07:19:21.114+00:00",[],{"EN":676},"Immunology and Allergy",{},{"id":679,"createTime":680,"updateTime":681,"relativeEntities":682,"label":683,"description":685,"parentId":26,"standard":26,"scholarHubFieldId":26},"1af9c91a-59a8-48f8-b117-f75b9207cb09","2023-05-29T10:24:13.173+00:00","2023-11-21T07:47:43.788+00:00",[],{"EN":684},"Endocrinology, Diabetes and Metabolism",{},{"id":687,"createTime":688,"updateTime":689,"relativeEntities":690,"label":691,"description":693,"parentId":26,"standard":26,"scholarHubFieldId":26},"b2f3603d-283c-49e1-a8f1-01f0de24243c","2023-05-29T10:24:14.495+00:00","2023-11-21T07:19:21.118+00:00",[],{"EN":692},"Immunology",{},{"id":695,"createTime":696,"updateTime":697,"relativeEntities":698,"label":699,"description":701,"parentId":26,"standard":26,"scholarHubFieldId":26},"97cdf9a1-b6ca-4a4d-aa74-b136947bc142","2023-05-29T10:24:03.260+00:00","2023-11-21T06:49:46.360+00:00",[],{"EN":700},"Biochemistry, Genetics and Molecular Biology (miscellaneous)",{},[703,713],{"id":704,"createTime":705,"updateTime":706,"relativeEntities":707,"slug":708,"properties":709,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":52,"url":26,"parentIds":712,"statistic":26},"c204a4fd-ec04-47ff-9c5b-5d693c99cecf","2023-05-29T10:24:07.053+00:00","2024-02-19T16:29:56.082+00:00",[],"Elsevier-BV",{"title":710},{"EN":711},"Elsevier BV",[],{"id":714,"createTime":715,"updateTime":716,"relativeEntities":717,"slug":718,"properties":719,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":116,"url":26,"parentIds":722,"statistic":26},"85fc6dd3-e353-4ce6-9d33-a98bddca22e8","2023-05-29T12:06:36.475+00:00","2024-02-19T17:14:20.667+00:00",[],"ELSEVIER-SCI-LTD",{"title":720},{"EN":721},"ELSEVIER SCI LTD",[],[724,746],{"id":725,"indexDatabase":726,"url":738,"indexYears":739,"academicFieldIds":740,"indexDatabaseRanking":745},"6a578004-16cd-43ed-affc-2c86b0fb7db8",{"id":727,"createTime":728,"updateTime":729,"relativeEntities":730,"label":731,"description":733,"key":735,"publicationTags":736,"standard":26},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":732,"VI":732},"Scopus - Elsevier",{"EN":732,"VI":734},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[737],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F17421","1996-2025",[741,742,743,744],"2e85ca04-4b9c-4f3e-be83-f6e278d9077d","8e5f5f89-df86-44a7-bb58-d8bad424ac5f","5b134d7d-51cf-4eea-aade-eaec47ba2837","e872d6d8-194c-4b83-9ea3-8b78dd28210d","SCOPUS__Q1",{"id":747,"indexDatabase":748,"url":762,"indexYears":26,"academicFieldIds":763,"indexDatabaseRanking":26},"27151484-1329-4a07-99cf-7867ddb8d159",{"id":749,"createTime":750,"updateTime":751,"relativeEntities":752,"label":753,"description":755,"key":758,"publicationTags":759,"standard":26},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":754,"VI":754},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":756,"EN":757},"Cơ sở dữ liệu SCIE","SCIE database","scie",[760,761],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1359-6101",[764,765],"10e9c71e-2256-419c-bdd2-a39e436e76e3","8eb75d88-0c7a-497c-a346-e729afc75040",{"meta":767,"data":769},{"total":768},"612",[770,1291,1534,1680,2185,2521,3546,4025,4210,4749],{"id":771,"createTime":772,"updateTime":772,"relativeEntities":773,"slug":774,"properties":775,"entityType":788,"verifyStatus":25,"verifyTime":789,"verifyNote":790,"syncStatus":28,"languages":791,"translateLanguages":26,"viewCount":36,"primaryUrl":792,"fullTextUrl":26,"authors":793,"publicationType":880,"publisherRelationship":881,"citationCount":911,"citationInfo":912,"publishDate":918,"publishYear":919,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":920,"isForceReanalyzing":1290},"8b2ad25e-0ba6-4349-a8cd-1b77ad6d7fbf","2024-08-09T06:46:37.621+00:00",[],"Mechanisms-involved-in-the-therapeutic-properties-of-mesenchymal-stem-cells",{"mag":776,"keywords":778,"openalex":779,"abstract":781,"title":782,"pm":784,"doi":786},{"VOID":777},"2071904806",{},{"VOID":780},"W2071904806",{},{"EN":783},"Mechanisms involved in the therapeutic properties of mesenchymal stem cells",{"VOID":785},"19926330",{"VOID":787},"10.1016\u002Fj.cytogfr.2009.10.002","PUBLICATION","2024-08-09T06:46:37.620+00:00","Auto Verify",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS135961010900077X",[794,815,836,863],{"id":795,"sortIndex":115,"researcher":26,"roles":796,"affiliations":797,"properties":808},"e96972bf-23e9-4a35-8c3f-6789d13d09ae",[],[798],{"id":799,"sortIndex":36,"affiliation":800,"properties":26},"5c6b2bad-6228-4b77-a556-0cd5e4dbec53",{"id":801,"createTime":802,"updateTime":802,"relativeEntities":803,"slug":804,"properties":805,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"50af8eed-626d-476b-be4f-b943d2711654","2024-08-09T06:46:37.631+00:00",[],"National-Institute-of-Science-and-Technology-for-Stem-Cells-and-Cell-Therapy-Centro-Regional-de-Hemoterapia-de-Ribeir%C3%A3o-Preto-HCFMRP-Universidade-de-S%C3%A3o-Paulo-Rua-Tenente-Cat%C3%A3o-Roxo-2501-Ribeir%C3%A3o-Preto-SP-14051-140-Brazil",{"title":806},{"EN":807},"National Institute of Science and Technology for Stem Cells and Cell Therapy, Centro Regional de Hemoterapia de Ribeirão Preto - HCFMRP\u002FUniversidade de São Paulo, Rua Tenente Catão Roxo 2501, Ribeirão Preto, SP 14051-140, Brazil",{"openalex":809,"orcid":811,"title":813},{"VOID":810},"A5055291063",{"VOID":812},"https:\u002F\u002Forcid.org\u002F0000-0002-4878-417X",{"EN":814},"Aparecida Maria Fontes",{"id":816,"sortIndex":59,"researcher":26,"roles":817,"affiliations":818,"properties":829},"04e4c3e6-7e29-4496-a729-b520474849e6",[],[819],{"id":820,"sortIndex":36,"affiliation":821,"properties":26},"1aa7f4f9-f5e0-4030-a1f9-da1712faf104",{"id":822,"createTime":823,"updateTime":823,"relativeEntities":824,"slug":825,"properties":826,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"505ab8bc-bf44-4cf2-ac51-da9470d2b729","2024-08-09T06:46:37.661+00:00",[],"Skeletal-Research-Center-Department-of-Biology-Case-Western-Reserve-University-2080-Adelbert-Road-Millis-Science-Center-Room-118-Cleveland-OH-44106-7080-United-States",{"title":827},{"EN":828},"Skeletal Research Center, Department of Biology, Case Western Reserve University, 2080 Adelbert Road, Millis Science Center, Room 118, Cleveland, OH 44106-7080, United States",{"openalex":830,"orcid":832,"title":834},{"VOID":831},"A5086513199",{"VOID":833},"https:\u002F\u002Forcid.org\u002F0000-0002-8677-6621",{"EN":835},"Arnold I. Caplan",{"id":837,"sortIndex":114,"researcher":26,"roles":838,"affiliations":839,"properties":856},"6950f105-2638-4fe9-9852-d4f329ff3a06",[],[840,850],{"id":841,"sortIndex":36,"affiliation":842,"properties":26},"8a0e9f54-6334-4849-94d2-045fd71e8cb4",{"id":843,"createTime":844,"updateTime":844,"relativeEntities":845,"slug":846,"properties":847,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"213a49ab-2f5f-40ed-8dd5-bb5037a41075","2024-08-09T06:46:37.649+00:00",[],"Department-of-Clinical-Medicine-Faculdade-de-Medicina-de-Ribeir%C3%A3o-Preto-Universidade-de-S%C3%A3o-Paulo-Av-Bandeirantes-3900-Ribeir%C3%A3o-Preto-SP-14048-900-Brazil",{"title":848},{"EN":849},"Department of Clinical Medicine, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes 3900, Ribeirão Preto, SP 14048-900, Brazil",{"id":851,"sortIndex":115,"affiliation":852,"properties":26},"91c110fb-c185-4124-ae29-2a362826eb80",{"id":801,"createTime":802,"updateTime":802,"relativeEntities":853,"slug":804,"properties":854,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":855},{"EN":807},{"openalex":857,"orcid":859,"title":861},{"VOID":858},"A5035206619",{"VOID":860},"https:\u002F\u002Forcid.org\u002F0000-0002-7364-2595",{"EN":862},"Dimas Tadeu Covas",{"id":864,"sortIndex":36,"researcher":26,"roles":865,"affiliations":866,"properties":873},"094f088c-2634-47a1-a918-10697241d8ba",[],[867],{"id":868,"sortIndex":36,"affiliation":869,"properties":26},"ec21fdb1-e252-41ab-8287-4bbfe47316d8",{"id":801,"createTime":802,"updateTime":802,"relativeEntities":870,"slug":804,"properties":871,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":872},{"EN":807},{"openalex":874,"orcid":876,"title":878},{"VOID":875},"A5027095191",{"VOID":877},"https:\u002F\u002Forcid.org\u002F0000-0001-5775-2869",{"EN":879},"Lindolfo da Silva Meirelles","ARTICLE",{"url":26,"publisher":882,"properties":904},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":883,"slug":663,"properties":884,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":887,"manageAffiliations":888,"indexDatabases":889,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":885,"title":886},{"VOID":666},{"EN":668},[],[],[890,897],{"id":747,"indexDatabase":891,"url":762,"indexYears":26,"academicFieldIds":896,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":892,"label":893,"description":894,"key":758,"publicationTags":895,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":898,"url":738,"indexYears":739,"academicFieldIds":903,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":899,"label":900,"description":901,"key":735,"publicationTags":902,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":905,"pages":907,"issue":909},{"VOID":906},"20",{"VOID":908},"419-427",{"VOID":910},"5-6",1289,{"total":911,"publishYear":26,"statisticByYear":913},{"2012":253,"2013":251,"2014":367,"2015":914,"2016":251,"2017":915,"2018":161,"2019":627,"2020":916,"2021":917,"2022":353,"2023":534,"2024":255},110,96,118,112,"2009-10-01",2009,[921,925,929,933,937,941,945,949,953,957,961,965,969,973,977,981,985,989,993,997,1001,1005,1009,1013,1017,1021,1025,1029,1033,1037,1041,1045,1049,1053,1057,1061,1065,1068,1072,1076,1080,1084,1088,1092,1096,1100,1104,1108,1112,1116,1120,1124,1128,1132,1136,1140,1144,1148,1152,1156,1160,1164,1168,1172,1176,1180,1184,1188,1192,1196,1199,1203,1207,1211,1215,1219,1223,1227,1231,1235,1239,1242,1246,1250,1254,1258,1262,1266,1270,1274,1278,1282,1286],{"id":26,"text":922,"url":26,"identifiers":923},"Caplan, 1991, Mesenchymal stem cells, J Orthop Res, 9, 641, 10.1002\u002Fjor.1100090504",{"doi":924},"10.1002\u002Fjor.1100090504",{"id":26,"text":926,"url":26,"identifiers":927},"Phinney, 2002, Building a consensus regarding the nature and origin of mesenchymal stem cells, J Cell Biochem Suppl, 38, 7, 10.1002\u002Fjcb.10084",{"doi":928},"10.1002\u002Fjcb.10084",{"id":26,"text":930,"url":26,"identifiers":931},"Ohgushi, 1999, Stem cell technology and bioceramics: from cell to gene engineering, J Biomed Mater Res, 48, 913, 10.1002\u002F(SICI)1097-4636(1999)48:6\u003C913::AID-JBM22>3.0.CO;2-0",{"doi":932},"10.1002\u002F(SICI)1097-4636(1999)48:6\u003C913::AID-JBM22>3.0.CO;2-0",{"id":26,"text":934,"url":26,"identifiers":935},"Prockop, 1997, Marrow stromal cells as stem cells for nonhematopoietic tissues, Science, 276, 71, 10.1126\u002Fscience.276.5309.71",{"doi":936},"10.1126\u002Fscience.276.5309.71",{"id":26,"text":938,"url":26,"identifiers":939},"Dexter, 1977, Conditions controlling the proliferation of haemopoietic stem cells in vitro, J Cell Physiol, 91, 335, 10.1002\u002Fjcp.1040910303",{"doi":940},"10.1002\u002Fjcp.1040910303",{"id":26,"text":942,"url":26,"identifiers":943},"Lanotte, 1981, Histochemical and ultrastructural characteristics of a cell line from human bone-marrow stroma, J Cell Sci, 50, 281, 10.1242\u002Fjcs.50.1.281",{"doi":944},"10.1242\u002Fjcs.50.1.281",{"id":26,"text":946,"url":26,"identifiers":947},"Owen, 1988, Marrow stromal stem cells, J Cell Sci Suppl, 10, 63, 10.1242\u002Fjcs.1988.Supplement_10.5",{"doi":948},"10.1242\u002Fjcs.1988.Supplement_10.5",{"id":26,"text":950,"url":26,"identifiers":951},"da Silva Meirelles, 2009, Methodology, biology and clinical applications of mesenchymal stem cells, Front Biosci, 14, 4281, 10.2741\u002F3528",{"doi":952},"10.2741\u002F3528",{"id":26,"text":954,"url":26,"identifiers":955},"Caplan, 2001, Mesenchymal stem cells: building blocks for molecular medicine in the 21st century, Trends Mol Med, 7, 259, 10.1016\u002FS1471-4914(01)02016-0",{"doi":956},"10.1016\u002FS1471-4914(01)02016-0",{"id":26,"text":958,"url":26,"identifiers":959},"da Silva Meirelles, 2008, In search of the in vivo identity of mesenchymal stem cells, Stem Cells, 26, 2287, 10.1634\u002Fstemcells.2007-1122",{"doi":960},"10.1634\u002Fstemcells.2007-1122",{"id":26,"text":962,"url":26,"identifiers":963},"Horwitz, 2005, Clarification of the nomenclature for MSC: the international society for cellular therapy position statement, Cytotherapy, 7, 393, 10.1080\u002F14653240500319234",{"doi":964},"10.1080\u002F14653240500319234",{"id":26,"text":966,"url":26,"identifiers":967},"Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080\u002F14653240600855905",{"doi":968},"10.1080\u002F14653240600855905",{"id":26,"text":970,"url":26,"identifiers":971},"Traktuev, 2008, A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks, Circ Res, 102, 77, 10.1161\u002FCIRCRESAHA.107.159475",{"doi":972},"10.1161\u002FCIRCRESAHA.107.159475",{"id":26,"text":974,"url":26,"identifiers":975},"Yoshimura, 2006, Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates, J Cell Physiol, 208, 64, 10.1002\u002Fjcp.20636",{"doi":976},"10.1002\u002Fjcp.20636",{"id":26,"text":978,"url":26,"identifiers":979},"Lennon, 1996, Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation, In Vitro Cell Dev Biol Anim, 32, 602, 10.1007\u002FBF02724045",{"doi":980},"10.1007\u002FBF02724045",{"id":26,"text":982,"url":26,"identifiers":983},"Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126\u002Fscience.284.5411.143",{"doi":984},"10.1126\u002Fscience.284.5411.143",{"id":26,"text":986,"url":26,"identifiers":987},"Muraglia, 2000, Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model, J Cell Sci, 113, 1161, 10.1242\u002Fjcs.113.7.1161",{"doi":988},"10.1242\u002Fjcs.113.7.1161",{"id":26,"text":990,"url":26,"identifiers":991},"da Silva Meirelles, 2006, Mesenchymal stem cells reside in virtually all post-natal organs and tissues, J Cell Sci, 119, 2204, 10.1242\u002Fjcs.02932",{"doi":992},"10.1242\u002Fjcs.02932",{"id":26,"text":994,"url":26,"identifiers":995},"Diaz-Romero, 2005, Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture, J Cell Physiol, 202, 731, 10.1002\u002Fjcp.20164",{"doi":996},"10.1002\u002Fjcp.20164",{"id":26,"text":998,"url":26,"identifiers":999},"Bianco, 2001, Bone marrow stromal stem cells: nature, biology, and potential applications, Stem Cells, 19, 180, 10.1634\u002Fstemcells.19-3-180",{"doi":1000},"10.1634\u002Fstemcells.19-3-180",{"id":26,"text":1002,"url":26,"identifiers":1003},"Crisan, 2008, A perivascular origin for mesenchymal stem cells in multiple human organs, Cell Stem Cell, 3, 301, 10.1016\u002Fj.stem.2008.07.003",{"doi":1004},"10.1016\u002Fj.stem.2008.07.003",{"id":26,"text":1006,"url":26,"identifiers":1007},"Fleming, 1998, Monoclonal antibody against adult marrow-derived mesenchymal stem cells recognizes developing vasculature in embryonic human skin, Dev Dyn, 212, 119, 10.1002\u002F(SICI)1097-0177(199805)212:1\u003C119::AID-AJA11>3.0.CO;2-2",{"doi":1008},"10.1002\u002F(SICI)1097-0177(199805)212:1\u003C119::AID-AJA11>3.0.CO;2-2",{"id":26,"text":1010,"url":26,"identifiers":1011},"Shi, 2003, Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp, J Bone Miner Res, 18, 696, 10.1359\u002Fjbmr.2003.18.4.696",{"doi":1012},"10.1359\u002Fjbmr.2003.18.4.696",{"id":26,"text":1014,"url":26,"identifiers":1015},"Brighton, 1992, The pericyte as a possible osteoblast progenitor cell, Clin Orthop Relat Res, 275, 287, 10.1097\u002F00003086-199202000-00043",{"doi":1016},"10.1097\u002F00003086-199202000-00043",{"id":26,"text":1018,"url":26,"identifiers":1019},"Covas, 2008, Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts, Exp Hematol, 36, 642, 10.1016\u002Fj.exphem.2007.12.015",{"doi":1020},"10.1016\u002Fj.exphem.2007.12.015",{"id":26,"text":1022,"url":26,"identifiers":1023},"Doherty, 1998, Vascular pericytes express osteogenic potential in vitro and in vivo, J Bone Miner Res, 13, 828, 10.1359\u002Fjbmr.1998.13.5.828",{"doi":1024},"10.1359\u002Fjbmr.1998.13.5.828",{"id":26,"text":1026,"url":26,"identifiers":1027},"Farrington-Rock, 2004, Chondrogenic and adipogenic potential of microvascular pericytes, Circulation, 110, 2226, 10.1161\u002F01.CIR.0000144457.55518.E5",{"doi":1028},"10.1161\u002F01.CIR.0000144457.55518.E5",{"id":26,"text":1030,"url":26,"identifiers":1031},"Brighton, 1997, Early histologic and ultrastructural changes in microvessels of periosteal callus, J Orthop Trauma, 11, 244, 10.1097\u002F00005131-199705000-00002",{"doi":1032},"10.1097\u002F00005131-199705000-00002",{"id":26,"text":1034,"url":26,"identifiers":1035},"Bruno, 2009, Isolation and characterization of resident mesenchymal stem cells in human glomeruli, Stem Cells Dev, 10.1089\u002Fscd.2008.0320",{"doi":1036},"10.1089\u002Fscd.2008.0320",{"id":26,"text":1038,"url":26,"identifiers":1039},"Chan, 2006, Identification of label-retaining cells in mouse endometrium, Stem Cells, 24, 1529, 10.1634\u002Fstemcells.2005-0411",{"doi":1040},"10.1634\u002Fstemcells.2005-0411",{"id":26,"text":1042,"url":26,"identifiers":1043},"Davidoff, 2004, Progenitor cells of the testosterone-producing Leydig cells revealed, J Cell Biol, 167, 935, 10.1083\u002Fjcb.200409107",{"doi":1044},"10.1083\u002Fjcb.200409107",{"id":26,"text":1046,"url":26,"identifiers":1047},"Diaz-Flores, 1991, Inducible perivascular cells contribute to the neochondrogenesis in grafted perichondrium, Anat Rec, 229, 1, 10.1002\u002Far.1092290102",{"doi":1048},"10.1002\u002Far.1092290102",{"id":26,"text":1050,"url":26,"identifiers":1051},"Diaz-Flores, 1992, Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis, Clin Orthop Relat Res, 275, 280, 10.1097\u002F00003086-199202000-00042",{"doi":1052},"10.1097\u002F00003086-199202000-00042",{"id":26,"text":1054,"url":26,"identifiers":1055},"McCulloch, 1985, Progenitor cell populations in the periodontal ligament of mice, Anat Rec, 211, 258, 10.1002\u002Far.1092110305",{"doi":1056},"10.1002\u002Far.1092110305",{"id":26,"text":1058,"url":26,"identifiers":1059},"Richardson, 1982, Response of pericytes to thermal lesion in the inguinal fat pad of 10-day-old rats, Acta Anat (Basel), 114, 41, 10.1159\u002F000145577",{"doi":1060},"10.1159\u002F000145577",{"id":26,"text":1062,"url":26,"identifiers":1063},"Tang, 2008, White fat progenitor cells reside in the adipose vasculature, Science, 322, 583, 10.1126\u002Fscience.1156232",{"doi":1064},"10.1126\u002Fscience.1156232",{"id":26,"text":1066,"url":26,"identifiers":1067},"da Silva Meirelles, 2008, MSC frequency correlates with blood vessel density in equine adipose tissue, Tissue Eng Part A",{},{"id":26,"text":1069,"url":26,"identifiers":1070},"Arthur, 2009, The therapeutic applications of multipotential mesenchymal\u002Fstromal stem cells in skeletal tissue repair, J Cell Physiol, 218, 237, 10.1002\u002Fjcp.21592",{"doi":1071},"10.1002\u002Fjcp.21592",{"id":26,"text":1073,"url":26,"identifiers":1074},"Covas, 2005, Mesenchymal stem cells can be obtained from the human saphena vein, Exp Cell Res, 309, 340, 10.1016\u002Fj.yexcr.2005.06.005",{"doi":1075},"10.1016\u002Fj.yexcr.2005.06.005",{"id":26,"text":1077,"url":26,"identifiers":1078},"Panepucci, 2004, Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells, Stem Cells, 22, 1263, 10.1634\u002Fstemcells.2004-0024",{"doi":1079},"10.1634\u002Fstemcells.2004-0024",{"id":26,"text":1081,"url":26,"identifiers":1082},"Silva, 2003, The profile of gene expression of human marrow mesenchymal stem cells, Stem Cells, 21, 661, 10.1634\u002Fstemcells.21-6-661",{"doi":1083},"10.1634\u002Fstemcells.21-6-661",{"id":26,"text":1085,"url":26,"identifiers":1086},"Sacchetti, 2007, Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment, Cell, 131, 324, 10.1016\u002Fj.cell.2007.08.025",{"doi":1087},"10.1016\u002Fj.cell.2007.08.025",{"id":26,"text":1089,"url":26,"identifiers":1090},"Bianco, 2008, Mesenchymal stem cells: revisiting history, concepts, and assays, Cell Stem Cell, 2, 313, 10.1016\u002Fj.stem.2008.03.002",{"doi":1091},"10.1016\u002Fj.stem.2008.03.002",{"id":26,"text":1093,"url":26,"identifiers":1094},"Caplan, 2006, Mesenchymal stem cells as trophic mediators, J Cell Biochem, 98, 1076, 10.1002\u002Fjcb.20886",{"doi":1095},"10.1002\u002Fjcb.20886",{"id":26,"text":1097,"url":26,"identifiers":1098},"Karp, 2009, Mesenchymal stem cell homing: the devil is in the details, Cell Stem Cell, 4, 206, 10.1016\u002Fj.stem.2009.02.001",{"doi":1099},"10.1016\u002Fj.stem.2009.02.001",{"id":26,"text":1101,"url":26,"identifiers":1102},"Rojas, 2005, Bone marrow-derived mesenchymal stem cells in repair of the injured lung, Am J Respir Cell Mol Biol, 33, 145, 10.1165\u002Frcmb.2004-0330OC",{"doi":1103},"10.1165\u002Frcmb.2004-0330OC",{"id":26,"text":1105,"url":26,"identifiers":1106},"Ponte, 2007, The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities, Stem Cells, 25, 1737, 10.1634\u002Fstemcells.2007-0054",{"doi":1107},"10.1634\u002Fstemcells.2007-0054",{"id":26,"text":1109,"url":26,"identifiers":1110},"Ruster, 2006, Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells, Blood, 108, 3938, 10.1182\u002Fblood-2006-05-025098",{"doi":1111},"10.1182\u002Fblood-2006-05-025098",{"id":26,"text":1113,"url":26,"identifiers":1114},"Segers, 2006, Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms, Am J Physiol Heart Circ Physiol, 290, H1370, 10.1152\u002Fajpheart.00523.2005",{"doi":1115},"10.1152\u002Fajpheart.00523.2005",{"id":26,"text":1117,"url":26,"identifiers":1118},"Raheja, 2008, Hypoxic osteocytes recruit human MSCs through an OPN\u002FCD44-mediated pathway, Biochem Biophys Res Commun, 366, 1061, 10.1016\u002Fj.bbrc.2007.12.076",{"doi":1119},"10.1016\u002Fj.bbrc.2007.12.076",{"id":26,"text":1121,"url":26,"identifiers":1122},"Herrera, 2007, Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury, Kidney Int, 72, 430, 10.1038\u002Fsj.ki.5002334",{"doi":1123},"10.1038\u002Fsj.ki.5002334",{"id":26,"text":1125,"url":26,"identifiers":1126},"Nolte, 2002, The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors, Immunology, 106, 299, 10.1046\u002Fj.1365-2567.2002.01443.x",{"doi":1127},"10.1046\u002Fj.1365-2567.2002.01443.x",{"id":26,"text":1129,"url":26,"identifiers":1130},"Togel, 2007, Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury, Am J Physiol Renal Physiol, 292, F1626, 10.1152\u002Fajprenal.00339.2006",{"doi":1131},"10.1152\u002Fajprenal.00339.2006",{"id":26,"text":1133,"url":26,"identifiers":1134},"Parekkadan, 2007, Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure, PLoS One, 2, e941, 10.1371\u002Fjournal.pone.0000941",{"doi":1135},"10.1371\u002Fjournal.pone.0000941",{"id":26,"text":1137,"url":26,"identifiers":1138},"Block, 2009, Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1, Stem Cells, 27, 670, 10.1002\u002Fstem.20080742",{"doi":1139},"10.1002\u002Fstem.20080742",{"id":26,"text":1141,"url":26,"identifiers":1142},"Rehman, 2004, Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation, 109, 1292, 10.1161\u002F01.CIR.0000121425.42966.F1",{"doi":1143},"10.1161\u002F01.CIR.0000121425.42966.F1",{"id":26,"text":1145,"url":26,"identifiers":1146},"Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182\u002Fblood.V99.10.3838",{"doi":1147},"10.1182\u002Fblood.V99.10.3838",{"id":26,"text":1149,"url":26,"identifiers":1150},"Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182\u002Fblood-2002-07-2104",{"doi":1151},"10.1182\u002Fblood-2002-07-2104",{"id":26,"text":1153,"url":26,"identifiers":1154},"Martinet, 2009, A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells, Eur J Immunol, 39, 752, 10.1002\u002Feji.200838812",{"doi":1155},"10.1002\u002Feji.200838812",{"id":26,"text":1157,"url":26,"identifiers":1158},"Rasmusson, 2007, Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes, J Leukoc Biol, 82, 887, 10.1189\u002Fjlb.0307140",{"doi":1159},"10.1189\u002Fjlb.0307140",{"id":26,"text":1161,"url":26,"identifiers":1162},"Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182\u002Fblood-2005-07-2657",{"doi":1163},"10.1182\u002Fblood-2005-07-2657",{"id":26,"text":1165,"url":26,"identifiers":1166},"Traggiai, 2008, Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients, Stem Cells, 26, 562, 10.1634\u002Fstemcells.2007-0528",{"doi":1167},"10.1634\u002Fstemcells.2007-0528",{"id":26,"text":1169,"url":26,"identifiers":1170},"Sotiropoulou, 2006, Interactions between human mesenchymal stem cells and natural killer cells, Stem Cells, 24, 74, 10.1634\u002Fstemcells.2004-0359",{"doi":1171},"10.1634\u002Fstemcells.2004-0359",{"id":26,"text":1173,"url":26,"identifiers":1174},"Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182\u002Fblood-2005-07-2775",{"doi":1175},"10.1182\u002Fblood-2005-07-2775",{"id":26,"text":1177,"url":26,"identifiers":1178},"Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182\u002Fblood-2004-04-1559",{"doi":1179},"10.1182\u002Fblood-2004-04-1559",{"id":26,"text":1181,"url":26,"identifiers":1182},"Nemeth, 2009, Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat Med, 15, 42, 10.1038\u002Fnm.1905",{"doi":1183},"10.1038\u002Fnm.1905",{"id":26,"text":1185,"url":26,"identifiers":1186},"Rafei, 2008, Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction, Blood, 112, 4991, 10.1182\u002Fblood-2008-07-166892",{"doi":1187},"10.1182\u002Fblood-2008-07-166892",{"id":26,"text":1189,"url":26,"identifiers":1190},"Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, 109, 228, 10.1182\u002Fblood-2006-02-002246",{"doi":1191},"10.1182\u002Fblood-2006-02-002246",{"id":26,"text":1193,"url":26,"identifiers":1194},"Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182\u002Fblood-2003-11-3909",{"doi":1195},"10.1182\u002Fblood-2003-11-3909",{"id":26,"text":1197,"url":26,"identifiers":1198},"Nasef, 2007, Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells, Gene Expr, 13, 217",{},{"id":26,"text":1200,"url":26,"identifiers":1201},"Nasef, 2007, Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G, Transplantation, 84, 231, 10.1097\u002F01.tp.0000267918.07906.08",{"doi":1202},"10.1097\u002F01.tp.0000267918.07906.08",{"id":26,"text":1204,"url":26,"identifiers":1205},"Rizzo, 2008, A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells, Cytotherapy, 10, 364, 10.1080\u002F14653240802105299",{"doi":1206},"10.1080\u002F14653240802105299",{"id":26,"text":1208,"url":26,"identifiers":1209},"Nasef, 2008, Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression, Cell Immunol, 253, 16, 10.1016\u002Fj.cellimm.2008.06.002",{"doi":1210},"10.1016\u002Fj.cellimm.2008.06.002",{"id":26,"text":1212,"url":26,"identifiers":1213},"Di Ianni, 2008, Mesenchymal cells recruit and regulate T regulatory cells, Exp Hematol, 36, 309, 10.1016\u002Fj.exphem.2007.11.007",{"doi":1214},"10.1016\u002Fj.exphem.2007.11.007",{"id":26,"text":1216,"url":26,"identifiers":1217},"Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016\u002FS0140-6736(04)16104-7",{"doi":1218},"10.1016\u002FS0140-6736(04)16104-7",{"id":26,"text":1220,"url":26,"identifiers":1221},"Iyer, 2008, Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies, Expert Opin Biol Ther, 8, 569, 10.1517\u002F14712598.8.5.569",{"doi":1222},"10.1517\u002F14712598.8.5.569",{"id":26,"text":1224,"url":26,"identifiers":1225},"Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046\u002Fj.1365-3083.2003.01176.x",{"doi":1226},"10.1046\u002Fj.1365-3083.2003.01176.x",{"id":26,"text":1228,"url":26,"identifiers":1229},"Chan, 2006, Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma, Blood, 107, 4817, 10.1182\u002Fblood-2006-01-0057",{"doi":1230},"10.1182\u002Fblood-2006-01-0057",{"id":26,"text":1232,"url":26,"identifiers":1233},"Ryan, 2007, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clin Exp Immunol, 149, 353, 10.1111\u002Fj.1365-2249.2007.03422.x",{"doi":1234},"10.1111\u002Fj.1365-2249.2007.03422.x",{"id":26,"text":1236,"url":26,"identifiers":1237},"Nehme, 2008, Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes, Invest Ophthalmol Vis Sci, 49, 2030, 10.1167\u002Fiovs.07-0273",{"doi":1238},"10.1167\u002Fiovs.07-0273",{"id":26,"text":1240,"url":26,"identifiers":1241},"Suga, 2008, IFATS series: FGF-2-induced HGF secretion by adipose-derived stromal cells inhibits post-injury fibrogenesis through a JNK-dependent mechanism, Stem Cells",{},{"id":26,"text":1243,"url":26,"identifiers":1244},"Li, 2009, Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure, Mol Biol Rep, 36, 725, 10.1007\u002Fs11033-008-9235-2",{"doi":1245},"10.1007\u002Fs11033-008-9235-2",{"id":26,"text":1247,"url":26,"identifiers":1248},"Haynesworth, 1996, Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha, J Cell Physiol, 166, 585, 10.1002\u002F(SICI)1097-4652(199603)166:3\u003C585::AID-JCP13>3.0.CO;2-6",{"doi":1249},"10.1002\u002F(SICI)1097-4652(199603)166:3\u003C585::AID-JCP13>3.0.CO;2-6",{"id":26,"text":1251,"url":26,"identifiers":1252},"Majumdar, 1998, Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells, J Cell Physiol, 176, 57, 10.1002\u002F(SICI)1097-4652(199807)176:1\u003C57::AID-JCP7>3.0.CO;2-7",{"doi":1253},"10.1002\u002F(SICI)1097-4652(199807)176:1\u003C57::AID-JCP7>3.0.CO;2-7",{"id":26,"text":1255,"url":26,"identifiers":1256},"Sugiyama, 2006, Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches, Immunity, 25, 977, 10.1016\u002Fj.immuni.2006.10.016",{"doi":1257},"10.1016\u002Fj.immuni.2006.10.016",{"id":26,"text":1259,"url":26,"identifiers":1260},"Ohab, 2006, A neurovascular niche for neurogenesis after stroke, J Neurosci, 26, 13007, 10.1523\u002FJNEUROSCI.4323-06.2006",{"doi":1261},"10.1523\u002FJNEUROSCI.4323-06.2006",{"id":26,"text":1263,"url":26,"identifiers":1264},"Seo, 2009, Differential expression of stromal cell-derived factor 1 in human brain microvascular endothelial cells and pericytes involves histone modifications, Biochem Biophys Res Commun, 10.1016\u002Fj.bbrc.2009.03.049",{"doi":1265},"10.1016\u002Fj.bbrc.2009.03.049",{"id":26,"text":1267,"url":26,"identifiers":1268},"Sundberg, 2002, Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo, Lab Invest, 82, 387, 10.1038\u002Flabinvest.3780433",{"doi":1269},"10.1038\u002Flabinvest.3780433",{"id":26,"text":1271,"url":26,"identifiers":1272},"Kinnaird, 2004, Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms, Circulation, 109, 1543, 10.1161\u002F01.CIR.0000124062.31102.57",{"doi":1273},"10.1161\u002F01.CIR.0000124062.31102.57",{"id":26,"text":1275,"url":26,"identifiers":1276},"Hung, 2007, Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis, Stem Cells, 25, 2363, 10.1634\u002Fstemcells.2006-0686",{"doi":1277},"10.1634\u002Fstemcells.2006-0686",{"id":26,"text":1279,"url":26,"identifiers":1280},"Sorrell, 2009, Influence of adult mesenchymal stem cells on in vitro vascular formation, Tissue Eng Part A, 10.1089\u002Ften.tea.2008.0254",{"doi":1281},"10.1089\u002Ften.tea.2008.0254",{"id":26,"text":1283,"url":26,"identifiers":1284},"Sanz, 2008, Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels, Microvasc Res, 75, 308, 10.1016\u002Fj.mvr.2007.11.007",{"doi":1285},"10.1016\u002Fj.mvr.2007.11.007",{"id":26,"text":1287,"url":26,"identifiers":1288},"Rollins, 1997, Chemokines, Blood, 90, 909, 10.1182\u002Fblood.V90.3.909",{"doi":1289},"10.1182\u002Fblood.V90.3.909",false,{"id":1292,"createTime":1293,"updateTime":1293,"relativeEntities":1294,"slug":1295,"properties":1296,"entityType":788,"verifyStatus":25,"verifyTime":1293,"verifyNote":790,"syncStatus":28,"languages":1309,"translateLanguages":26,"viewCount":36,"primaryUrl":1310,"fullTextUrl":26,"authors":1311,"publicationType":880,"publisherRelationship":1331,"citationCount":279,"citationInfo":1361,"publishDate":1363,"publishYear":1364,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1365,"isForceReanalyzing":1290},"2b0a96bf-88c9-4528-a156-ed978e1e9570","2024-10-02T12:46:57.092+00:00",[],"TGF-%CE%B2-signaling-by-Smad-proteins",{"mag":1297,"keywords":1299,"openalex":1300,"abstract":1302,"title":1303,"pm":1305,"doi":1307},{"VOID":1298},"2090905598",{},{"VOID":1301},"W2090905598",{},{"EN":1304},"TGF-β signaling by Smad proteins",{"VOID":1306},"10879283",{"VOID":1308},"10.1016\u002Fs1359-6101(99)00025-8",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610199000258",[1312],{"id":1313,"sortIndex":36,"researcher":26,"roles":1314,"affiliations":1315,"properties":1326},"47a9e1f5-d1b3-4b33-bff3-8024f5e1053e",[],[1316],{"id":1317,"sortIndex":36,"affiliation":1318,"properties":26},"1d75558a-c45c-466b-8208-c42f83228df6",{"id":1319,"createTime":1320,"updateTime":1320,"relativeEntities":1321,"slug":1322,"properties":1323,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2048773c-3f34-420a-954f-f6b736713011","2024-10-02T12:46:57.110+00:00",[],"Department-of-Biochemistry-The-Cancer-Institute-of-the-Japanese-Foundation-for-Cancer-Research-JFCR-1-37-1-Kami-ikebukuro-Toshima-ku-Tokyo-Japan-miyazono-ind-umin-ac-jp",{"title":1324},{"EN":1325},"Department of Biochemistry, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), 1-37-1 Kami-ikebukuro, Toshima-ku, Tokyo, Japan. miyazono-ind@umin.ac.jp",{"openalex":1327,"title":1329},{"VOID":1328},"A5019919849",{"EN":1330},"Kohei Miyazono",{"url":26,"publisher":1332,"properties":1354},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1333,"slug":663,"properties":1334,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":1337,"manageAffiliations":1338,"indexDatabases":1339,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1335,"title":1336},{"VOID":666},{"EN":668},[],[],[1340,1347],{"id":747,"indexDatabase":1341,"url":762,"indexYears":26,"academicFieldIds":1346,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":1342,"label":1343,"description":1344,"key":758,"publicationTags":1345,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":1348,"url":738,"indexYears":739,"academicFieldIds":1353,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":1349,"label":1350,"description":1351,"key":735,"publicationTags":1352,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":1355,"pages":1357,"issue":1359},{"VOID":1356},"11",{"VOID":1358},"15-22",{"VOID":1360},"1-2",{"total":279,"publishYear":26,"statisticByYear":1362},{"2012":244,"2013":234,"2014":396,"2015":516,"2016":336,"2017":336,"2018":103,"2019":173,"2020":222,"2021":356,"2022":356,"2023":234,"2024":135},"2000-04-01",2000,[1366,1370,1374,1378,1382,1386,1390,1394,1398,1402,1406,1410,1414,1418,1422,1426,1430,1434,1438,1442,1446,1450,1454,1458,1462,1466,1470,1474,1478,1482,1486,1490,1494,1498,1502,1506,1510,1514,1518,1522,1526,1530],{"id":26,"text":1367,"url":26,"identifiers":1368},"Heldin, 1997, TGF-β signalling from cell membrane to nucleus through SMAD proteins, Nature, 390, 465, 10.1038\u002F37284",{"doi":1369},"10.1038\u002F37284",{"id":26,"text":1371,"url":26,"identifiers":1372},"Massagué, 1998, TGF-β signal transduction, Annu. Rev. Biochem., 67, 753, 10.1146\u002Fannurev.biochem.67.1.753",{"doi":1373},"10.1146\u002Fannurev.biochem.67.1.753",{"id":26,"text":1375,"url":26,"identifiers":1376},"Miyazono K, ten Dijke P, Heldin C-H. TGF-β signaling by Smad proteins. Adv Immunol (in press), 2000",{"doi":1377},"10.1016\u002FS0065-2776(00)75003-6",{"id":26,"text":1379,"url":26,"identifiers":1380},"Katagiri, 1994, Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage, J. Cell. Biol., 127, 1755, 10.1083\u002Fjcb.127.6.1755",{"doi":1381},"10.1083\u002Fjcb.127.6.1755",{"id":26,"text":1383,"url":26,"identifiers":1384},"Takeda, 1998, Identification of a novel bone morphogenetic protein-responsive gene that may function as a noncoding RNA, J. Biol. Chem., 273, 17,079, 10.1074\u002Fjbc.273.27.17079",{"doi":1385},"10.1074\u002Fjbc.273.27.17079",{"id":26,"text":1387,"url":26,"identifiers":1388},"Ebisawa, 1999, Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation, J. Cell. Sci., 112, 3519, 10.1242\u002Fjcs.112.20.3519",{"doi":1389},"10.1242\u002Fjcs.112.20.3519",{"id":26,"text":1391,"url":26,"identifiers":1392},"Fujii M, Takeda K, Imamura T, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblastic and chondroblastic differentiation. Mol Biol Cell 1999;10:3801–13",{"doi":1393},"10.1091\u002Fmbc.10.11.3801",{"id":26,"text":1395,"url":26,"identifiers":1396},"Kawabata, 1998, Signal transduction by bone morphogenetic proteins, Cytokine Growth Factor Rev., 9, 49, 10.1016\u002FS1359-6101(97)00036-1",{"doi":1397},"10.1016\u002FS1359-6101(97)00036-1",{"id":26,"text":1399,"url":26,"identifiers":1400},"ten Dijke, 1994, Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4, J. Biol. Chem., 269, 16,985, 10.1016\u002FS0021-9258(17)32506-1",{"doi":1401},"10.1016\u002FS0021-9258(17)32506-1",{"id":26,"text":1403,"url":26,"identifiers":1404},"Macı́as-Silva, 1998, Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2, J. Biol. Chem., 273, 25,628, 10.1074\u002Fjbc.273.40.25628",{"doi":1405},"10.1074\u002Fjbc.273.40.25628",{"id":26,"text":1407,"url":26,"identifiers":1408},"Itoh, 1998, Transforming growth factor β1 induces nuclear export of inhibitory Smad7, J. Biol. Chem., 273, 29,195, 10.1074\u002Fjbc.273.44.29195",{"doi":1409},"10.1074\u002Fjbc.273.44.29195",{"id":26,"text":1411,"url":26,"identifiers":1412},"Shukunami, 1996, Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)\u002FPTH-related peptide receptor, J. Cell. Biol., 133, 457, 10.1083\u002Fjcb.133.2.457",{"doi":1413},"10.1083\u002Fjcb.133.2.457",{"id":26,"text":1415,"url":26,"identifiers":1416},"Asahina, 1993, Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria, J. Cell. Biol., 123, 921, 10.1083\u002Fjcb.123.4.921",{"doi":1417},"10.1083\u002Fjcb.123.4.921",{"id":26,"text":1419,"url":26,"identifiers":1420},"Nakamura, 1999, p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth\u002Fdifferentiation factor-5 in ATDC5 cells, Exp. Cell. Res., 250, 351, 10.1006\u002Fexcr.1999.4535",{"doi":1421},"10.1006\u002Fexcr.1999.4535",{"id":26,"text":1423,"url":26,"identifiers":1424},"Nakao, 1999, Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice, J. Clin. Invest., 104, 5, 10.1172\u002FJCI6094",{"doi":1425},"10.1172\u002FJCI6094",{"id":26,"text":1427,"url":26,"identifiers":1428},"Zawel, 1998, Human Smad3 and Smad4 are sequence-specific transcription activators, Mol. Cell, 1, 611, 10.1016\u002FS1097-2765(00)80061-1",{"doi":1429},"10.1016\u002FS1097-2765(00)80061-1",{"id":26,"text":1431,"url":26,"identifiers":1432},"Dennler, 1998, Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene, EMBO J., 17, 3091, 10.1093\u002Femboj\u002F17.11.3091",{"doi":1433},"10.1093\u002Femboj\u002F17.11.3091",{"id":26,"text":1435,"url":26,"identifiers":1436},"Jonk, 1998, Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer, J. Biol. Chem., 273, 21,145, 10.1074\u002Fjbc.273.33.21145",{"doi":1437},"10.1074\u002Fjbc.273.33.21145",{"id":26,"text":1439,"url":26,"identifiers":1440},"Takenoshita, 1998, Characterization of MADH2\u002FSmad2 gene, a human Mad homolog responsible for transforming growth factor-β and activin signal transduction pathway, Genomics, 48, 1, 10.1006\u002Fgeno.1997.5149",{"doi":1441},"10.1006\u002Fgeno.1997.5149",{"id":26,"text":1443,"url":26,"identifiers":1444},"Yagi, 1999, Alternatively-spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3, J. Biol. Chem., 274, 703, 10.1074\u002Fjbc.274.2.703",{"doi":1445},"10.1074\u002Fjbc.274.2.703",{"id":26,"text":1447,"url":26,"identifiers":1448},"Dennler, 1999, A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3, Oncogene, 18, 1643, 10.1038\u002Fsj.onc.1202729",{"doi":1449},"10.1038\u002Fsj.onc.1202729",{"id":26,"text":1451,"url":26,"identifiers":1452},"Labbé, 1998, Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2, Mol. Cell, 2, 109, 10.1016\u002FS1097-2765(00)80119-7",{"doi":1453},"10.1016\u002FS1097-2765(00)80119-7",{"id":26,"text":1455,"url":26,"identifiers":1456},"Yanagisawa, 1999, Convergence of transforming growth factor-β and vitamin D signaling pathways on Smad transcriptional coactivators, Science, 283, 1317, 10.1126\u002Fscience.283.5406.1317",{"doi":1457},"10.1126\u002Fscience.283.5406.1317",{"id":26,"text":1459,"url":26,"identifiers":1460},"Komori, 1997, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755, 10.1016\u002FS0092-8674(00)80258-5",{"doi":1461},"10.1016\u002FS0092-8674(00)80258-5",{"id":26,"text":1463,"url":26,"identifiers":1464},"Otto, 1997, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, Cell, 89, 765, 10.1016\u002FS0092-8674(00)80259-7",{"doi":1465},"10.1016\u002FS0092-8674(00)80259-7",{"id":26,"text":1467,"url":26,"identifiers":1468},"Okuda, 1996, AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis, Cell, 84, 321, 10.1016\u002FS0092-8674(00)80986-1",{"doi":1469},"10.1016\u002FS0092-8674(00)80986-1",{"id":26,"text":1471,"url":26,"identifiers":1472},"Shi, 1998, CBFα3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Ig α promoter, J. Immunol., 161, 6751, 10.4049\u002Fjimmunol.161.12.6751",{"doi":1473},"10.4049\u002Fjimmunol.161.12.6751",{"id":26,"text":1475,"url":26,"identifiers":1476},"Hanai, 1999, Interaction and functional cooperation of PEBP2\u002FCBF with Smads: synergistic induction of the immunoglobulin germline Cα promoter, J. Biol. Chem., 274, 31,577, 10.1074\u002Fjbc.274.44.31577",{"doi":1477},"10.1074\u002Fjbc.274.44.31577",{"id":26,"text":1479,"url":26,"identifiers":1480},"Pardali E, Xie X-Q, Itoh S, Konstantinos A, Panagiotis T, Heldin C-H, ten Dijke P, Grundström T, Sideras P. Smad and AML proteins synergistically confer TGFβ1 responsiveness of human germ-line IgA genes. J Biol Chem (in press), 2000",{"doi":1481},"10.1074\u002Fjbc.275.5.3552",{"id":26,"text":1483,"url":26,"identifiers":1484},"Nishihara, 1998, Role of p300, a transcriptional coactivator, in signalling of TGF-β, Gene Cells, 3, 613, 10.1046\u002Fj.1365-2443.1998.00217.x",{"doi":1485},"10.1046\u002Fj.1365-2443.1998.00217.x",{"id":26,"text":1487,"url":26,"identifiers":1488},"Feng, 1998, The tumor suppressor Smad4\u002FDPC4 and transcriptional adaptor CBP\u002Fp300 are coactivators for Smad3 in TGF-β-induced transcriptional activation, Genes Dev., 12, 2153, 10.1101\u002Fgad.12.14.2153",{"doi":1489},"10.1101\u002Fgad.12.14.2153",{"id":26,"text":1491,"url":26,"identifiers":1492},"Janknecht, 1998, TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP\u002Fp300, Genes Dev., 12, 2114, 10.1101\u002Fgad.12.14.2114",{"doi":1493},"10.1101\u002Fgad.12.14.2114",{"id":26,"text":1495,"url":26,"identifiers":1496},"Pouponnot, 1998, Physical and functional interaction of Smads and p300\u002FCBP, J. Biol. Chem., 273, 22,865, 10.1074\u002Fjbc.273.36.22865",{"doi":1497},"10.1074\u002Fjbc.273.36.22865",{"id":26,"text":1499,"url":26,"identifiers":1500},"Shen, 1998, TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300\u002FCREB-binding protein, Mol. Biol. Cell., 9, 3309, 10.1091\u002Fmbc.9.12.3309",{"doi":1501},"10.1091\u002Fmbc.9.12.3309",{"id":26,"text":1503,"url":26,"identifiers":1504},"Nishihara, 1999, E1A inhibits transforming growth factor-β signaling through binding to Smad proteins, J. Biol. Chem., 274, 28,716, 10.1074\u002Fjbc.274.40.28716",{"doi":1505},"10.1074\u002Fjbc.274.40.28716",{"id":26,"text":1507,"url":26,"identifiers":1508},"Nakashima, 1999, Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300, Science, 284, 479, 10.1126\u002Fscience.284.5413.479",{"doi":1509},"10.1126\u002Fscience.284.5413.479",{"id":26,"text":1511,"url":26,"identifiers":1512},"Wotton, 1999, A Smad transcriptional corepressor, Cell, 97, 29, 10.1016\u002FS0092-8674(00)80712-6",{"doi":1513},"10.1016\u002FS0092-8674(00)80712-6",{"id":26,"text":1515,"url":26,"identifiers":1516},"Nomura, 1999, Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor, Genes Dev., 13, 412, 10.1101\u002Fgad.13.4.412",{"doi":1517},"10.1101\u002Fgad.13.4.412",{"id":26,"text":1519,"url":26,"identifiers":1520},"Akiyoshi S, Inoue H, Hanai J-i, Kusanagi K, Nemoto N, Miyazono K, Kawabata M. c-Ski acts as a transcriptional co-repressor in TGF-β signaling through interaction with Smads. J Biol Chem 1999;274:35269–77",{"doi":1521},"10.1074\u002Fjbc.274.49.35269",{"id":26,"text":1523,"url":26,"identifiers":1524},"Luo, 1999, The Ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling, Genes Dev., 13, 2196, 10.1101\u002Fgad.13.17.2196",{"doi":1525},"10.1101\u002Fgad.13.17.2196",{"id":26,"text":1527,"url":26,"identifiers":1528},"Sun, 1999, Interaction of the Ski oncoprotein with Smad3 regulates TGF-β signaling, Mol. Cell, 4, 499, 10.1016\u002FS1097-2765(00)80201-4",{"doi":1529},"10.1016\u002FS1097-2765(00)80201-4",{"id":26,"text":1531,"url":26,"identifiers":1532},"Stroschein, 1999, Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein, Science, 286, 771, 10.1126\u002Fscience.286.5440.771",{"doi":1533},"10.1126\u002Fscience.286.5440.771",{"id":1535,"createTime":1536,"updateTime":1536,"relativeEntities":1537,"slug":1538,"properties":1539,"entityType":788,"verifyStatus":25,"verifyTime":1554,"verifyNote":790,"syncStatus":28,"languages":1555,"translateLanguages":26,"viewCount":36,"primaryUrl":1556,"fullTextUrl":26,"authors":1557,"publicationType":880,"publisherRelationship":1644,"citationCount":1674,"citationInfo":1675,"publishDate":1677,"publishYear":1678,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1679,"isForceReanalyzing":1290},"9a4eb98b-2cb6-418f-a7b2-543fe454bbc0","2024-09-25T06:13:17.778+00:00",[],"Dendritic-cells-and-cytokines-in-human-inflammatory-and-autoimmune-diseases",{"mag":1540,"keywords":1542,"pmc":1543,"openalex":1545,"abstract":1547,"title":1548,"pm":1550,"doi":1552},{"VOID":1541},"2078009629",{},{"VOID":1544},"2413068",{"VOID":1546},"W2078009629",{},{"EN":1549},"Dendritic cells and cytokines in human inflammatory and autoimmune diseases",{"VOID":1551},"18258476",{"VOID":1553},"10.1016\u002Fj.cytogfr.2007.10.004","2024-09-25T06:13:17.777+00:00",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610107001049",[1558,1589,1610,1627],{"id":1559,"sortIndex":36,"researcher":26,"roles":1560,"affiliations":1561,"properties":1582},"ebe0a088-345b-4396-bf12-bf2832c4d83b",[],[1562,1572],{"id":1563,"sortIndex":36,"affiliation":1564,"properties":26},"ea49f063-75bd-43c6-ad58-b26d1e6011d5",{"id":1565,"createTime":1566,"updateTime":1566,"relativeEntities":1567,"slug":1568,"properties":1569,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e897d5a3-356b-43ee-a57b-331f4414706c","2024-09-25T06:13:17.816+00:00",[],"CNRS-UMR-5164-33076-Bordeaux-France",{"title":1570},{"EN":1571},"CNRS-UMR 5164, 33076 Bordeaux, France",{"id":1573,"sortIndex":115,"affiliation":1574,"properties":26},"a3d7dde9-0f3a-4e22-a5c5-a0c32dbe1e5e",{"id":1575,"createTime":1576,"updateTime":1576,"relativeEntities":1577,"slug":1578,"properties":1579,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d0964d38-0e26-4d30-afb6-057601e2e26f","2024-09-25T06:13:17.827+00:00",[],"Universit%C3%A9-Bordeaux-2-33076-Bordeaux-France",{"title":1580},{"EN":1581},"Université Bordeaux 2, 33076 Bordeaux, France",{"openalex":1583,"orcid":1585,"title":1587},{"VOID":1584},"A5018396975",{"VOID":1586},"https:\u002F\u002Forcid.org\u002F0000-0002-5374-3639",{"EN":1588},"Patrick Blanco",{"id":1590,"sortIndex":115,"researcher":26,"roles":1591,"affiliations":1592,"properties":1603},"d06e8189-a377-480c-bc25-079ab5a8b0d6",[],[1593],{"id":1594,"sortIndex":36,"affiliation":1595,"properties":26},"8c409fe5-3dd0-44cc-ab9c-4b948e9d8d91",{"id":1596,"createTime":1597,"updateTime":1597,"relativeEntities":1598,"slug":1599,"properties":1600,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"97cfa33a-1171-4743-b66f-b34203450784","2024-09-25T06:13:17.853+00:00",[],"Baylor-Institute-for-Immunology-Research-and-Baylor-Research-Institute-Dallas-TX-USA",{"title":1601},{"EN":1602},"Baylor Institute for Immunology Research and Baylor Research Institute, Dallas, TX, USA",{"openalex":1604,"orcid":1606,"title":1608},{"VOID":1605},"A5039519155",{"VOID":1607},"https:\u002F\u002Forcid.org\u002F0000-0002-1600-6066",{"EN":1609},"Karolina Palucka",{"id":1611,"sortIndex":59,"researcher":26,"roles":1612,"affiliations":1613,"properties":1620},"48352c9b-f3b8-4c86-b70a-6f018405a873",[],[1614],{"id":1615,"sortIndex":36,"affiliation":1616,"properties":26},"958f82fe-7e3d-4661-a7b2-d0df888860cf",{"id":1596,"createTime":1597,"updateTime":1597,"relativeEntities":1617,"slug":1599,"properties":1618,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1619},{"EN":1602},{"openalex":1621,"orcid":1623,"title":1625},{"VOID":1622},"A5002962815",{"VOID":1624},"https:\u002F\u002Forcid.org\u002F0000-0003-3535-7221",{"EN":1626},"Jacques Banchereau",{"id":1628,"sortIndex":114,"researcher":26,"roles":1629,"affiliations":1630,"properties":1637},"e9ac73c7-d98f-4995-9d3e-1c58592389d5",[],[1631],{"id":1632,"sortIndex":36,"affiliation":1633,"properties":26},"738efe39-71c0-4a04-ab10-ee9e814b21c0",{"id":1596,"createTime":1597,"updateTime":1597,"relativeEntities":1634,"slug":1599,"properties":1635,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1636},{"EN":1602},{"openalex":1638,"orcid":1640,"title":1642},{"VOID":1639},"A5041412546",{"VOID":1641},"https:\u002F\u002Forcid.org\u002F0000-0002-8806-8426",{"EN":1643},"Virginia Pascual",{"url":26,"publisher":1645,"properties":1667},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1646,"slug":663,"properties":1647,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":1650,"manageAffiliations":1651,"indexDatabases":1652,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1648,"title":1649},{"VOID":666},{"EN":668},[],[],[1653,1660],{"id":747,"indexDatabase":1654,"url":762,"indexYears":26,"academicFieldIds":1659,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":1655,"label":1656,"description":1657,"key":758,"publicationTags":1658,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":1661,"url":738,"indexYears":739,"academicFieldIds":1666,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":1662,"label":1663,"description":1664,"key":735,"publicationTags":1665,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":1668,"pages":1670,"issue":1672},{"VOID":1669},"19",{"VOID":1671},"41-52",{"VOID":1673},"1",500,{"total":1674,"publishYear":26,"statisticByYear":1676},{"2012":241,"2013":240,"2014":242,"2015":238,"2016":234,"2017":287,"2018":244,"2019":396,"2020":159,"2021":252,"2022":168,"2023":255,"2024":234},"2008-02-01",2008,[],{"id":1681,"createTime":1682,"updateTime":1682,"relativeEntities":1683,"slug":1684,"properties":1685,"entityType":788,"verifyStatus":25,"verifyTime":1682,"verifyNote":790,"syncStatus":28,"languages":1698,"translateLanguages":26,"viewCount":36,"primaryUrl":1699,"fullTextUrl":26,"authors":1700,"publicationType":880,"publisherRelationship":1722,"citationCount":163,"citationInfo":1751,"publishDate":1753,"publishYear":1364,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1754,"isForceReanalyzing":1290},"0a1e01b8-b220-418b-84f5-1fdd0028dd91","2024-09-03T14:36:47.183+00:00",[],"Wnt-%CE%B2-catenin-signaling",{"mag":1686,"keywords":1688,"openalex":1689,"abstract":1691,"title":1692,"pm":1694,"doi":1696},{"VOID":1687},"1999112733",{},{"VOID":1690},"W1999112733",{},{"EN":1693},"Wnt\u002Fβ-catenin signaling",{"VOID":1695},"10959075",{"VOID":1697},"10.1016\u002Fs1359-6101(00)00011-3",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610100000113",[1701],{"id":1702,"sortIndex":36,"researcher":26,"roles":1703,"affiliations":1704,"properties":1715},"ef49e5ec-ab5e-4927-9239-5d74253b3aaf",[],[1705],{"id":1706,"sortIndex":36,"affiliation":1707,"properties":26},"44f647b2-b5ff-404c-83a0-f47151973591",{"id":1708,"createTime":1709,"updateTime":1709,"relativeEntities":1710,"slug":1711,"properties":1712,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5713834e-4e99-4931-ad65-897f3a510dc5","2024-09-03T14:36:47.197+00:00",[],"Laboratory-of-Molecular-and-Genetic-Information-Institute-for-Molecular-and-Cellular-Biosciences-The-University-of-Tokyo-1-1-1-Yayoi-Bunkyo-ku-113-0032-Tokyo-Japan-akiyama-imcbns-iam-u-tokyo-ac-jp",{"title":1713},{"EN":1714},"Laboratory of Molecular and Genetic Information, Institute for Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, 113-0032, Tokyo, Japan. akiyama@imcbns.iam.u-tokyo.ac.jp",{"openalex":1716,"orcid":1718,"title":1720},{"VOID":1717},"A5012769131",{"VOID":1719},"https:\u002F\u002Forcid.org\u002F0000-0002-2321-1412",{"EN":1721},"Takashi Akiyoshi",{"url":26,"publisher":1723,"properties":1745},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1724,"slug":663,"properties":1725,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":1728,"manageAffiliations":1729,"indexDatabases":1730,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1726,"title":1727},{"VOID":666},{"EN":668},[],[],[1731,1738],{"id":747,"indexDatabase":1732,"url":762,"indexYears":26,"academicFieldIds":1737,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":1733,"label":1734,"description":1735,"key":758,"publicationTags":1736,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":1739,"url":738,"indexYears":739,"academicFieldIds":1744,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":1740,"label":1741,"description":1742,"key":735,"publicationTags":1743,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":1746,"pages":1747,"issue":1749},{"VOID":1356},{"VOID":1748},"273-282",{"VOID":1750},"4",{"total":163,"publishYear":26,"statisticByYear":1752},{"2012":539,"2013":285,"2014":239,"2015":124,"2016":242,"2017":298,"2018":298,"2019":103,"2020":356,"2021":124,"2022":158,"2023":116,"2024":135},"2000-12-01",[1755,1759,1763,1767,1771,1775,1778,1782,1786,1790,1794,1798,1802,1806,1810,1814,1818,1822,1826,1830,1834,1838,1842,1846,1850,1854,1858,1862,1866,1870,1874,1878,1882,1886,1889,1893,1897,1901,1904,1908,1911,1915,1919,1923,1927,1931,1934,1938,1942,1946,1950,1953,1957,1961,1965,1969,1973,1977,1981,1985,1989,1993,1997,2001,2005,2009,2013,2017,2021,2025,2029,2033,2037,2041,2045,2049,2053,2057,2061,2065,2069,2073,2077,2081,2085,2089,2093,2097,2101,2105,2109,2113,2117,2121,2125,2129,2133,2137,2141,2145,2149,2153,2157,2161,2165,2169,2173,2177,2181],{"id":26,"text":1756,"url":26,"identifiers":1757},"Cadigan, 1997, Wnt signaling: a common theme in animal development, Genes Dev., 11, 3286, 10.1101\u002Fgad.11.24.3286",{"doi":1758},"10.1101\u002Fgad.11.24.3286",{"id":26,"text":1760,"url":26,"identifiers":1761},"Miller, 1996, Signal transduction through beta-catenin and specification of cell fate during embryogenesis, Genes Dev., 10, 2527, 10.1101\u002Fgad.10.20.2527",{"doi":1762},"10.1101\u002Fgad.10.20.2527",{"id":26,"text":1764,"url":26,"identifiers":1765},"Klingensmith, 1994, Signaling by wingless in Drosophila, Dev. Biol., 166, 396, 10.1006\u002Fdbio.1994.1325",{"doi":1766},"10.1006\u002Fdbio.1994.1325",{"id":26,"text":1768,"url":26,"identifiers":1769},"Gumbiner, 1995, Signal transduction of beta-catenin, Curr. Opin. Cell Biol., 7, 634, 10.1016\u002F0955-0674(95)80104-9",{"doi":1770},"10.1016\u002F0955-0674(95)80104-9",{"id":26,"text":1772,"url":26,"identifiers":1773},"Nusse, 1992, Wnt genes, Cell, 69, 1073, 10.1016\u002F0092-8674(92)90630-U",{"doi":1774},"10.1016\u002F0092-8674(92)90630-U",{"id":26,"text":1776,"url":26,"identifiers":1777},"Polakis, 1997, The adenomatous polyposis coli (APC) tumor suppressor, Biochim. Biophys. Acta., 1332, F127",{},{"id":26,"text":1779,"url":26,"identifiers":1780},"Tsukamoto, 1988, Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice, Cell, 55, 619, 10.1016\u002F0092-8674(88)90220-6",{"doi":1781},"10.1016\u002F0092-8674(88)90220-6",{"id":26,"text":1783,"url":26,"identifiers":1784},"Donehower, 1995, Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability, Genes Dev., 9, 882, 10.1101\u002Fgad.9.7.882",{"doi":1785},"10.1101\u002Fgad.9.7.882",{"id":26,"text":1787,"url":26,"identifiers":1788},"Dickinson, 1992, The role of Wnt genes in vertebrate development, Curr. Opin. Genet. Dev., 2, 562, 10.1016\u002FS0959-437X(05)80172-8",{"doi":1789},"10.1016\u002FS0959-437X(05)80172-8",{"id":26,"text":1791,"url":26,"identifiers":1792},"Dickinson, 1994, Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system, Development, 120, 1453, 10.1242\u002Fdev.120.6.1453",{"doi":1793},"10.1242\u002Fdev.120.6.1453",{"id":26,"text":1795,"url":26,"identifiers":1796},"Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016\u002FS0092-8674(00)81333-1",{"doi":1797},"10.1016\u002FS0092-8674(00)81333-1",{"id":26,"text":1799,"url":26,"identifiers":1800},"Bienz, 1999, APC: the plot thickens, Curr. Opin. Genet. Dev., 9, 595, 10.1016\u002FS0959-437X(99)00016-7",{"doi":1801},"10.1016\u002FS0959-437X(99)00016-7",{"id":26,"text":1803,"url":26,"identifiers":1804},"Behrens, 1996, Functional interaction of beta-catenin with the transcription factor LEF-1, Nature, 382, 638, 10.1038\u002F382638a0",{"doi":1805},"10.1038\u002F382638a0",{"id":26,"text":1807,"url":26,"identifiers":1808},"Molenaar, 1996, XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos, Cell, 86, 391, 10.1016\u002FS0092-8674(00)80112-9",{"doi":1809},"10.1016\u002FS0092-8674(00)80112-9",{"id":26,"text":1811,"url":26,"identifiers":1812},"Brunner, 1997, Pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila, Nature, 385, 829, 10.1038\u002F385829a0",{"doi":1813},"10.1038\u002F385829a0",{"id":26,"text":1815,"url":26,"identifiers":1816},"Riese, 1997, LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic, Cell, 88, 777, 10.1016\u002FS0092-8674(00)81924-8",{"doi":1817},"10.1016\u002FS0092-8674(00)81924-8",{"id":26,"text":1819,"url":26,"identifiers":1820},"van de Wetering, 1997, Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF, Cell, 88, 789, 10.1016\u002FS0092-8674(00)81925-X",{"doi":1821},"10.1016\u002FS0092-8674(00)81925-X",{"id":26,"text":1823,"url":26,"identifiers":1824},"Takeichi, 1991, Cadherin cell adhesion receptors as a morphogenetic regulator, Science, 251, 1451, 10.1126\u002Fscience.2006419",{"doi":1825},"10.1126\u002Fscience.2006419",{"id":26,"text":1827,"url":26,"identifiers":1828},"Aberle, 1996, Single amino acid substitutions in proteins of the armadillo gene family abolish their binding to alpha-catenin, J. Biol. Chem., 271, 1520, 10.1074\u002Fjbc.271.3.1520",{"doi":1829},"10.1074\u002Fjbc.271.3.1520",{"id":26,"text":1831,"url":26,"identifiers":1832},"Redies, 1996, Cadherins in the developing central nervous system: an adhesive code for segmental and functional subdivisions, Dev. Biol., 180, 413, 10.1006\u002Fdbio.1996.0315",{"doi":1833},"10.1006\u002Fdbio.1996.0315",{"id":26,"text":1835,"url":26,"identifiers":1836},"Tao, 1996, Beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex, J. Cell Biol., 134, 1271, 10.1083\u002Fjcb.134.5.1271",{"doi":1837},"10.1083\u002Fjcb.134.5.1271",{"id":26,"text":1839,"url":26,"identifiers":1840},"Nishimura, 1999, Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex, Nat. Med., 5, 164, 10.1038\u002F5526",{"doi":1841},"10.1038\u002F5526",{"id":26,"text":1843,"url":26,"identifiers":1844},"Levesque, 1999, Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin, J. Neurochem., 72, 999, 10.1046\u002Fj.1471-4159.1999.0720999.x",{"doi":1845},"10.1046\u002Fj.1471-4159.1999.0720999.x",{"id":26,"text":1847,"url":26,"identifiers":1848},"Haegel, 1995, Lack of beta-catenin affects mouse development at gastrulation, Development, 121, 3529, 10.1242\u002Fdev.121.11.3529",{"doi":1849},"10.1242\u002Fdev.121.11.3529",{"id":26,"text":1851,"url":26,"identifiers":1852},"Huelsken, 2000, Requirement for beta-catenin in anterior–posterior axis formation in mice, J. Cell Biol., 148, 567, 10.1083\u002Fjcb.148.3.567",{"doi":1853},"10.1083\u002Fjcb.148.3.567",{"id":26,"text":1855,"url":26,"identifiers":1856},"Huber, 1997, Three-dimensional structure of the armadillo repeat region of beta-catenin, Cell, 90, 871, 10.1016\u002FS0092-8674(00)80352-9",{"doi":1857},"10.1016\u002FS0092-8674(00)80352-9",{"id":26,"text":1859,"url":26,"identifiers":1860},"Rubinfeld, 1993, Association of the APC gene product with beta-catenin, Science, 262, 1731, 10.1126\u002Fscience.8259518",{"doi":1861},"10.1126\u002Fscience.8259518",{"id":26,"text":1863,"url":26,"identifiers":1864},"Rubinfeld, 1995, The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin, J. Biol. Chem., 270, 5549, 10.1074\u002Fjbc.270.10.5549",{"doi":1865},"10.1074\u002Fjbc.270.10.5549",{"id":26,"text":1867,"url":26,"identifiers":1868},"Orsulic, 1996, An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling, J. Cell Biol., 134, 1283, 10.1083\u002Fjcb.134.5.1283",{"doi":1869},"10.1083\u002Fjcb.134.5.1283",{"id":26,"text":1871,"url":26,"identifiers":1872},"Pai, 1996, Drosophila alpha-catenin and E-cadherin bind to distinct regions of Drosophila Armadillo, J. Biol. Chem., 271, 32,411, 10.1074\u002Fjbc.271.50.32411",{"doi":1873},"10.1074\u002Fjbc.271.50.32411",{"id":26,"text":1875,"url":26,"identifiers":1876},"Baeg, 1995, The tumour suppressor gene product APC blocks cell cycle progression from G0\u002FG1 to S phase, Embo. J., 14, 5618, 10.1002\u002Fj.1460-2075.1995.tb00249.x",{"doi":1877},"10.1002\u002Fj.1460-2075.1995.tb00249.x",{"id":26,"text":1879,"url":26,"identifiers":1880},"Morin, 1996, Apoptosis and APC in colorectal tumorigenesis, Proc. Natl. Acad. Sci. USA, 93, 7950, 10.1073\u002Fpnas.93.15.7950",{"doi":1881},"10.1073\u002Fpnas.93.15.7950",{"id":26,"text":1883,"url":26,"identifiers":1884},"Smith, 1993, The APC gene product in normal and tumor cells, Proc. Natl. Acad. Sci. USA, 90, 2846, 10.1073\u002Fpnas.90.7.2846",{"doi":1885},"10.1073\u002Fpnas.90.7.2846",{"id":26,"text":1887,"url":26,"identifiers":1888},"Miyashiro, 1995, Subcellular localization of the APC protein: immunoelectron microscopic study of the association of the APC protein with catenin, Oncogene, 11, 89",{},{"id":26,"text":1890,"url":26,"identifiers":1891},"Nathke, 1996, The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration, J. Cell Biol., 134, 165, 10.1083\u002Fjcb.134.1.165",{"doi":1892},"10.1083\u002Fjcb.134.1.165",{"id":26,"text":1894,"url":26,"identifiers":1895},"Senda, 1996, The tumor suppressor protein APC colocalizes with beta-catenin in the colon epithelial cells, Biochem. Biophys. Res. Commun., 223, 329, 10.1006\u002Fbbrc.1996.0894",{"doi":1896},"10.1006\u002Fbbrc.1996.0894",{"id":26,"text":1898,"url":26,"identifiers":1899},"Su, 1993, Association of the APC tumor suppressor protein with catenins, Science, 262, 1734, 10.1126\u002Fscience.8259519",{"doi":1900},"10.1126\u002Fscience.8259519",{"id":26,"text":1902,"url":26,"identifiers":1903},"Su, 1995, APC binds to the novel protein EB1, Cancer Res., 55, 2972",{},{"id":26,"text":1905,"url":26,"identifiers":1906},"Matsumine, 1996, Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein, Science, 272, 1020, 10.1126\u002Fscience.272.5264.1020",{"doi":1907},"10.1126\u002Fscience.272.5264.1020",{"id":26,"text":1909,"url":26,"identifiers":1910},"Rubinfeld, 1997, Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene, Cancer Res., 57, 4624",{},{"id":26,"text":1912,"url":26,"identifiers":1913},"Korinek, 1997, Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−\u002F− colon carcinoma, Science, 275, 1784, 10.1126\u002Fscience.275.5307.1784",{"doi":1914},"10.1126\u002Fscience.275.5307.1784",{"id":26,"text":1916,"url":26,"identifiers":1917},"Morin, 1997, Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC, Science, 275, 1787, 10.1126\u002Fscience.275.5307.1787",{"doi":1918},"10.1126\u002Fscience.275.5307.1787",{"id":26,"text":1920,"url":26,"identifiers":1921},"Rubinfeld, 1997, Stabilization of beta-catenin by genetic defects in melanoma cell lines, Science, 275, 1790, 10.1126\u002Fscience.275.5307.1790",{"doi":1922},"10.1126\u002Fscience.275.5307.1790",{"id":26,"text":1924,"url":26,"identifiers":1925},"Polakis, 1999, The oncogenic activation of beta-catenin, Curr. Opin. Genet. Dev., 9, 15, 10.1016\u002FS0959-437X(99)80003-3",{"doi":1926},"10.1016\u002FS0959-437X(99)80003-3",{"id":26,"text":1928,"url":26,"identifiers":1929},"Morin, 1999, Beta-catenin signaling and cancer, Bioessays, 21, 1021, 10.1002\u002F(SICI)1521-1878(199912)22:1\u003C1021::AID-BIES6>3.0.CO;2-P",{"doi":1930},"10.1002\u002F(SICI)1521-1878(199912)22:1\u003C1021::AID-BIES6>3.0.CO;2-P",{"id":26,"text":1932,"url":26,"identifiers":1933},"Romagnolo, 1999, Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin, Cancer Res., 59, 3875",{},{"id":26,"text":1935,"url":26,"identifiers":1936},"Harada, 1999, Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene, Embo. J., 18, 5931, 10.1093\u002Femboj\u002F18.21.5931",{"doi":1937},"10.1093\u002Femboj\u002F18.21.5931",{"id":26,"text":1939,"url":26,"identifiers":1940},"Wong, 1998, Effects of forced expression of an NH2-terminal truncated Beta-catenin on mouse intestinal epithelial homeostasis, J. Cell Biol., 141, 765, 10.1083\u002Fjcb.141.3.765",{"doi":1941},"10.1083\u002Fjcb.141.3.765",{"id":26,"text":1943,"url":26,"identifiers":1944},"Gat, 1998, De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin, Cell, 95, 605, 10.1016\u002FS0092-8674(00)81631-1",{"doi":1945},"10.1016\u002FS0092-8674(00)81631-1",{"id":26,"text":1947,"url":26,"identifiers":1948},"Chan, 1999, A common human skin tumour is caused by activating mutations in beta-catenin, Nat. Genet., 21, 410, 10.1038\u002F7747",{"doi":1949},"10.1038\u002F7747",{"id":26,"text":1951,"url":26,"identifiers":1952},"Nakagawa, 1998, Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin, Cancer Res., 58, 5176",{},{"id":26,"text":1954,"url":26,"identifiers":1955},"van Es, 1999, Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor, Curr. Biol., 9, 105, 10.1016\u002FS0960-9822(99)80024-4",{"doi":1956},"10.1016\u002FS0960-9822(99)80024-4",{"id":26,"text":1958,"url":26,"identifiers":1959},"Vleminckx, 1997, Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an ectopic dorsoanterior axis, J. Cell Biol., 136, 411, 10.1083\u002Fjcb.136.2.411",{"doi":1960},"10.1083\u002Fjcb.136.2.411",{"id":26,"text":1962,"url":26,"identifiers":1963},"Hayashi, 1997, A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo, Proc. Natl. Acad. Sci. USA, 94, 242, 10.1073\u002Fpnas.94.1.242",{"doi":1964},"10.1073\u002Fpnas.94.1.242",{"id":26,"text":1966,"url":26,"identifiers":1967},"Rocheleau, 1997, Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos, Cell, 90, 707, 10.1016\u002FS0092-8674(00)80531-0",{"doi":1968},"10.1016\u002FS0092-8674(00)80531-0",{"id":26,"text":1970,"url":26,"identifiers":1971},"Hamada, 1999, Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin, Science, 283, 1739, 10.1126\u002Fscience.283.5408.1739",{"doi":1972},"10.1126\u002Fscience.283.5408.1739",{"id":26,"text":1974,"url":26,"identifiers":1975},"Ahmed, 1998, Regulation of armadillo by a Drosophila APC inhibits neuronal apoptosis during retinal development, Cell, 93, 1171, 10.1016\u002FS0092-8674(00)81461-0",{"doi":1976},"10.1016\u002FS0092-8674(00)81461-0",{"id":26,"text":1978,"url":26,"identifiers":1979},"McCartney, 1999, Drosophila APC2 is a cytoskeletally-associated protein that regulates wingless signaling in the embryonic epidermis, J. Cell Biol., 146, 1303, 10.1083\u002Fjcb.146.6.1303",{"doi":1980},"10.1083\u002Fjcb.146.6.1303",{"id":26,"text":1982,"url":26,"identifiers":1983},"Yu, 1999, A new Drosophila APC homologue associated with adhesive zones of epithelial cells, Nat. Cell Biol., 1, 144, 10.1038\u002F11064",{"doi":1984},"10.1038\u002F11064",{"id":26,"text":1986,"url":26,"identifiers":1987},"Jacobs-Cohen, 1984, Knobbly, a new dominant mutation in the mouse that affects embryonic ectoderm organization, Genet. Res., 43, 43, 10.1017\u002FS0016672300025702",{"doi":1988},"10.1017\u002FS0016672300025702",{"id":26,"text":1990,"url":26,"identifiers":1991},"Perry, 1995, Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus, Genetics, 141, 321, 10.1093\u002Fgenetics\u002F141.1.321",{"doi":1992},"10.1093\u002Fgenetics\u002F141.1.321",{"id":26,"text":1994,"url":26,"identifiers":1995},"Zeng, 1997, The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation, Cell, 90, 181, 10.1016\u002FS0092-8674(00)80324-4",{"doi":1996},"10.1016\u002FS0092-8674(00)80324-4",{"id":26,"text":1998,"url":26,"identifiers":1999},"Hart, 1998, Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta, Curr. Biol., 8, 573, 10.1016\u002FS0960-9822(98)70226-X",{"doi":2000},"10.1016\u002FS0960-9822(98)70226-X",{"id":26,"text":2002,"url":26,"identifiers":2003},"Ikeda, 1998, Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections, J. Histochem. Cytochem., 46, 397, 10.1177\u002F002215549804600314",{"doi":2004},"10.1177\u002F002215549804600314",{"id":26,"text":2006,"url":26,"identifiers":2007},"Itoh, 1998, Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin, Curr. Biol., 8, 591, 10.1016\u002FS0960-9822(98)70229-5",{"doi":2008},"10.1016\u002FS0960-9822(98)70229-5",{"id":26,"text":2010,"url":26,"identifiers":2011},"Kishida, 1998, Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin, J. Biol. Chem., 273, 10,823, 10.1074\u002Fjbc.273.18.10823",{"doi":2012},"10.1074\u002Fjbc.273.18.10823",{"id":26,"text":2014,"url":26,"identifiers":2015},"Nakamura, 1998, Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level, Genes Cells, 3, 395, 10.1046\u002Fj.1365-2443.1998.00198.x",{"doi":2016},"10.1046\u002Fj.1365-2443.1998.00198.x",{"id":26,"text":2018,"url":26,"identifiers":2019},"Sakanaka, 1998, Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription, Proc. Natl. Acad. Sci. USA, 95, 3020, 10.1073\u002Fpnas.95.6.3020",{"doi":2020},"10.1073\u002Fpnas.95.6.3020",{"id":26,"text":2022,"url":26,"identifiers":2023},"Behrens, 1998, Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta, Science, 280, 596, 10.1126\u002Fscience.280.5363.596",{"doi":2024},"10.1126\u002Fscience.280.5363.596",{"id":26,"text":2026,"url":26,"identifiers":2027},"Yamamoto, 1998, Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos, Mol. Cell Biol., 18, 2867, 10.1128\u002FMCB.18.5.2867",{"doi":2028},"10.1128\u002FMCB.18.5.2867",{"id":26,"text":2030,"url":26,"identifiers":2031},"Willert, 1999, A Drosophila Axin homolog, Daxin, inhibits Wnt signaling, Development, 126, 4165, 10.1242\u002Fdev.126.18.4165",{"doi":2032},"10.1242\u002Fdev.126.18.4165",{"id":26,"text":2034,"url":26,"identifiers":2035},"Sakanaka, 1999, Functional domains of axin. Importance of the C terminus as an oligomerization domain, J. Biol. Chem., 274, 14,090, 10.1074\u002Fjbc.274.20.14090",{"doi":2036},"10.1074\u002Fjbc.274.20.14090",{"id":26,"text":2038,"url":26,"identifiers":2039},"Hsu, 1999, Identification of a domain of Axin that binds to the serine\u002Fthreonine protein phosphatase 2A and a self-binding domain, J. Biol. Chem., 274, 3439, 10.1074\u002Fjbc.274.6.3439",{"doi":2040},"10.1074\u002Fjbc.274.6.3439",{"id":26,"text":2042,"url":26,"identifiers":2043},"Willert, 1999, Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex, Genes Dev., 13, 1768, 10.1101\u002Fgad.13.14.1768",{"doi":2044},"10.1101\u002Fgad.13.14.1768",{"id":26,"text":2046,"url":26,"identifiers":2047},"Yamamoto, 1999, Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability, J. Biol. Chem., 274, 10,681, 10.1074\u002Fjbc.274.16.10681",{"doi":2048},"10.1074\u002Fjbc.274.16.10681",{"id":26,"text":2050,"url":26,"identifiers":2051},"Kishida, 1999, DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability, Mol. Cell Biol., 19, 4414, 10.1128\u002FMCB.19.6.4414",{"doi":2052},"10.1128\u002FMCB.19.6.4414",{"id":26,"text":2054,"url":26,"identifiers":2055},"Li, 1999, Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1, Embo. J., 18, 4233, 10.1093\u002Femboj\u002F18.15.4233",{"doi":2056},"10.1093\u002Femboj\u002F18.15.4233",{"id":26,"text":2058,"url":26,"identifiers":2059},"Yost, 1998, GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis, Cell, 93, 1031, 10.1016\u002FS0092-8674(00)81208-8",{"doi":2060},"10.1016\u002FS0092-8674(00)81208-8",{"id":26,"text":2062,"url":26,"identifiers":2063},"Kawahara K, Morishita T, Nakamura T, Hamada F, Toyoshima K, Akiyama T. Down-regulation of β-catenin by the colorectal tumor supressor APC requires association with Axin and β-catenin. J Biol Chem 2000;275:8369–74",{"doi":2064},"10.1074\u002Fjbc.275.12.8369",{"id":26,"text":2066,"url":26,"identifiers":2067},"Seeling, 1999, Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A, Science, 283, 2089, 10.1126\u002Fscience.283.5410.2089",{"doi":2068},"10.1126\u002Fscience.283.5410.2089",{"id":26,"text":2070,"url":26,"identifiers":2071},"Aberle, 1997, Beta-catenin is a target for the ubiquitin-proteasome pathway, Embo. J., 16, 3797, 10.1093\u002Femboj\u002F16.13.3797",{"doi":2072},"10.1093\u002Femboj\u002F16.13.3797",{"id":26,"text":2074,"url":26,"identifiers":2075},"Yost, 1996, The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3, Genes Dev., 10, 1443, 10.1101\u002Fgad.10.12.1443",{"doi":2076},"10.1101\u002Fgad.10.12.1443",{"id":26,"text":2078,"url":26,"identifiers":2079},"Zecca, 1996, Direct and long-range action of a wingless morphogen gradient, Cell, 87, 833, 10.1016\u002FS0092-8674(00)81991-1",{"doi":2080},"10.1016\u002FS0092-8674(00)81991-1",{"id":26,"text":2082,"url":26,"identifiers":2083},"Munemitsu, 1996, Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein, Mol. Cell Biol., 16, 4088, 10.1128\u002FMCB.16.8.4088",{"doi":2084},"10.1128\u002FMCB.16.8.4088",{"id":26,"text":2086,"url":26,"identifiers":2087},"Pai, 1997, Negative regulation of Armadillo, a Wingless effector in Drosophila, Development, 124, 2255, 10.1242\u002Fdev.124.11.2255",{"doi":2088},"10.1242\u002Fdev.124.11.2255",{"id":26,"text":2090,"url":26,"identifiers":2091},"Jiang, 1998, Regulation of the Hedgehog and Wingless signalling pathways by the F-box\u002FWD40-repeat protein Slimb, Nature, 391, 493, 10.1038\u002F35154",{"doi":2092},"10.1038\u002F35154",{"id":26,"text":2094,"url":26,"identifiers":2095},"Hart, 1999, The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell, Curr. Biol., 9, 207, 10.1016\u002FS0960-9822(99)80091-8",{"doi":2096},"10.1016\u002FS0960-9822(99)80091-8",{"id":26,"text":2098,"url":26,"identifiers":2099},"Kitagawa, 1999, An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin, Embo. J., 18, 2401, 10.1093\u002Femboj\u002F18.9.2401",{"doi":2100},"10.1093\u002Femboj\u002F18.9.2401",{"id":26,"text":2102,"url":26,"identifiers":2103},"Fuchs, 1999, HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin, Oncogene, 18, 2039, 10.1038\u002Fsj.onc.1202760",{"doi":2104},"10.1038\u002Fsj.onc.1202760",{"id":26,"text":2106,"url":26,"identifiers":2107},"Margottin, 1998, A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif, Mol. Cell, 1, 565, 10.1016\u002FS1097-2765(00)80056-8",{"doi":2108},"10.1016\u002FS1097-2765(00)80056-8",{"id":26,"text":2110,"url":26,"identifiers":2111},"Travis, 1991, LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function, Genes Dev., 5, 880, 10.1101\u002Fgad.5.5.880",{"doi":2112},"10.1101\u002Fgad.5.5.880",{"id":26,"text":2114,"url":26,"identifiers":2115},"Waterman, 1991, A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer, Genes Dev., 5, 656, 10.1101\u002Fgad.5.4.656",{"doi":2116},"10.1101\u002Fgad.5.4.656",{"id":26,"text":2118,"url":26,"identifiers":2119},"van de Wetering, 1991, Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box, Embo. J., 10, 123, 10.1002\u002Fj.1460-2075.1991.tb07928.x",{"doi":2120},"10.1002\u002Fj.1460-2075.1991.tb07928.x",{"id":26,"text":2122,"url":26,"identifiers":2123},"Giese, 1992, The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures, Cell, 69, 185, 10.1016\u002F0092-8674(92)90129-Z",{"doi":2124},"10.1016\u002F0092-8674(92)90129-Z",{"id":26,"text":2126,"url":26,"identifiers":2127},"Verbeek, 1995, An HMG-box-containing T-cell factor required for thymocyte differentiation, Nature, 374, 70, 10.1038\u002F374070a0",{"doi":2128},"10.1038\u002F374070a0",{"id":26,"text":2130,"url":26,"identifiers":2131},"Schilham, 1998, Critical involvement of Tcf-1 in expansion of thymocytes, J. Immunol., 161, 3984, 10.4049\u002Fjimmunol.161.8.3984",{"doi":2132},"10.4049\u002Fjimmunol.161.8.3984",{"id":26,"text":2134,"url":26,"identifiers":2135},"Roose, 1999, Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1, Science, 285, 1923, 10.1126\u002Fscience.285.5435.1923",{"doi":2136},"10.1126\u002Fscience.285.5435.1923",{"id":26,"text":2138,"url":26,"identifiers":2139},"Korinek, 1998, Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4, Nat. Genet., 19, 379, 10.1038\u002F1270",{"doi":2140},"10.1038\u002F1270",{"id":26,"text":2142,"url":26,"identifiers":2143},"Galceran, 1999, Wnt3a−\u002F−-like phenotype and limb deficiency in Lef1(−\u002F−)Tcf1(−\u002F−) mice, Genes Dev., 13, 709, 10.1101\u002Fgad.13.6.709",{"doi":2144},"10.1101\u002Fgad.13.6.709",{"id":26,"text":2146,"url":26,"identifiers":2147},"Cavallo, 1998, Drosophila Tcf and Groucho interact to repress Wingless signalling activity, Nature, 395, 604, 10.1038\u002F26982",{"doi":2148},"10.1038\u002F26982",{"id":26,"text":2150,"url":26,"identifiers":2151},"Roose, 1998, The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors, Nature, 395, 608, 10.1038\u002F26989",{"doi":2152},"10.1038\u002F26989",{"id":26,"text":2154,"url":26,"identifiers":2155},"Waltzer, 1998, Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling, Nature, 395, 521, 10.1038\u002F26785",{"doi":2156},"10.1038\u002F26785",{"id":26,"text":2158,"url":26,"identifiers":2159},"Ishitani, 1999, The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF, Nature, 399, 798, 10.1038\u002F21674",{"doi":2160},"10.1038\u002F21674",{"id":26,"text":2162,"url":26,"identifiers":2163},"Meneghini, 1999, MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans, Nature, 399, 793, 10.1038\u002F21666",{"doi":2164},"10.1038\u002F21666",{"id":26,"text":2166,"url":26,"identifiers":2167},"Brannon, 1997, A beta-catenin\u002FXTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus, Genes Dev., 11, 2359, 10.1101\u002Fgad.11.18.2359",{"doi":2168},"10.1101\u002Fgad.11.18.2359",{"id":26,"text":2170,"url":26,"identifiers":2171},"Laurent, 1997, The Xenopus homeobox gene twin mediates Wnt induction of goosecoid in establishment of Spemann’s organizer, Development, 124, 4905, 10.1242\u002Fdev.124.23.4905",{"doi":2172},"10.1242\u002Fdev.124.23.4905",{"id":26,"text":2174,"url":26,"identifiers":2175},"McKendry, 1997, LEF-1\u002FTCF proteins mediate wnt-inducible transcription from the Xenopus nodal-related 3 promoter, Dev. Biol., 192, 420, 10.1006\u002Fdbio.1997.8797",{"doi":2176},"10.1006\u002Fdbio.1997.8797",{"id":26,"text":2178,"url":26,"identifiers":2179},"Tetsu, 1999, Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells, Nature, 398, 422, 10.1038\u002F18884",{"doi":2180},"10.1038\u002F18884",{"id":26,"text":2182,"url":26,"identifiers":2183},"He, 1998, Identification of c-MYC as a target of the APC pathway, Science, 281, 1509, 10.1126\u002Fscience.281.5382.1509",{"doi":2184},"10.1126\u002Fscience.281.5382.1509",{"id":2186,"createTime":2187,"updateTime":2187,"relativeEntities":2188,"slug":2189,"properties":2190,"entityType":788,"verifyStatus":25,"verifyTime":2187,"verifyNote":790,"syncStatus":28,"languages":2203,"translateLanguages":26,"viewCount":36,"primaryUrl":2204,"fullTextUrl":26,"authors":2205,"publicationType":880,"publisherRelationship":2242,"citationCount":2272,"citationInfo":2273,"publishDate":2275,"publishYear":2276,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2277,"isForceReanalyzing":1290},"f9eba00a-a539-4c59-a94e-b55ae7e89055","2024-09-30T22:38:17.886+00:00",[],"Fibroblast-growth-factor-signaling-in-tumorigenesis",{"mag":2191,"keywords":2193,"openalex":2194,"abstract":2196,"title":2197,"pm":2199,"doi":2201},{"VOID":2192},"2081855695",{},{"VOID":2195},"W2081855695",{},{"EN":2198},"Fibroblast growth factor signaling in tumorigenesis",{"VOID":2200},"15863033",{"VOID":2202},"10.1016\u002Fj.cytogfr.2005.01.003",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610105000043",[2206,2225],{"id":2207,"sortIndex":115,"researcher":26,"roles":2208,"affiliations":2209,"properties":2220},"3ddb6fd1-380a-4355-a412-53f090801efd",[],[2210],{"id":2211,"sortIndex":36,"affiliation":2212,"properties":26},"18d15fef-ee50-4db5-a3ea-05d388e528b0",{"id":2213,"createTime":2214,"updateTime":2214,"relativeEntities":2215,"slug":2216,"properties":2217,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7001702b-2bda-40e3-b965-6618db6cecaf","2024-09-30T22:38:17.911+00:00",[],"Cancer-Research-UK-London-Research-Institute-Viral-Carcinogenesis-Laboratory-214-61-Lincoln-s-Inn-Fields-London-WC2A-3PX-UK-",{"title":2218},{"EN":2219},"Cancer Research UK London Research Institute, Viral Carcinogenesis, Laboratory 214, 61 Lincoln's Inn Fields, London WC2A 3PX, UK.",{"openalex":2221,"title":2223},{"VOID":2222},"A5037675485",{"EN":2224},"Clive Dickson",{"id":2226,"sortIndex":36,"researcher":26,"roles":2227,"affiliations":2228,"properties":2235},"b879fb7d-ec29-4afb-b126-972f90e6fcf4",[],[2229],{"id":2230,"sortIndex":36,"affiliation":2231,"properties":26},"efb4a247-ea92-4bd0-a1b1-26817cdd79da",{"id":2213,"createTime":2214,"updateTime":2214,"relativeEntities":2232,"slug":2216,"properties":2233,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2234},{"EN":2219},{"openalex":2236,"orcid":2238,"title":2240},{"VOID":2237},"A5047857642",{"VOID":2239},"https:\u002F\u002Forcid.org\u002F0000-0002-4738-0173",{"EN":2241},"Richard Grose",{"url":26,"publisher":2243,"properties":2265},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2244,"slug":663,"properties":2245,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":2248,"manageAffiliations":2249,"indexDatabases":2250,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":2246,"title":2247},{"VOID":666},{"EN":668},[],[],[2251,2258],{"id":747,"indexDatabase":2252,"url":762,"indexYears":26,"academicFieldIds":2257,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":2253,"label":2254,"description":2255,"key":758,"publicationTags":2256,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":2259,"url":738,"indexYears":739,"academicFieldIds":2264,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":2260,"label":2261,"description":2262,"key":735,"publicationTags":2263,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":2266,"pages":2268,"issue":2270},{"VOID":2267},"16",{"VOID":2269},"179-186",{"VOID":2271},"2",395,{"total":2272,"publishYear":26,"statisticByYear":2274},{"2012":238,"2013":238,"2014":234,"2015":238,"2016":260,"2017":298,"2018":356,"2019":51,"2020":298,"2021":53,"2022":124,"2023":51,"2024":162},"2005-04-01",2005,[2278,2282,2286,2290,2294,2298,2302,2306,2310,2314,2318,2322,2326,2330,2334,2338,2342,2346,2350,2354,2358,2362,2366,2370,2373,2377,2381,2385,2389,2393,2397,2401,2404,2408,2412,2415,2419,2423,2427,2431,2435,2439,2443,2447,2451,2454,2458,2461,2465,2469,2473,2477,2481,2485,2489,2493,2497,2501,2505,2509,2513,2517],{"id":26,"text":2279,"url":26,"identifiers":2280},"Ornitz, 2001, Fibroblast growth factors, Genome Biol, 2, 3005, 10.1186\u002Fgb-2001-2-3-reviews3005",{"doi":2281},"10.1186\u002Fgb-2001-2-3-reviews3005",{"id":26,"text":2283,"url":26,"identifiers":2284},"McKeehan, 1998, The heparan–sulfate fibroblast growth-factor family—diversity of structure and function, Prog Nucleic Acid Res Mol Biol, 59, 135, 10.1016\u002FS0079-6603(08)61031-4",{"doi":2285},"10.1016\u002FS0079-6603(08)61031-4",{"id":26,"text":2287,"url":26,"identifiers":2288},"Klint, 1999, Signal transduction by fibroblast growth factor receptors, Front Biosci, 4, 165, 10.2741\u002FKlint",{"doi":2289},"10.2741\u002FKlint",{"id":26,"text":2291,"url":26,"identifiers":2292},"Casci, 1999, Sprouty, an intracellular inhibitor of Ras signalling, Cell, 96, 655, 10.1016\u002FS0092-8674(00)80576-0",{"doi":2293},"10.1016\u002FS0092-8674(00)80576-0",{"id":26,"text":2295,"url":26,"identifiers":2296},"Hacohen, 1998, Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways, Cell, 92, 253, 10.1016\u002FS0092-8674(00)80919-8",{"doi":2297},"10.1016\u002FS0092-8674(00)80919-8",{"id":26,"text":2299,"url":26,"identifiers":2300},"Furthauer, 2002, Sef is a feedback-induced antagonist of Ras\u002FMAPK-mediated FGF signalling, Nat Cell Biol, 4, 170, 10.1038\u002Fncb750",{"doi":2301},"10.1038\u002Fncb750",{"id":26,"text":2303,"url":26,"identifiers":2304},"Tsang, 2002, Identification of Sef, a novel modulator of FGF signalling, Nat Cell Biol, 4, 165, 10.1038\u002Fncb749",{"doi":2305},"10.1038\u002Fncb749",{"id":26,"text":2307,"url":26,"identifiers":2308},"Ciruna, 1997, Chimeric analysis of fibroblast growth-factor receptor-1 (FGFR1) function—a role for FGFR1 in morphogenetic movement through the primitive streak, Development, 124, 2829, 10.1242\u002Fdev.124.14.2829",{"doi":2309},"10.1242\u002Fdev.124.14.2829",{"id":26,"text":2311,"url":26,"identifiers":2312},"Deng, 1994, Murine FGFR-1 is required for early postimplantation growth and axial organization, Genes Dev, 8, 3045, 10.1101\u002Fgad.8.24.3045",{"doi":2313},"10.1101\u002Fgad.8.24.3045",{"id":26,"text":2315,"url":26,"identifiers":2316},"Ciruna, 2001, FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak, Dev Cell, 1, 37, 10.1016\u002FS1534-5807(01)00017-X",{"doi":2317},"10.1016\u002FS1534-5807(01)00017-X",{"id":26,"text":2319,"url":26,"identifiers":2320},"Yamaguchi, 1994, FGFR-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation, Genes Dev, 8, 3032, 10.1101\u002Fgad.8.24.3032",{"doi":2321},"10.1101\u002Fgad.8.24.3032",{"id":26,"text":2323,"url":26,"identifiers":2324},"Beiman, 1996, Heartless a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages, Genes Dev, 10, 2993, 10.1101\u002Fgad.10.23.2993",{"doi":2325},"10.1101\u002Fgad.10.23.2993",{"id":26,"text":2327,"url":26,"identifiers":2328},"Gisselbrecht, 1996, Heartless encodes a fibroblast growth factor receptor (DFR1\u002FDFGF-R2) involved in the directional migration of early mesodermal cells in the Drosophila embryo, Genes Dev, 10, 3003, 10.1101\u002Fgad.10.23.3003",{"doi":2329},"10.1101\u002Fgad.10.23.3003",{"id":26,"text":2331,"url":26,"identifiers":2332},"De Moerlooze, 2000, An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal–epithelial signalling during mouse organogenesis, Development, 127, 483, 10.1242\u002Fdev.127.3.483",{"doi":2333},"10.1242\u002Fdev.127.3.483",{"id":26,"text":2335,"url":26,"identifiers":2336},"Petiot, 2003, A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning, Development, 130, 5493, 10.1242\u002Fdev.00788",{"doi":2337},"10.1242\u002Fdev.00788",{"id":26,"text":2339,"url":26,"identifiers":2340},"Revest, 2001, Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb, J Immunol, 167, 1954, 10.4049\u002Fjimmunol.167.4.1954",{"doi":2341},"10.4049\u002Fjimmunol.167.4.1954",{"id":26,"text":2343,"url":26,"identifiers":2344},"Yu, 2003, Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth, Development, 130, 3063, 10.1242\u002Fdev.00491",{"doi":2345},"10.1242\u002Fdev.00491",{"id":26,"text":2347,"url":26,"identifiers":2348},"Colvin, 1996, Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3, Nat Genet, 12, 390, 10.1038\u002Fng0496-390",{"doi":2349},"10.1038\u002Fng0496-390",{"id":26,"text":2351,"url":26,"identifiers":2352},"Werner, 1994, The function of KGF in morphogenesis of epithelium and reepithelialization of wounds, Science, 266, 819, 10.1126\u002Fscience.7973639",{"doi":2353},"10.1126\u002Fscience.7973639",{"id":26,"text":2355,"url":26,"identifiers":2356},"Jameson, 2002, A role for skin gammadelta T cells in wound repair, Science, 296, 747, 10.1126\u002Fscience.1069639",{"doi":2357},"10.1126\u002Fscience.1069639",{"id":26,"text":2359,"url":26,"identifiers":2360},"Werner, 1998, Keratinocyte growth factor: a unique player in epithelial repair processes, Cytokine Growth Factor Rev, 9, 153, 10.1016\u002FS1359-6101(98)00010-0",{"doi":2361},"10.1016\u002FS1359-6101(98)00010-0",{"id":26,"text":2363,"url":26,"identifiers":2364},"Meropol, 2003, Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant, J Clin Oncol, 21, 1452, 10.1200\u002FJCO.2003.10.079",{"doi":2365},"10.1200\u002FJCO.2003.10.079",{"id":26,"text":2367,"url":26,"identifiers":2368},"Callahan, 2000, MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways, Oncogene, 19, 992, 10.1038\u002Fsj.onc.1203276",{"doi":2369},"10.1038\u002Fsj.onc.1203276",{"id":26,"text":2371,"url":26,"identifiers":2372},"Katoh, 2002, WNT and FGF gene clusters (review), Int J Oncol, 21, 1269",{},{"id":26,"text":2374,"url":26,"identifiers":2375},"Dickson, 2000, Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors, Breast Cancer Res, 2, 191, 10.1186\u002Fbcr53",{"doi":2376},"10.1186\u002Fbcr53",{"id":26,"text":2378,"url":26,"identifiers":2379},"Peters, 1986, Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus, Nature, 320, 628, 10.1038\u002F320628a0",{"doi":2380},"10.1038\u002F320628a0",{"id":26,"text":2382,"url":26,"identifiers":2383},"van Leeuwen, 1995, Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer, Semin Cancer Biol, 6, 127, 10.1006\u002Fscbi.1995.0018",{"doi":2384},"10.1006\u002Fscbi.1995.0018",{"id":26,"text":2386,"url":26,"identifiers":2387},"Shackleford, 1993, Mouse mammary-tumor virus-infection accelerates mammary carcinogenesis in wnt-1 transgenic mice by insertional activation of int-2\u002Ffgf-3 and hst\u002Ffgf-4, Proc Natl Acad Sci USA, 90, 740, 10.1073\u002Fpnas.90.2.740",{"doi":2388},"10.1073\u002Fpnas.90.2.740",{"id":26,"text":2390,"url":26,"identifiers":2391},"Welm, 2002, Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland, J Cell Biol, 157, 703, 10.1083\u002Fjcb.200107119",{"doi":2392},"10.1083\u002Fjcb.200107119",{"id":26,"text":2394,"url":26,"identifiers":2395},"Cunha, 2003, Role of the stromal microenvironment in carcinogenesis of the prostate, Int J Cancer, 107, 1, 10.1002\u002Fijc.11335",{"doi":2396},"10.1002\u002Fijc.11335",{"id":26,"text":2398,"url":26,"identifiers":2399},"Yan, 1993, Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy, Mol Cell Biol, 13, 4513, 10.1128\u002FMCB.13.8.4513",{"doi":2400},"10.1128\u002FMCB.13.8.4513",{"id":26,"text":2402,"url":26,"identifiers":2403},"Feng, 1997, Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells, Cancer Res, 57, 5369",{},{"id":26,"text":2405,"url":26,"identifiers":2406},"Ornitz, 2002, FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease, Genes Dev, 16, 1446, 10.1101\u002Fgad.990702",{"doi":2407},"10.1101\u002Fgad.990702",{"id":26,"text":2409,"url":26,"identifiers":2410},"Kandel, 1991, Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma, Cell, 66, 1095, 10.1016\u002F0092-8674(91)90033-U",{"doi":2411},"10.1016\u002F0092-8674(91)90033-U",{"id":26,"text":2413,"url":26,"identifiers":2414},"Arbeit, 1996, Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice, Oncogene, 13, 1847",{},{"id":26,"text":2416,"url":26,"identifiers":2417},"Jouanneau, 1994, A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression, Proc Natl Acad Sci USA, 91, 286, 10.1073\u002Fpnas.91.1.286",{"doi":2418},"10.1073\u002Fpnas.91.1.286",{"id":26,"text":2420,"url":26,"identifiers":2421},"Jouanneau, 1997, FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo, Oncogene, 14, 671, 10.1038\u002Fsj.onc.1200883",{"doi":2422},"10.1038\u002Fsj.onc.1200883",{"id":26,"text":2424,"url":26,"identifiers":2425},"Okada-Ban, 1999, Nuclear 24kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells, Oncogene, 18, 6719, 10.1038\u002Fsj.onc.1203092",{"doi":2426},"10.1038\u002Fsj.onc.1203092",{"id":26,"text":2428,"url":26,"identifiers":2429},"Ricol, 1999, Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer, Oncogene, 18, 7234, 10.1038\u002Fsj.onc.1203186",{"doi":2430},"10.1038\u002Fsj.onc.1203186",{"id":26,"text":2432,"url":26,"identifiers":2433},"Diez de Medina, 1997, Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas, Oncogene, 14, 323, 10.1038\u002Fsj.onc.1200830",{"doi":2434},"10.1038\u002Fsj.onc.1200830",{"id":26,"text":2436,"url":26,"identifiers":2437},"Cappellen, 1997, Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder, Oncogene, 14, 3059, 10.1038\u002Fsj.onc.1201154",{"doi":2438},"10.1038\u002Fsj.onc.1201154",{"id":26,"text":2440,"url":26,"identifiers":2441},"Cappellen, 1999, Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas, Nat Genet, 23, 18, 10.1038\u002F12615",{"doi":2442},"10.1038\u002F12615",{"id":26,"text":2444,"url":26,"identifiers":2445},"Cross, 2002, Tyrosine kinase fusion genes in chronic myeloproliferative diseases, Leukemia, 16, 1207, 10.1038\u002Fsj.leu.2402556",{"doi":2446},"10.1038\u002Fsj.leu.2402556",{"id":26,"text":2448,"url":26,"identifiers":2449},"Munro, 2003, Fibroblast growth factors and their receptors in transitional cell carcinoma, J Urol, 169, 675, 10.1016\u002FS0022-5347(05)63991-2",{"doi":2450},"10.1016\u002FS0022-5347(05)63991-2",{"id":26,"text":2452,"url":26,"identifiers":2453},"Bakkar, 2003, FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder, Cancer Res, 63, 8108",{},{"id":26,"text":2455,"url":26,"identifiers":2456},"Karoui, 2001, No evidence of somatic FGFR3 mutation in various types of carcinoma, Oncogene, 20, 5059, 10.1038\u002Fsj.onc.1204651",{"doi":2457},"10.1038\u002Fsj.onc.1204651",{"id":26,"text":2459,"url":26,"identifiers":2460},"Jang, 2001, Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers, Cancer Res, 61, 3541",{},{"id":26,"text":2462,"url":26,"identifiers":2463},"van Rhijn, 2002, Frequent FGFR3 mutations in urothelial papilloma, J Pathol, 198, 245, 10.1002\u002Fpath.1202",{"doi":2464},"10.1002\u002Fpath.1202",{"id":26,"text":2466,"url":26,"identifiers":2467},"Trudel S, Ely S, Farooqi Y, Affer M, Robbiani DF, Chesi M, et al. Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma. Blood 2004;103(9):3521–8.",{"doi":2468},"10.1182\u002Fblood-2003-10-3650",{"id":26,"text":2470,"url":26,"identifiers":2471},"Reiter, 1998, Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome, Blood, 92, 1735, 10.1182\u002Fblood.V92.5.1735",{"doi":2472},"10.1182\u002Fblood.V92.5.1735",{"id":26,"text":2474,"url":26,"identifiers":2475},"Smedley, 1998, The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP, Hum Mol Genet, 7, 637, 10.1093\u002Fhmg\u002F7.4.637",{"doi":2476},"10.1093\u002Fhmg\u002F7.4.637",{"id":26,"text":2478,"url":26,"identifiers":2479},"Popovici, 1998, Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13), Proc Natl Acad Sci USA, 95, 5712, 10.1073\u002Fpnas.95.10.5712",{"doi":2480},"10.1073\u002Fpnas.95.10.5712",{"id":26,"text":2482,"url":26,"identifiers":2483},"Xiao, 1998, FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia\u002Flymphoma syndrome, Nat Genet, 18, 84, 10.1038\u002Fng0198-84",{"doi":2484},"10.1038\u002Fng0198-84",{"id":26,"text":2486,"url":26,"identifiers":2487},"Popovici, 1999, The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1, Blood, 93, 1381, 10.1182\u002Fblood.V93.4.1381",{"doi":2488},"10.1182\u002Fblood.V93.4.1381",{"id":26,"text":2490,"url":26,"identifiers":2491},"Guasch, 2000, FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33), Blood, 95, 1788, 10.1182\u002Fblood.V95.5.1788.005k15_1788_1796",{"doi":2492},"10.1182\u002Fblood.V95.5.1788.005k15_1788_1796",{"id":26,"text":2494,"url":26,"identifiers":2495},"Guasch, 2003, Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3), Blood, 101, 286, 10.1182\u002Fblood-2002-02-0577",{"doi":2496},"10.1182\u002Fblood-2002-02-0577",{"id":26,"text":2498,"url":26,"identifiers":2499},"Heath, 2004, Critical role of STAT5 activation in transformation mediated by ZNF198–FGFR1, J Biol Chem, 279, 6666, 10.1074\u002Fjbc.M308743200",{"doi":2500},"10.1074\u002Fjbc.M308743200",{"id":26,"text":2502,"url":26,"identifiers":2503},"Demiroglu, 2001, The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins, Blood, 98, 3778, 10.1182\u002Fblood.V98.13.3778",{"doi":2504},"10.1182\u002Fblood.V98.13.3778",{"id":26,"text":2506,"url":26,"identifiers":2507},"Roumiantsev, 2004, Distinct stem cell myeloproliferative\u002FT lymphoma syndromes induced by ZNF198–FGFR1 and BCR–FGFR1 fusion genes from 8p11 translocations, Cancer Cell, 5, 287, 10.1016\u002FS1535-6108(04)00053-4",{"doi":2508},"10.1016\u002FS1535-6108(04)00053-4",{"id":26,"text":2510,"url":26,"identifiers":2511},"Cortes, 2003, Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies, Blood, 101, 1692, 10.1182\u002Fblood-2002-07-1973",{"doi":2512},"10.1182\u002Fblood-2002-07-1973",{"id":26,"text":2514,"url":26,"identifiers":2515},"Kurzrock, 2004, Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome, J Clin Oncol, 22, 1287, 10.1200\u002FJCO.2004.08.082",{"doi":2516},"10.1200\u002FJCO.2004.08.082",{"id":26,"text":2518,"url":26,"identifiers":2519},"Fioretos, 2001, Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL, Genes Chromosomes Cancer, 32, 302, 10.1002\u002Fgcc.1195",{"doi":2520},"10.1002\u002Fgcc.1195",{"id":2522,"createTime":2523,"updateTime":2523,"relativeEntities":2524,"slug":2525,"properties":2526,"entityType":788,"verifyStatus":25,"verifyTime":2523,"verifyNote":790,"syncStatus":28,"languages":2539,"translateLanguages":26,"viewCount":36,"primaryUrl":2540,"fullTextUrl":26,"authors":2541,"publicationType":880,"publisherRelationship":2653,"citationCount":2682,"citationInfo":2683,"publishDate":2685,"publishYear":2686,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2687,"isForceReanalyzing":1290},"89994743-db8b-4caf-967a-b1d347e11043","2024-10-11T01:54:18.714+00:00",[],"The-chemokine-system-in-cancer-biology-and-therapy",{"mag":2527,"keywords":2529,"openalex":2530,"abstract":2532,"title":2533,"pm":2535,"doi":2537},{"VOID":2528},"2119752261",{},{"VOID":2531},"W2119752261",{},{"EN":2534},"The chemokine system in cancer biology and therapy",{"VOID":2536},"20004131",{"VOID":2538},"10.1016\u002Fj.cytogfr.2009.11.007",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610109001142",[2542,2563,2585,2602,2619,2636],{"id":2543,"sortIndex":59,"researcher":26,"roles":2544,"affiliations":2545,"properties":2556},"46ab7e4b-2097-4b2a-874d-3dd5c5853ac7",[],[2546],{"id":2547,"sortIndex":36,"affiliation":2548,"properties":26},"da05c207-0416-4f2c-b0b9-cd26a2727a4d",{"id":2549,"createTime":2550,"updateTime":2550,"relativeEntities":2551,"slug":2552,"properties":2553,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"31020367-d0a8-4a48-91a6-e6eeb7deb0b7","2024-10-11T01:54:18.766+00:00",[],"IRCCS-Istituto-Clinico-Humanitas-I-20089-Rozzano-Milan-Italy",{"title":2554},{"EN":2555},"IRCCS Istituto Clinico Humanitas, I-20089 Rozzano, Milan, Italy",{"openalex":2557,"orcid":2559,"title":2561},{"VOID":2558},"A5084497328",{"VOID":2560},"https:\u002F\u002Forcid.org\u002F0000-0002-4348-6341",{"EN":2562},"Luca Zammataro",{"id":2564,"sortIndex":115,"researcher":26,"roles":2565,"affiliations":2566,"properties":2578},"cffc2a59-bc49-403f-be9f-6544f5bc5a4b",[],[2567],{"id":2568,"sortIndex":36,"affiliation":2569,"properties":26},"b526fa95-d2d2-4246-9ec9-c2aae1c43769",{"id":2570,"createTime":2571,"updateTime":2572,"relativeEntities":2573,"slug":2574,"properties":2575,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5c9e28e4-fe62-4550-8502-bb2d830a7e12","2023-12-19T06:25:13.019+00:00","2024-10-11T01:54:18.735+00:00",[],"Department-of-Translational-Medicine-University-of-Milan-I-20089-Rozzano-Milan-Italy",{"title":2576},{"VI":2577},"Department of Translational Medicine, University of Milan, I-20089 Rozzano (Milan), Italy",{"openalex":2579,"orcid":2581,"title":2583},{"VOID":2580},"A5065174717",{"VOID":2582},"https:\u002F\u002Forcid.org\u002F0000-0002-2996-9515",{"EN":2584},"Benedetta Savino",{"id":2586,"sortIndex":162,"researcher":26,"roles":2587,"affiliations":2588,"properties":2595},"36b4592a-93cb-451e-b98c-03ab72c488cc",[],[2589],{"id":2590,"sortIndex":36,"affiliation":2591,"properties":26},"04418450-0623-46cc-9846-2a695e6f82f5",{"id":2570,"createTime":2571,"updateTime":2572,"relativeEntities":2592,"slug":2574,"properties":2593,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2594},{"VI":2577},{"openalex":2596,"orcid":2598,"title":2600},{"VOID":2597},"A5021472413",{"VOID":2599},"https:\u002F\u002Forcid.org\u002F0000-0003-3346-5333",{"EN":2601},"Raffaella Bonecchi",{"id":2603,"sortIndex":111,"researcher":26,"roles":2604,"affiliations":2605,"properties":2612},"c9ed8d54-2b10-43be-9a25-2c0b8e5657ad",[],[2606],{"id":2607,"sortIndex":36,"affiliation":2608,"properties":26},"e3952ea8-cbf1-47a7-8653-412e85c2a47f",{"id":2549,"createTime":2550,"updateTime":2550,"relativeEntities":2609,"slug":2552,"properties":2610,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2611},{"EN":2555},{"openalex":2613,"orcid":2615,"title":2617},{"VOID":2614},"A5065211137",{"VOID":2616},"https:\u002F\u002Forcid.org\u002F0000-0002-6697-6028",{"EN":2618},"Paola Allavena",{"id":2620,"sortIndex":36,"researcher":26,"roles":2621,"affiliations":2622,"properties":2629},"ead9cc12-ce47-418d-a966-4be5f3f6e1a4",[],[2623],{"id":2624,"sortIndex":36,"affiliation":2625,"properties":26},"b5f6c050-2627-4951-845a-b1cf9e902b9e",{"id":2570,"createTime":2571,"updateTime":2572,"relativeEntities":2626,"slug":2574,"properties":2627,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2628},{"VI":2577},{"openalex":2630,"orcid":2632,"title":2634},{"VOID":2631},"A5048654641",{"VOID":2633},"https:\u002F\u002Forcid.org\u002F0000-0001-5578-236X",{"EN":2635},"Alberto Mantovani",{"id":2637,"sortIndex":114,"researcher":26,"roles":2638,"affiliations":2639,"properties":2646},"7ab7da10-708c-4a7b-b351-0027f9e18990",[],[2640],{"id":2641,"sortIndex":36,"affiliation":2642,"properties":26},"415be086-a500-4074-815d-682f95541587",{"id":2570,"createTime":2571,"updateTime":2572,"relativeEntities":2643,"slug":2574,"properties":2644,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2645},{"VI":2577},{"openalex":2647,"orcid":2649,"title":2651},{"VOID":2648},"A5018870571",{"VOID":2650},"https:\u002F\u002Forcid.org\u002F0000-0003-3077-590X",{"EN":2652},"Massimo Locati",{"url":26,"publisher":2654,"properties":2676},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2655,"slug":663,"properties":2656,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":2659,"manageAffiliations":2660,"indexDatabases":2661,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":2657,"title":2658},{"VOID":666},{"EN":668},[],[],[2662,2669],{"id":747,"indexDatabase":2663,"url":762,"indexYears":26,"academicFieldIds":2668,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":2664,"label":2665,"description":2666,"key":758,"publicationTags":2667,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":2670,"url":738,"indexYears":739,"academicFieldIds":2675,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":2671,"label":2672,"description":2673,"key":735,"publicationTags":2674,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":2677,"pages":2679,"issue":2681},{"VOID":2678},"21",{"VOID":2680},"27-39",{"VOID":1673},367,{"total":2682,"publishYear":26,"statisticByYear":2684},{"2012":255,"2013":79,"2014":398,"2015":168,"2016":516,"2017":234,"2018":222,"2019":124,"2020":260,"2021":124,"2022":237,"2023":298,"2024":52},"2010-02-01",2010,[2688,2692,2696,2700,2704,2708,2712,2716,2720,2724,2728,2732,2736,2740,2744,2748,2752,2756,2760,2764,2768,2772,2776,2780,2784,2788,2792,2796,2800,2804,2808,2812,2816,2820,2824,2828,2832,2836,2840,2844,2848,2852,2856,2860,2864,2868,2872,2876,2879,2883,2886,2889,2893,2897,2901,2905,2908,2912,2916,2920,2924,2928,2932,2936,2940,2943,2947,2951,2955,2959,2963,2967,2971,2975,2979,2983,2987,2991,2995,2999,3003,3007,3011,3015,3019,3023,3027,3031,3034,3038,3042,3045,3049,3053,3057,3060,3064,3068,3072,3076,3080,3083,3087,3091,3095,3099,3103,3107,3111,3115,3119,3123,3127,3131,3135,3139,3143,3147,3151,3155,3159,3163,3167,3171,3175,3179,3183,3187,3190,3194,3198,3202,3206,3210,3214,3218,3222,3226,3230,3233,3237,3241,3245,3249,3253,3257,3261,3265,3268,3272,3275,3279,3283,3287,3291,3295,3299,3302,3306,3310,3314,3318,3322,3326,3330,3334,3338,3342,3346,3350,3354,3358,3362,3366,3370,3374,3378,3382,3386,3390,3394,3398,3402,3406,3410,3414,3418,3422,3426,3430,3434,3438,3442,3446,3450,3454,3458,3462,3465,3469,3473,3477,3481,3485,3488,3492,3496,3500,3504,3508,3512,3516,3520,3524,3527,3531,3535,3538,3542],{"id":26,"text":2689,"url":26,"identifiers":2690},"Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016\u002FS0140-6736(00)04046-0",{"doi":2691},"10.1016\u002FS0140-6736(00)04046-0",{"id":26,"text":2693,"url":26,"identifiers":2694},"Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038\u002Fnature07205",{"doi":2695},"10.1038\u002Fnature07205",{"id":26,"text":2697,"url":26,"identifiers":2698},"Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038\u002Fnature01322",{"doi":2699},"10.1038\u002Fnature01322",{"id":26,"text":2701,"url":26,"identifiers":2702},"Mantovani, 2009, Cancer: inflaming metastasis, Nature, 457, 36, 10.1038\u002F457036b",{"doi":2703},"10.1038\u002F457036b",{"id":26,"text":2705,"url":26,"identifiers":2706},"Balkwill, 2004, Cancer and the chemokine network, Nat Rev Cancer, 4, 540, 10.1038\u002Fnrc1388",{"doi":2707},"10.1038\u002Fnrc1388",{"id":26,"text":2709,"url":26,"identifiers":2710},"Bottazzi, 1983, Regulation of the macrophage content of neoplasms by chemoattractants, Science, 220, 210, 10.1126\u002Fscience.6828888",{"doi":2711},"10.1126\u002Fscience.6828888",{"id":26,"text":2713,"url":26,"identifiers":2714},"Mantovani, 1999, The chemokine system: redundancy for robust outputs, Immunol Today, 20, 254, 10.1016\u002FS0167-5699(99)01469-3",{"doi":2715},"10.1016\u002FS0167-5699(99)01469-3",{"id":26,"text":2717,"url":26,"identifiers":2718},"Mantovani, 2006, Tuning inflammation and immunity by chemokine sequestration: decoys and more, Nat Rev Immunol, 6, 907, 10.1038\u002Fnri1964",{"doi":2719},"10.1038\u002Fnri1964",{"id":26,"text":2721,"url":26,"identifiers":2722},"Nibbs, 2007, The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors, J Clin Invest, 117, 1884, 10.1172\u002FJCI30068",{"doi":2723},"10.1172\u002FJCI30068",{"id":26,"text":2725,"url":26,"identifiers":2726},"Vetrano S, Borroni EM, Sarukhan A, et al. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 2009; Oct 20 [Epub ahead of print].",{"doi":2727},"10.1136\u002Fgut.2009.183772",{"id":26,"text":2729,"url":26,"identifiers":2730},"Mantovani, 2006, Role of tumor-associated macrophages in tumor progression and invasion, Cancer Metastasis Rev, 25, 315, 10.1007\u002Fs10555-006-9001-7",{"doi":2731},"10.1007\u002Fs10555-006-9001-7",{"id":26,"text":2733,"url":26,"identifiers":2734},"Markiewski, 2009, Is complement good or bad for cancer patients? A new perspective on an old dilemma, Trends Immunol, 30, 286, 10.1016\u002Fj.it.2009.04.002",{"doi":2735},"10.1016\u002Fj.it.2009.04.002",{"id":26,"text":2737,"url":26,"identifiers":2738},"Proost, 2006, Natural post-translational modifications of chemokines, Biochem Soc Trans, 34, 997, 10.1042\u002FBST0340997",{"doi":2739},"10.1042\u002FBST0340997",{"id":26,"text":2741,"url":26,"identifiers":2742},"Proost, 2008, Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation, J Exp Med, 205, 2085, 10.1084\u002Fjem.20080305",{"doi":2743},"10.1084\u002Fjem.20080305",{"id":26,"text":2745,"url":26,"identifiers":2746},"Grisotto, 2006, The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells, J Clin Invest, 116, 1264, 10.1172\u002FJCI26666",{"doi":2747},"10.1172\u002FJCI26666",{"id":26,"text":2749,"url":26,"identifiers":2750},"Yang, 2000, Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma, J Exp Med, 191, 445, 10.1084\u002Fjem.191.3.445",{"doi":2751},"10.1084\u002Fjem.191.3.445",{"id":26,"text":2753,"url":26,"identifiers":2754},"Sozzani, 1998, The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant, Blood, 92, 4036, 10.1182\u002Fblood.V92.11.4036",{"doi":2755},"10.1182\u002Fblood.V92.11.4036",{"id":26,"text":2757,"url":26,"identifiers":2758},"Stine, 2000, KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells, Blood, 95, 1151, 10.1182\u002Fblood.V95.4.1151.004k37_1151_1157",{"doi":2759},"10.1182\u002Fblood.V95.4.1151.004k37_1151_1157",{"id":26,"text":2761,"url":26,"identifiers":2762},"Endres, 1999, The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8, J Exp Med, 189, 1993, 10.1084\u002Fjem.189.12.1993",{"doi":2763},"10.1084\u002Fjem.189.12.1993",{"id":26,"text":2765,"url":26,"identifiers":2766},"Borrello, 2005, Induction of a proinflammatory program in normal human thyrocytes by the RET\u002FPTC1 oncogene, Proc Natl Acad Sci USA, 102, 14825, 10.1073\u002Fpnas.0503039102",{"doi":2767},"10.1073\u002Fpnas.0503039102",{"id":26,"text":2769,"url":26,"identifiers":2770},"Mestdagt, 2006, Transactivation of MCP-1\u002FCCL2 by beta-catenin\u002FTCF-4 in human breast cancer cells, Int J Cancer, 118, 35, 10.1002\u002Fijc.21291",{"doi":2771},"10.1002\u002Fijc.21291",{"id":26,"text":2773,"url":26,"identifiers":2774},"Sparmann, 2004, Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, 6, 447, 10.1016\u002Fj.ccr.2004.09.028",{"doi":2775},"10.1016\u002Fj.ccr.2004.09.028",{"id":26,"text":2777,"url":26,"identifiers":2778},"Yan, 2009, Identification of GRO1 as a critical determinant for mutant p53 gain of function, J Biol Chem, 284, 12178, 10.1074\u002Fjbc.M900994200",{"doi":2779},"10.1074\u002Fjbc.M900994200",{"id":26,"text":2781,"url":26,"identifiers":2782},"Soucek, 2007, Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors, Nat Med, 13, 1211, 10.1038\u002Fnm1649",{"doi":2783},"10.1038\u002Fnm1649",{"id":26,"text":2785,"url":26,"identifiers":2786},"Buonamici, 2009, CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia, Nature, 459, 1000, 10.1038\u002Fnature08020",{"doi":2787},"10.1038\u002Fnature08020",{"id":26,"text":2789,"url":26,"identifiers":2790},"Richmond, 2002, Nf-kappa B, chemokine gene transcription and tumour growth, Nat Rev Immunol, 2, 664, 10.1038\u002Fnri887",{"doi":2791},"10.1038\u002Fnri887",{"id":26,"text":2793,"url":26,"identifiers":2794},"Schwieger, 2009, Homing and invasiveness of MLL\u002FENL leukemic cells is regulated by MEF2C, Blood, 10.1182\u002Fblood-2008-05-158196",{"doi":2795},"10.1182\u002Fblood-2008-05-158196",{"id":26,"text":2797,"url":26,"identifiers":2798},"Akekawatchai, 2005, Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells, J Biol Chem, 280, 39701, 10.1074\u002Fjbc.M509829200",{"doi":2799},"10.1074\u002Fjbc.M509829200",{"id":26,"text":2801,"url":26,"identifiers":2802},"Mira, 2001, A role for chemokine receptor transactivation in growth factor signaling, EMBO Rep, 2, 151, 10.1093\u002Fembo-reports\u002Fkve027",{"doi":2803},"10.1093\u002Fembo-reports\u002Fkve027",{"id":26,"text":2805,"url":26,"identifiers":2806},"Wallace, 2009, Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma, Cancer Res, 69, 5726, 10.1158\u002F0008-5472.CAN-09-0390",{"doi":2807},"10.1158\u002F0008-5472.CAN-09-0390",{"id":26,"text":2809,"url":26,"identifiers":2810},"Kulbe, 2005, The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells, Cancer Res, 65, 10355, 10.1158\u002F0008-5472.CAN-05-0957",{"doi":2811},"10.1158\u002F0008-5472.CAN-05-0957",{"id":26,"text":2813,"url":26,"identifiers":2814},"Schioppa, 2003, Regulation of the chemokine receptor CXCR4 by hypoxia, J Exp Med, 198, 1391, 10.1084\u002Fjem.20030267",{"doi":2815},"10.1084\u002Fjem.20030267",{"id":26,"text":2817,"url":26,"identifiers":2818},"Staller, 2003, Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL, Nature, 425, 307, 10.1038\u002Fnature01874",{"doi":2819},"10.1038\u002Fnature01874",{"id":26,"text":2821,"url":26,"identifiers":2822},"Li, 2009, Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells, Cancer Biol Ther, 8, 322, 10.4161\u002Fcbt.8.4.7332",{"doi":2823},"10.4161\u002Fcbt.8.4.7332",{"id":26,"text":2825,"url":26,"identifiers":2826},"Bierie, 2009, Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer, J Clin Invest, 119, 1571, 10.1172\u002FJCI37480",{"doi":2827},"10.1172\u002FJCI37480",{"id":26,"text":2829,"url":26,"identifiers":2830},"Yang, 2008, Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis, Cancer Cell, 13, 23, 10.1016\u002Fj.ccr.2007.12.004",{"doi":2831},"10.1016\u002Fj.ccr.2007.12.004",{"id":26,"text":2833,"url":26,"identifiers":2834},"Sauve, 2009, Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway, Cancer Res, 69, 5793, 10.1158\u002F0008-5472.CAN-08-4924",{"doi":2835},"10.1158\u002F0008-5472.CAN-08-4924",{"id":26,"text":2837,"url":26,"identifiers":2838},"Huang, 2007, Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells, Cancer Res, 67, 5906, 10.1158\u002F0008-5472.CAN-07-0691",{"doi":2839},"10.1158\u002F0008-5472.CAN-07-0691",{"id":26,"text":2841,"url":26,"identifiers":2842},"Mantovani, 2004, Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors, Semin Cancer Biol, 14, 155, 10.1016\u002Fj.semcancer.2003.10.001",{"doi":2843},"10.1016\u002Fj.semcancer.2003.10.001",{"id":26,"text":2845,"url":26,"identifiers":2846},"Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer, 4, 71, 10.1038\u002Fnrc1256",{"doi":2847},"10.1038\u002Fnrc1256",{"id":26,"text":2849,"url":26,"identifiers":2850},"Walter, 1991, Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein\u002FJE, Int J Cancer, 49, 431, 10.1002\u002Fijc.2910490321",{"doi":2851},"10.1002\u002Fijc.2910490321",{"id":26,"text":2853,"url":26,"identifiers":2854},"Lavergne, 2004, Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration, J Immunol, 173, 3755, 10.4049\u002Fjimmunol.173.6.3755",{"doi":2855},"10.4049\u002Fjimmunol.173.6.3755",{"id":26,"text":2857,"url":26,"identifiers":2858},"Manome, 1995, Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors, Cancer Immunol Immunother, 41, 227, 10.1007\u002FBF01516997",{"doi":2859},"10.1007\u002FBF01516997",{"id":26,"text":2861,"url":26,"identifiers":2862},"Rollins, 1991, Suppression of tumor formation in vivo by expression of the JE gene in malignant cells, Mol Cell Biol, 11, 3125, 10.1128\u002FMCB.11.6.3125",{"doi":2863},"10.1128\u002FMCB.11.6.3125",{"id":26,"text":2865,"url":26,"identifiers":2866},"Conti, 2004, CCL2 (monocyte chemoattractant protein-1) and cancer, Semin Cancer Biol, 14, 149, 10.1016\u002Fj.semcancer.2003.10.009",{"doi":2867},"10.1016\u002Fj.semcancer.2003.10.009",{"id":26,"text":2869,"url":26,"identifiers":2870},"Sawanobori, 2008, Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice, Blood, 111, 5457, 10.1182\u002Fblood-2008-01-136895",{"doi":2871},"10.1182\u002Fblood-2008-01-136895",{"id":26,"text":2873,"url":26,"identifiers":2874},"Soria, 2008, The inflammatory chemokines CCL2 and CCL5 in breast cancer, Cancer Lett, 267, 271, 10.1016\u002Fj.canlet.2008.03.018",{"doi":2875},"10.1016\u002Fj.canlet.2008.03.018",{"id":26,"text":2877,"url":26,"identifiers":2878},"Okada, 2009, Tumor-associated macrophage\u002Fmicroglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1, Int J Oncol, 34, 1621",{},{"id":26,"text":2880,"url":26,"identifiers":2881},"Fujimoto, 2009, Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression, Int J Cancer, 125, 1276, 10.1002\u002Fijc.24378",{"doi":2882},"10.1002\u002Fijc.24378",{"id":26,"text":2884,"url":26,"identifiers":2885},"Luboshits, 1999, Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma, Cancer Res, 59, 4681",{},{"id":26,"text":2887,"url":26,"identifiers":2888},"Ueno, 2000, Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer, Clin Cancer Res, 6, 3282",{},{"id":26,"text":2890,"url":26,"identifiers":2891},"Harlin, 2009, Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment, Cancer Res, 69, 3077, 10.1158\u002F0008-5472.CAN-08-2281",{"doi":2892},"10.1158\u002F0008-5472.CAN-08-2281",{"id":26,"text":2894,"url":26,"identifiers":2895},"Ohta, 2002, Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas, Int J Cancer, 102, 220, 10.1002\u002Fijc.10705",{"doi":2896},"10.1002\u002Fijc.10705",{"id":26,"text":2898,"url":26,"identifiers":2899},"Hu, 2009, Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis, Clin Cancer Res, 10.1158\u002F1078-0432.CCR-08-2491",{"doi":2900},"10.1158\u002F1078-0432.CCR-08-2491",{"id":26,"text":2902,"url":26,"identifiers":2903},"Loberg, 2007, CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration, Neoplasia, 9, 556, 10.1593\u002Fneo.07307",{"doi":2904},"10.1593\u002Fneo.07307",{"id":26,"text":2906,"url":26,"identifiers":2907},"Monti, 2003, The CC chemokine MCP-1\u002FCCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity, Cancer Res, 63, 7451",{},{"id":26,"text":2909,"url":26,"identifiers":2910},"Karnoub, 2007, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, 449, 557, 10.1038\u002Fnature06188",{"doi":2911},"10.1038\u002Fnature06188",{"id":26,"text":2913,"url":26,"identifiers":2914},"Bailey, 2007, Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer, Clin Exp Metastasis, 24, 121, 10.1007\u002Fs10585-007-9060-3",{"doi":2915},"10.1007\u002Fs10585-007-9060-3",{"id":26,"text":2917,"url":26,"identifiers":2918},"Soria, 2008, Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions, Cytokine, 44, 191, 10.1016\u002Fj.cyto.2008.08.002",{"doi":2919},"10.1016\u002Fj.cyto.2008.08.002",{"id":26,"text":2921,"url":26,"identifiers":2922},"Dwyer, 2007, Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells, Clin Cancer Res, 13, 5020, 10.1158\u002F1078-0432.CCR-07-0731",{"doi":2923},"10.1158\u002F1078-0432.CCR-07-0731",{"id":26,"text":2925,"url":26,"identifiers":2926},"Sugasawa, 2008, Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination, Int J Cancer, 122, 2535, 10.1002\u002Fijc.23401",{"doi":2927},"10.1002\u002Fijc.23401",{"id":26,"text":2929,"url":26,"identifiers":2930},"Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038\u002Fnri2506",{"doi":2931},"10.1038\u002Fnri2506",{"id":26,"text":2933,"url":26,"identifiers":2934},"Fridlender, 2009, Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN, Cancer Cell, 16, 183, 10.1016\u002Fj.ccr.2009.06.017",{"doi":2935},"10.1016\u002Fj.ccr.2009.06.017",{"id":26,"text":2937,"url":26,"identifiers":2938},"Nozawa, 2006, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis, Proc Natl Acad Sci USA, 103, 12493, 10.1073\u002Fpnas.0601807103",{"doi":2939},"10.1073\u002Fpnas.0601807103",{"id":26,"text":2941,"url":26,"identifiers":2942},"Bellocq, 1998, Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome, Am J Pathol, 152, 83",{},{"id":26,"text":2944,"url":26,"identifiers":2945},"Tazzyman, 2009, Neutrophils: key mediators of tumour angiogenesis, Int J Exp Pathol, 90, 222, 10.1111\u002Fj.1365-2613.2009.00641.x",{"doi":2946},"10.1111\u002Fj.1365-2613.2009.00641.x",{"id":26,"text":2948,"url":26,"identifiers":2949},"Xie, 2001, Interleukin-8 and human cancer biology, Cytokine Growth Factor Rev, 12, 375, 10.1016\u002FS1359-6101(01)00016-8",{"doi":2950},"10.1016\u002FS1359-6101(01)00016-8",{"id":26,"text":2952,"url":26,"identifiers":2953},"Cuenca, 1992, Characterization of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement, Surg Oncol, 1, 323, 10.1016\u002F0960-7404(92)90094-2",{"doi":2954},"10.1016\u002F0960-7404(92)90094-2",{"id":26,"text":2956,"url":26,"identifiers":2957},"Eck, 2003, Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma, Clin Exp Immunol, 134, 508, 10.1111\u002Fj.1365-2249.2003.02305.x",{"doi":2958},"10.1111\u002Fj.1365-2249.2003.02305.x",{"id":26,"text":2960,"url":26,"identifiers":2961},"Dhawan, 2002, Role of CXCL1 in tumorigenesis of melanoma, J Leukoc Biol, 72, 9, 10.1189\u002Fjlb.72.1.9",{"doi":2962},"10.1189\u002Fjlb.72.1.9",{"id":26,"text":2964,"url":26,"identifiers":2965},"Wislez, 2004, Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells, Inflamm Res, 53, 4, 10.1007\u002Fs00011-003-1215-3",{"doi":2966},"10.1007\u002Fs00011-003-1215-3",{"id":26,"text":2968,"url":26,"identifiers":2969},"Gijsbers, 2005, GCP-2\u002FCXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors, Exp Cell Res, 303, 331, 10.1016\u002Fj.yexcr.2004.09.027",{"doi":2970},"10.1016\u002Fj.yexcr.2004.09.027",{"id":26,"text":2972,"url":26,"identifiers":2973},"Proost, 1993, Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8, J Immunol, 150, 1000, 10.4049\u002Fjimmunol.150.3.1000",{"doi":2974},"10.4049\u002Fjimmunol.150.3.1000",{"id":26,"text":2976,"url":26,"identifiers":2977},"Fioretti, 1998, Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor, J Immunol, 161, 342, 10.4049\u002Fjimmunol.161.1.342",{"doi":2978},"10.4049\u002Fjimmunol.161.1.342",{"id":26,"text":2980,"url":26,"identifiers":2981},"Lee, 2000, IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration, J Immunol, 164, 2769, 10.4049\u002Fjimmunol.164.5.2769",{"doi":2982},"10.4049\u002Fjimmunol.164.5.2769",{"id":26,"text":2984,"url":26,"identifiers":2985},"Benelli, 2002, Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation, FASEB J, 16, 267, 10.1096\u002Ffj.01-0651fje",{"doi":2986},"10.1096\u002Ffj.01-0651fje",{"id":26,"text":2988,"url":26,"identifiers":2989},"Bell, 1999, In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas, J Exp Med, 190, 1417, 10.1084\u002Fjem.190.10.1417",{"doi":2990},"10.1084\u002Fjem.190.10.1417",{"id":26,"text":2992,"url":26,"identifiers":2993},"Vicari, 2004, Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines, Semin Cancer Biol, 14, 161, 10.1016\u002Fj.semcancer.2003.10.002",{"doi":2994},"10.1016\u002Fj.semcancer.2003.10.002",{"id":26,"text":2996,"url":26,"identifiers":2997},"Kleeff, 1999, Detection and localization of MIP-3alpha\u002FLARC\u002FExodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer, Int J Cancer, 81, 650, 10.1002\u002F(SICI)1097-0215(19990517)81:4\u003C650::AID-IJC23>3.0.CO;2-#",{"doi":2998},"10.1002\u002F(SICI)1097-0215(19990517)81:4\u003C650::AID-IJC23>3.0.CO;2-#",{"id":26,"text":3000,"url":26,"identifiers":3001},"Scarpino, 2000, Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells, Am J Pathol, 156, 831, 10.1016\u002FS0002-9440(10)64951-6",{"doi":3002},"10.1016\u002FS0002-9440(10)64951-6",{"id":26,"text":3004,"url":26,"identifiers":3005},"Fushimi, 2000, Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth, J Clin Invest, 105, 1383, 10.1172\u002FJCI7548",{"doi":3006},"10.1172\u002FJCI7548",{"id":26,"text":3008,"url":26,"identifiers":3009},"Zou, 2001, Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nat Med, 7, 1339, 10.1038\u002Fnm1201-1339",{"doi":3010},"10.1038\u002Fnm1201-1339",{"id":26,"text":3012,"url":26,"identifiers":3013},"Treilleux, 2004, Dendritic cell infiltration and prognosis of early stage breast cancer, Clin Cancer Res, 10, 7466, 10.1158\u002F1078-0432.CCR-04-0684",{"doi":3014},"10.1158\u002F1078-0432.CCR-04-0684",{"id":26,"text":3016,"url":26,"identifiers":3017},"Ishigami, 2000, Prognostic value of intratumoral natural killer cells in gastric carcinoma, Cancer, 88, 577, 10.1002\u002F(SICI)1097-0142(20000201)88:3\u003C577::AID-CNCR13>3.0.CO;2-V",{"doi":3018},"10.1002\u002F(SICI)1097-0142(20000201)88:3\u003C577::AID-CNCR13>3.0.CO;2-V",{"id":26,"text":3020,"url":26,"identifiers":3021},"Villegas, 2002, Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer, Lung Cancer, 35, 23, 10.1016\u002FS0169-5002(01)00292-6",{"doi":3022},"10.1016\u002FS0169-5002(01)00292-6",{"id":26,"text":3024,"url":26,"identifiers":3025},"Hyakudomi, 2008, Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma, Ann Surg Oncol, 15, 1775, 10.1245\u002Fs10434-008-9876-3",{"doi":3026},"10.1245\u002Fs10434-008-9876-3",{"id":26,"text":3028,"url":26,"identifiers":3029},"Saudemont, 2005, NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells, Blood, 105, 2428, 10.1182\u002Fblood-2004-09-3458",{"doi":3030},"10.1182\u002Fblood-2004-09-3458",{"id":26,"text":3032,"url":26,"identifiers":3033},"Lavergne, 2003, Fractalkine mediates natural killer-dependent antitumor responses in vivo, Cancer Res, 63, 7468",{},{"id":26,"text":3035,"url":26,"identifiers":3036},"Wendel, 2008, Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands, Cancer Res, 68, 8437, 10.1158\u002F0008-5472.CAN-08-1440",{"doi":3037},"10.1158\u002F0008-5472.CAN-08-1440",{"id":26,"text":3039,"url":26,"identifiers":3040},"Ishida, 2006, CCR4 as a novel molecular target for immunotherapy of cancer, Cancer Sci, 97, 1139, 10.1111\u002Fj.1349-7006.2006.00307.x",{"doi":3041},"10.1111\u002Fj.1349-7006.2006.00307.x",{"id":26,"text":3043,"url":26,"identifiers":3044},"Liu, 2008, Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice, J Clin Invest, 118, 1165",{},{"id":26,"text":3046,"url":26,"identifiers":3047},"Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126\u002Fscience.1129139",{"doi":3048},"10.1126\u002Fscience.1129139",{"id":26,"text":3050,"url":26,"identifiers":3051},"Finn, 2008, Cancer immunology, N Engl J Med, 358, 2704, 10.1056\u002FNEJMra072739",{"doi":3052},"10.1056\u002FNEJMra072739",{"id":26,"text":3054,"url":26,"identifiers":3055},"Laghi, 2009, CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study, Lancet Oncol, 10, 877, 10.1016\u002FS1470-2045(09)70186-X",{"doi":3056},"10.1016\u002FS1470-2045(09)70186-X",{"id":26,"text":3058,"url":26,"identifiers":3059},"Oble, 2009, Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma, Cancer Immun, 9, 3",{},{"id":26,"text":3061,"url":26,"identifiers":3062},"Pan, 2006, CXCR3\u002FCXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis, J Immunol, 176, 1456, 10.4049\u002Fjimmunol.176.3.1456",{"doi":3063},"10.4049\u002Fjimmunol.176.3.1456",{"id":26,"text":3065,"url":26,"identifiers":3066},"Ohtani, 2009, Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma, J Pathol, 217, 21, 10.1002\u002Fpath.2448",{"doi":3067},"10.1002\u002Fpath.2448",{"id":26,"text":3069,"url":26,"identifiers":3070},"Musha, 2005, Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma, Int J Cancer, 116, 949, 10.1002\u002Fijc.21135",{"doi":3071},"10.1002\u002Fijc.21135",{"id":26,"text":3073,"url":26,"identifiers":3074},"Zeng, 2007, Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells, Cancer Res, 67, 2331, 10.1158\u002F0008-5472.CAN-06-3041",{"doi":3075},"10.1158\u002F0008-5472.CAN-06-3041",{"id":26,"text":3077,"url":26,"identifiers":3078},"Ludwig, 2005, Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells, J Neurochem, 93, 1293, 10.1111\u002Fj.1471-4159.2005.03123.x",{"doi":3079},"10.1111\u002Fj.1471-4159.2005.03123.x",{"id":26,"text":3081,"url":26,"identifiers":3082},"Wente, 2008, Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma, Int J Oncol, 33, 297",{},{"id":26,"text":3084,"url":26,"identifiers":3085},"Meijer, 2008, The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation, Cancer Res, 68, 4701, 10.1158\u002F0008-5472.CAN-08-0482",{"doi":3086},"10.1158\u002F0008-5472.CAN-08-0482",{"id":26,"text":3088,"url":26,"identifiers":3089},"Matsumura, 2008, Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells, J Immunol, 181, 3099, 10.4049\u002Fjimmunol.181.5.3099",{"doi":3090},"10.4049\u002Fjimmunol.181.5.3099",{"id":26,"text":3092,"url":26,"identifiers":3093},"Gutwein, 2009, Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients, Eur J Cancer, 45, 478, 10.1016\u002Fj.ejca.2008.10.023",{"doi":3094},"10.1016\u002Fj.ejca.2008.10.023",{"id":26,"text":3096,"url":26,"identifiers":3097},"Hojo, 2007, High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer, Cancer Res, 67, 4725, 10.1158\u002F0008-5472.CAN-06-3424",{"doi":3098},"10.1158\u002F0008-5472.CAN-06-3424",{"id":26,"text":3100,"url":26,"identifiers":3101},"Darash-Yahana, 2009, The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers, PLoS One, 4, e6695, 10.1371\u002Fjournal.pone.0006695",{"doi":3102},"10.1371\u002Fjournal.pone.0006695",{"id":26,"text":3104,"url":26,"identifiers":3105},"Gobert, 2009, Regulatory T cells recruited through CCL22\u002FCCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome, Cancer Res, 69, 2000, 10.1158\u002F0008-5472.CAN-08-2360",{"doi":3106},"10.1158\u002F0008-5472.CAN-08-2360",{"id":26,"text":3108,"url":26,"identifiers":3109},"Olkhanud, 2009, Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells, Cancer Res, 69, 5996, 10.1158\u002F0008-5472.CAN-08-4619",{"doi":3110},"10.1158\u002F0008-5472.CAN-08-4619",{"id":26,"text":3112,"url":26,"identifiers":3113},"Curiel, 2004, Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Med, 10, 942, 10.1038\u002Fnm1093",{"doi":3114},"10.1038\u002Fnm1093",{"id":26,"text":3116,"url":26,"identifiers":3117},"Miller, 2006, CD4+CD25 high T cells are enriched in the tumor and peripheral blood of prostate cancer patients, J Immunol, 177, 7398, 10.4049\u002Fjimmunol.177.10.7398",{"doi":3118},"10.4049\u002Fjimmunol.177.10.7398",{"id":26,"text":3120,"url":26,"identifiers":3121},"Mizukami, 2008, CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer, Int J Cancer, 122, 2286, 10.1002\u002Fijc.23392",{"doi":3122},"10.1002\u002Fijc.23392",{"id":26,"text":3124,"url":26,"identifiers":3125},"Mailloux, 2009, NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment, J Immunol, 182, 2753, 10.4049\u002Fjimmunol.0801124",{"doi":3126},"10.4049\u002Fjimmunol.0801124",{"id":26,"text":3128,"url":26,"identifiers":3129},"Strieter, 2006, Cancer CXC chemokine networks and tumour angiogenesis, Eur J Cancer, 42, 768, 10.1016\u002Fj.ejca.2006.01.006",{"doi":3130},"10.1016\u002Fj.ejca.2006.01.006",{"id":26,"text":3132,"url":26,"identifiers":3133},"Li, 2005, Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis, Angiogenesis, 8, 63, 10.1007\u002Fs10456-005-5208-4",{"doi":3134},"10.1007\u002Fs10456-005-5208-4",{"id":26,"text":3136,"url":26,"identifiers":3137},"Aalinkeel, 2004, Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells, Cancer Res, 64, 5311, 10.1158\u002F0008-5472.CAN-2506-2",{"doi":3138},"10.1158\u002F0008-5472.CAN-2506-2",{"id":26,"text":3140,"url":26,"identifiers":3141},"Mestas, 2005, The role of CXCR2\u002FCXCR2 ligand biological axis in renal cell carcinoma, J Immunol, 175, 5351, 10.4049\u002Fjimmunol.175.8.5351",{"doi":3142},"10.4049\u002Fjimmunol.175.8.5351",{"id":26,"text":3144,"url":26,"identifiers":3145},"Strieter, 2004, CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer, Ann N Y Acad Sci, 1028, 351, 10.1196\u002Fannals.1322.041",{"doi":3146},"10.1196\u002Fannals.1322.041",{"id":26,"text":3148,"url":26,"identifiers":3149},"Kryczek, 2005, CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, 65, 465, 10.1158\u002F0008-5472.465.65.2",{"doi":3150},"10.1158\u002F0008-5472.465.65.2",{"id":26,"text":3152,"url":26,"identifiers":3153},"Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\u002FCXCL12 secretion, Cell, 121, 335, 10.1016\u002Fj.cell.2005.02.034",{"doi":3154},"10.1016\u002Fj.cell.2005.02.034",{"id":26,"text":3156,"url":26,"identifiers":3157},"Miao, 2007, CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature, Proc Natl Acad Sci USA, 104, 15735, 10.1073\u002Fpnas.0610444104",{"doi":3158},"10.1073\u002Fpnas.0610444104",{"id":26,"text":3160,"url":26,"identifiers":3161},"Romagnani, 2001, Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity, J Clin Invest, 107, 53, 10.1172\u002FJCI9775",{"doi":3162},"10.1172\u002FJCI9775",{"id":26,"text":3164,"url":26,"identifiers":3165},"Naschberger, 2008, Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy, Int J Cancer, 123, 2120, 10.1002\u002Fijc.23764",{"doi":3166},"10.1002\u002Fijc.23764",{"id":26,"text":3168,"url":26,"identifiers":3169},"Sato, 2007, Expression of IP-10 related to angiogenesis in uterine cervical cancers, Br J Cancer, 96, 1735, 10.1038\u002Fsj.bjc.6603790",{"doi":3170},"10.1038\u002Fsj.bjc.6603790",{"id":26,"text":3172,"url":26,"identifiers":3173},"Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158\u002F0008-5472.CAN-05-4005",{"doi":3174},"10.1158\u002F0008-5472.CAN-05-4005",{"id":26,"text":3176,"url":26,"identifiers":3177},"Sozzani, 2007, Dendritic cell-endothelial cell cross-talk in angiogenesis, Trends Immunol, 28, 385, 10.1016\u002Fj.it.2007.07.006",{"doi":3178},"10.1016\u002Fj.it.2007.07.006",{"id":26,"text":3180,"url":26,"identifiers":3181},"Chen, 2009, Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis, Blood, 113, 1992, 10.1182\u002Fblood-2008-02-133751",{"doi":3182},"10.1182\u002Fblood-2008-02-133751",{"id":26,"text":3184,"url":26,"identifiers":3185},"Iba, 2002, Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs, Circulation, 106, 2019, 10.1161\u002F01.CIR.0000031332.45480.79",{"doi":3186},"10.1161\u002F01.CIR.0000031332.45480.79",{"id":26,"text":3188,"url":26,"identifiers":3189},"Balentien, 1991, Effects of MGSA\u002FGRO alpha on melanocyte transformation, Oncogene, 6, 1115",{},{"id":26,"text":3191,"url":26,"identifiers":3192},"Norgauer, 1996, Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells, J Immunol, 156, 1132, 10.4049\u002Fjimmunol.156.3.1132",{"doi":3193},"10.4049\u002Fjimmunol.156.3.1132",{"id":26,"text":3195,"url":26,"identifiers":3196},"Owen, 1997, Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity\u002Fgrowth-regulated cytokine beta and gamma proteins, Int J Cancer, 73, 94, 10.1002\u002F(SICI)1097-0215(19970926)73:1\u003C94::AID-IJC15>3.0.CO;2-5",{"doi":3197},"10.1002\u002F(SICI)1097-0215(19970926)73:1\u003C94::AID-IJC15>3.0.CO;2-5",{"id":26,"text":3199,"url":26,"identifiers":3200},"Takamori, 2000, Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1, Pancreas, 21, 52, 10.1097\u002F00006676-200007000-00051",{"doi":3201},"10.1097\u002F00006676-200007000-00051",{"id":26,"text":3203,"url":26,"identifiers":3204},"Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038\u002F35065016",{"doi":3205},"10.1038\u002F35065016",{"id":26,"text":3207,"url":26,"identifiers":3208},"Burger, 2006, CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment, Blood, 107, 1761, 10.1182\u002Fblood-2005-08-3182",{"doi":3209},"10.1182\u002Fblood-2005-08-3182",{"id":26,"text":3211,"url":26,"identifiers":3212},"Ehtesham, 2009, CXCR4 mediates the proliferation of glioblastoma progenitor cells, Cancer Lett, 274, 305, 10.1016\u002Fj.canlet.2008.09.034",{"doi":3213},"10.1016\u002Fj.canlet.2008.09.034",{"id":26,"text":3215,"url":26,"identifiers":3216},"Hermann, 2007, Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, 1, 313, 10.1016\u002Fj.stem.2007.06.002",{"doi":3217},"10.1016\u002Fj.stem.2007.06.002",{"id":26,"text":3219,"url":26,"identifiers":3220},"Varney, 2006, Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma, Am J Clin Pathol, 125, 209, 10.1309\u002FVPL5-R3JR-7F1D-6V03",{"doi":3221},"10.1309\u002FVPL5-R3JR-7F1D-6V03",{"id":26,"text":3223,"url":26,"identifiers":3224},"Murphy, 2005, Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer, Clin Cancer Res, 11, 4117, 10.1158\u002F1078-0432.CCR-04-1518",{"doi":3225},"10.1158\u002F1078-0432.CCR-04-1518",{"id":26,"text":3227,"url":26,"identifiers":3228},"Bajetto, 2006, Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration, Neurochem Int, 49, 423, 10.1016\u002Fj.neuint.2006.03.003",{"doi":3229},"10.1016\u002Fj.neuint.2006.03.003",{"id":26,"text":3231,"url":26,"identifiers":3232},"Rempel, 2000, Identification and localization of the cytokine SDF1 and its receptor. CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma, Clin Cancer Res, 6, 102",{},{"id":26,"text":3234,"url":26,"identifiers":3235},"Zhou, 2002, CXCR4 is a major chemokine receptor on glioma cells and mediates their survival, J Biol Chem, 277, 49481, 10.1074\u002Fjbc.M206222200",{"doi":3236},"10.1074\u002Fjbc.M206222200",{"id":26,"text":3238,"url":26,"identifiers":3239},"Ma, 2009, CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model, Mol Cancer Ther, 8, 490, 10.1158\u002F1535-7163.MCT-08-0485",{"doi":3240},"10.1158\u002F1535-7163.MCT-08-0485",{"id":26,"text":3242,"url":26,"identifiers":3243},"Walser, 2006, Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer, Cancer Res, 66, 7701, 10.1158\u002F0008-5472.CAN-06-0709",{"doi":3244},"10.1158\u002F0008-5472.CAN-06-0709",{"id":26,"text":3246,"url":26,"identifiers":3247},"Kawada, 2004, Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes, Cancer Res, 64, 4010, 10.1158\u002F0008-5472.CAN-03-1757",{"doi":3248},"10.1158\u002F0008-5472.CAN-03-1757",{"id":26,"text":3250,"url":26,"identifiers":3251},"Kawada, 2007, Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes, Oncogene, 26, 4679, 10.1038\u002Fsj.onc.1210267",{"doi":3252},"10.1038\u002Fsj.onc.1210267",{"id":26,"text":3254,"url":26,"identifiers":3255},"Jones, 2000, The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia, Blood, 95, 627, 10.1182\u002Fblood.V95.2.627",{"doi":3256},"10.1182\u002Fblood.V95.2.627",{"id":26,"text":3258,"url":26,"identifiers":3259},"Ghadjar, 2006, Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer, J Clin Oncol, 24, 1910, 10.1200\u002FJCO.2005.04.1822",{"doi":3260},"10.1200\u002FJCO.2005.04.1822",{"id":26,"text":3262,"url":26,"identifiers":3263},"Meijer, 2006, The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver, Cancer Res, 66, 9576, 10.1158\u002F0008-5472.CAN-06-1507",{"doi":3264},"10.1158\u002F0008-5472.CAN-06-1507",{"id":26,"text":3266,"url":26,"identifiers":3267},"Ding, 2003, Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma, Clin Cancer Res, 9, 3406",{},{"id":26,"text":3269,"url":26,"identifiers":3270},"Gunther, 2005, Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7, Int J Cancer, 116, 726, 10.1002\u002Fijc.21123",{"doi":3271},"10.1002\u002Fijc.21123",{"id":26,"text":3273,"url":26,"identifiers":3274},"Mashino, 2002, Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma, Cancer Res, 62, 2937",{},{"id":26,"text":3276,"url":26,"identifiers":3277},"Takanami, 2003, Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis, Int J Cancer, 105, 186, 10.1002\u002Fijc.11063",{"doi":3278},"10.1002\u002Fijc.11063",{"id":26,"text":3280,"url":26,"identifiers":3281},"Takeuchi, 2004, CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells, Clin Cancer Res, 10, 2351, 10.1158\u002F1078-0432.CCR-03-0195",{"doi":3282},"10.1158\u002F1078-0432.CCR-03-0195",{"id":26,"text":3284,"url":26,"identifiers":3285},"Wiley, 2001, Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma, J Natl Cancer Inst, 93, 1638, 10.1093\u002Fjnci\u002F93.21.1638",{"doi":3286},"10.1093\u002Fjnci\u002F93.21.1638",{"id":26,"text":3288,"url":26,"identifiers":3289},"Cabioglu, 2005, CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer, Clin Cancer Res, 11, 5686, 10.1158\u002F1078-0432.CCR-05-0014",{"doi":3290},"10.1158\u002F1078-0432.CCR-05-0014",{"id":26,"text":3292,"url":26,"identifiers":3293},"Ghadjar, 2009, The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer, Int J Cancer, 125, 741, 10.1002\u002Fijc.24468",{"doi":3294},"10.1002\u002Fijc.24468",{"id":26,"text":3296,"url":26,"identifiers":3297},"Harasawa, 2006, Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia\u002Flymphoma, Leuk Lymphoma, 47, 2163, 10.1080\u002F10428190600775599",{"doi":3298},"10.1080\u002F10428190600775599",{"id":26,"text":3300,"url":26,"identifiers":3301},"Ishida, 2003, Clinical significance of CCR4 expression in adult T-cell leukemia\u002Flymphoma: its close association with skin involvement and unfavorable outcome, Clin Cancer Res, 9, 3625",{},{"id":26,"text":3303,"url":26,"identifiers":3304},"Kleinhans, 2003, Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma, Blood, 101, 1487, 10.1182\u002Fblood-2002-02-0475",{"doi":3305},"10.1182\u002Fblood-2002-02-0475",{"id":26,"text":3307,"url":26,"identifiers":3308},"Letsch, 2004, Functional CCR9 expression is associated with small intestinal metastasis, J Invest Dermatol, 122, 685, 10.1111\u002Fj.0022-202X.2004.22315.x",{"doi":3309},"10.1111\u002Fj.0022-202X.2004.22315.x",{"id":26,"text":3311,"url":26,"identifiers":3312},"Simonetti, 2006, Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape, Eur J Cancer, 42, 1181, 10.1016\u002Fj.ejca.2006.01.043",{"doi":3313},"10.1016\u002Fj.ejca.2006.01.043",{"id":26,"text":3315,"url":26,"identifiers":3316},"Buri, 2001, CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease, Blood, 97, 1543, 10.1182\u002Fblood.V97.6.1543",{"doi":3317},"10.1182\u002Fblood.V97.6.1543",{"id":26,"text":3319,"url":26,"identifiers":3320},"Shulby, 2004, CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells, Cancer Res, 64, 4693, 10.1158\u002F0008-5472.CAN-03-3437",{"doi":3321},"10.1158\u002F0008-5472.CAN-03-3437",{"id":26,"text":3323,"url":26,"identifiers":3324},"Marchesi, 2008, The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma, Cancer Res, 68, 9060, 10.1158\u002F0008-5472.CAN-08-1810",{"doi":3325},"10.1158\u002F0008-5472.CAN-08-1810",{"id":26,"text":3327,"url":26,"identifiers":3328},"Darash-Yahana, 2004, Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis, FASEB J, 18, 1240, 10.1096\u002Ffj.03-0935fje",{"doi":3329},"10.1096\u002Ffj.03-0935fje",{"id":26,"text":3331,"url":26,"identifiers":3332},"Singh, 2009, CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion, Br J Cancer, 100, 1638, 10.1038\u002Fsj.bjc.6605055",{"doi":3333},"10.1038\u002Fsj.bjc.6605055",{"id":26,"text":3335,"url":26,"identifiers":3336},"Wang, 2006, A growth-related oncogene\u002FCXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer, Cancer Res, 66, 3071, 10.1158\u002F0008-5472.CAN-05-2871",{"doi":3337},"10.1158\u002F0008-5472.CAN-05-2871",{"id":26,"text":3339,"url":26,"identifiers":3340},"Wang, 2008, Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy, J Natl Cancer Inst, 100, 502, 10.1093\u002Fjnci\u002Fdjn059",{"doi":3341},"10.1093\u002Fjnci\u002Fdjn059",{"id":26,"text":3343,"url":26,"identifiers":3344},"Murakami, 2003, Immune evasion by murine melanoma mediated through CC chemokine receptor-10, J Exp Med, 198, 1337, 10.1084\u002Fjem.20030593",{"doi":3345},"10.1084\u002Fjem.20030593",{"id":26,"text":3347,"url":26,"identifiers":3348},"Manes, 2003, CCR5 expression influences the progression of human breast cancer in a p53-dependent manner, J Exp Med, 198, 1381, 10.1084\u002Fjem.20030580",{"doi":3349},"10.1084\u002Fjem.20030580",{"id":26,"text":3351,"url":26,"identifiers":3352},"Mooi, 2006, Oncogene-induced cell senescence—halting on the road to cancer, N Engl J Med, 355, 1037, 10.1056\u002FNEJMra062285",{"doi":3353},"10.1056\u002FNEJMra062285",{"id":26,"text":3355,"url":26,"identifiers":3356},"d’Adda di Fagagna, 2008, Living on a break: cellular senescence as a DNA-damage response, Nat Rev Cancer, 8, 512, 10.1038\u002Fnrc2440",{"doi":3357},"10.1038\u002Fnrc2440",{"id":26,"text":3359,"url":26,"identifiers":3360},"Coppe, 2008, Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor, PLoS Biol, 6, 2853, 10.1371\u002Fjournal.pbio.0060301",{"doi":3361},"10.1371\u002Fjournal.pbio.0060301",{"id":26,"text":3363,"url":26,"identifiers":3364},"Acosta, 2008, Chemokine signaling via the CXCR2 receptor reinforces senescence, Cell, 133, 1006, 10.1016\u002Fj.cell.2008.03.038",{"doi":3365},"10.1016\u002Fj.cell.2008.03.038",{"id":26,"text":3367,"url":26,"identifiers":3368},"Kuilman, 2008, Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, Cell, 133, 1019, 10.1016\u002Fj.cell.2008.03.039",{"doi":3369},"10.1016\u002Fj.cell.2008.03.039",{"id":26,"text":3371,"url":26,"identifiers":3372},"Acosta, 2009, A role for CXCR2 in senescence, but what about in cancer?, Cancer Res, 69, 2167, 10.1158\u002F0008-5472.CAN-08-3772",{"doi":3373},"10.1158\u002F0008-5472.CAN-08-3772",{"id":26,"text":3375,"url":26,"identifiers":3376},"Mangalmurti, 2009, Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation, Blood, 113, 1158, 10.1182\u002Fblood-2008-07-166264",{"doi":3377},"10.1182\u002Fblood-2008-07-166264",{"id":26,"text":3379,"url":26,"identifiers":3380},"Pruenster, 2009, The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity, Nat Immunol, 10, 101, 10.1038\u002Fni.1675",{"doi":3381},"10.1038\u002Fni.1675",{"id":26,"text":3383,"url":26,"identifiers":3384},"Addison, 2004, Overexpression of the Duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis, BMC Cancer, 4, 28, 10.1186\u002F1471-2407-4-28",{"doi":3385},"10.1186\u002F1471-2407-4-28",{"id":26,"text":3387,"url":26,"identifiers":3388},"Horton, 2007, Opposing roles of murine Duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth, Cancer Res, 67, 9791, 10.1158\u002F0008-5472.CAN-07-0246",{"doi":3389},"10.1158\u002F0008-5472.CAN-07-0246",{"id":26,"text":3391,"url":26,"identifiers":3392},"Lentsch, 2002, The Duffy antigen\u002Freceptor for chemokines (DARC) and prostate cancer. A role as clear as black and white?, FASEB J, 16, 1093, 10.1096\u002Ffj.02-0066hyp",{"doi":3393},"10.1096\u002Ffj.02-0066hyp",{"id":26,"text":3395,"url":26,"identifiers":3396},"Waugh, 2008, Multi-faceted roles for CXC-chemokines in prostate cancer progression, Front Biosci, 13, 4595, 10.2741\u002F3025",{"doi":3397},"10.2741\u002F3025",{"id":26,"text":3399,"url":26,"identifiers":3400},"Shen, 2006, The Duffy antigen\u002Freceptor for chemokines (DARC) regulates prostate tumor growth, Faseb J, 20, 59, 10.1096\u002Ffj.05-4764com",{"doi":3401},"10.1096\u002Ffj.05-4764com",{"id":26,"text":3403,"url":26,"identifiers":3404},"Bandyopadhyay, 2006, Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression, Nat Med, 12, 933, 10.1038\u002Fnm1444",{"doi":3405},"10.1038\u002Fnm1444",{"id":26,"text":3407,"url":26,"identifiers":3408},"Hemler, 2005, Tetraspanin functions and associated microdomains, Nat Rev Mol Cell Biol, 6, 801, 10.1038\u002Fnrm1736",{"doi":3409},"10.1038\u002Fnrm1736",{"id":26,"text":3411,"url":26,"identifiers":3412},"Horuk, 1994, Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line, J Biol Chem, 269, 17730, 10.1016\u002FS0021-9258(17)32501-2",{"doi":3413},"10.1016\u002FS0021-9258(17)32501-2",{"id":26,"text":3415,"url":26,"identifiers":3416},"Desbaillets, 1997, Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis, J Exp Med, 186, 1201, 10.1084\u002Fjem.186.8.1201",{"doi":3417},"10.1084\u002Fjem.186.8.1201",{"id":26,"text":3419,"url":26,"identifiers":3420},"Tang, 1998, Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines, DNA Seq, 9, 129, 10.3109\u002F10425179809072188",{"doi":3421},"10.3109\u002F10425179809072188",{"id":26,"text":3423,"url":26,"identifiers":3424},"Wang, 2006, Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential, Oncogene, 25, 7201, 10.1038\u002Fsj.onc.1209703",{"doi":3425},"10.1038\u002Fsj.onc.1209703",{"id":26,"text":3427,"url":26,"identifiers":3428},"Martinez de la Torre, 2007, Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6, Proc Natl Acad Sci USA, 104, 2319, 10.1073\u002Fpnas.0607514104",{"doi":3429},"10.1073\u002Fpnas.0607514104",{"id":26,"text":3431,"url":26,"identifiers":3432},"Nibbs, 2001, The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors, Am J Pathol, 158, 867, 10.1016\u002FS0002-9440(10)64035-7",{"doi":3433},"10.1016\u002FS0002-9440(10)64035-7",{"id":26,"text":3435,"url":26,"identifiers":3436},"McKimmie, 2008, Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1, J Immunol, 181, 8171, 10.4049\u002Fjimmunol.181.5.3353",{"doi":3437},"10.4049\u002Fjimmunol.181.5.3353",{"id":26,"text":3439,"url":26,"identifiers":3440},"Daibata, 2004, Differential gene-expression profiling in the leukemia cell lines derived from indolent and aggressive phases of CD56+ T-cell large granular lymphocyte leukemia, Int J Cancer, 108, 845, 10.1002\u002Fijc.11647",{"doi":3441},"10.1002\u002Fijc.11647",{"id":26,"text":3443,"url":26,"identifiers":3444},"Wu, 2008, Chemokine decoy receptor d6 plays a negative role in human breast cancer, Mol Cancer Res, 6, 1276, 10.1158\u002F1541-7786.MCR-07-2108",{"doi":3445},"10.1158\u002F1541-7786.MCR-07-2108",{"id":26,"text":3447,"url":26,"identifiers":3448},"Wang, 2008, The role of CXCR7\u002FRDC1 as a chemokine receptor for CXCL12\u002FSDF-1 in prostate cancer, J Biol Chem, 283, 4283, 10.1074\u002Fjbc.M707465200",{"doi":3449},"10.1074\u002Fjbc.M707465200",{"id":26,"text":3451,"url":26,"identifiers":3452},"Burns, 2006, A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development, J Exp Med, 203, 2201, 10.1084\u002Fjem.20052144",{"doi":3453},"10.1084\u002Fjem.20052144",{"id":26,"text":3455,"url":26,"identifiers":3456},"Raggo, 2005, Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus, Cancer Res, 65, 5084, 10.1158\u002F0008-5472.CAN-04-2822",{"doi":3457},"10.1158\u002F0008-5472.CAN-04-2822",{"id":26,"text":3459,"url":26,"identifiers":3460},"Iwakiri, 2009, Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer, Cancer, 115, 2580, 10.1002\u002Fcncr.24281",{"doi":3461},"10.1002\u002Fcncr.24281",{"id":26,"text":3463,"url":26,"identifiers":3464},"Broberg, 2002, Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15, Int J Oncol, 21, 321",{},{"id":26,"text":3466,"url":26,"identifiers":3467},"van Rechem, 2009, The scavenger chemokine (C-X-C motif)receptor7 CXCR7 is a direct target gene of hypermethylated in cancer 1 HIC1, J Biol Chem, 10.1074\u002Fjbc.M109.022350",{"doi":3468},"10.1074\u002Fjbc.M109.022350",{"id":26,"text":3470,"url":26,"identifiers":3471},"Takenaga, 2004, A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma, Biochem Biophys Res Commun, 320, 226, 10.1016\u002Fj.bbrc.2004.05.155",{"doi":3472},"10.1016\u002Fj.bbrc.2004.05.155",{"id":26,"text":3474,"url":26,"identifiers":3475},"Tamamura, 2003, T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer, FEBS Lett, 550, 79, 10.1016\u002FS0014-5793(03)00824-X",{"doi":3476},"10.1016\u002FS0014-5793(03)00824-X",{"id":26,"text":3478,"url":26,"identifiers":3479},"Kim, 2008, Inhibition of the CXCR4\u002FCXCL12 chemokine pathway reduces the development of murine pulmonary metastases, Clin Exp Metastasis, 25, 201, 10.1007\u002Fs10585-007-9133-3",{"doi":3480},"10.1007\u002Fs10585-007-9133-3",{"id":26,"text":3482,"url":26,"identifiers":3483},"Porvasnik, 2009, Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth, Prostate, 10.1002\u002Fpros.21008",{"doi":3484},"10.1002\u002Fpros.21008",{"id":26,"text":3486,"url":26,"identifiers":3487},"Richert, 2009, Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone, Oncol Rep, 21, 761",{},{"id":26,"text":3489,"url":26,"identifiers":3490},"Kwong, 2009, An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells, Mol Cancer Ther, 8, 1893, 10.1158\u002F1535-7163.MCT-08-0966",{"doi":3491},"10.1158\u002F1535-7163.MCT-08-0966",{"id":26,"text":3493,"url":26,"identifiers":3494},"Liles, 2003, Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood, 102, 2728, 10.1182\u002Fblood-2003-02-0663",{"doi":3495},"10.1182\u002Fblood-2003-02-0663",{"id":26,"text":3497,"url":26,"identifiers":3498},"De Clercq, 2009, The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil), Biochem Pharmacol, 77, 1655, 10.1016\u002Fj.bcp.2008.12.014",{"doi":3499},"10.1016\u002Fj.bcp.2008.12.014",{"id":26,"text":3501,"url":26,"identifiers":3502},"Perissinotto, 2005, Involvement of chemokine receptor 4\u002Fstromal cell-derived factor 1 system during osteosarcoma tumor progression, Clin Cancer Res, 11, 490, 10.1158\u002F1078-0432.490.11.2",{"doi":3503},"10.1158\u002F1078-0432.490.11.2",{"id":26,"text":3505,"url":26,"identifiers":3506},"Li, 2009, A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone, Cancer Res, 69, 1685, 10.1158\u002F0008-5472.CAN-08-2164",{"doi":3507},"10.1158\u002F0008-5472.CAN-08-2164",{"id":26,"text":3509,"url":26,"identifiers":3510},"Rozel, 2009, Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model, J Cell Biochem, 107, 58, 10.1002\u002Fjcb.22056",{"doi":3511},"10.1002\u002Fjcb.22056",{"id":26,"text":3513,"url":26,"identifiers":3514},"Ito, 2009, Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD\u002FShi-scid. IL-2Rgamma(null) mouse model, Cancer Immunol Immunother, 58, 1195, 10.1007\u002Fs00262-008-0632-0",{"doi":3515},"10.1007\u002Fs00262-008-0632-0",{"id":26,"text":3517,"url":26,"identifiers":3518},"Huang, 2002, Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma, Am J Pathol, 161, 125, 10.1016\u002FS0002-9440(10)64164-8",{"doi":3519},"10.1016\u002FS0002-9440(10)64164-8",{"id":26,"text":3521,"url":26,"identifiers":3522},"Melnikova, 2006, Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM\u002FMUC18 and IL-8, Pigment Cell Res, 19, 395, 10.1111\u002Fj.1600-0749.2006.00331.x",{"doi":3523},"10.1111\u002Fj.1600-0749.2006.00331.x",{"id":26,"text":3525,"url":26,"identifiers":3526},"Mian, 2003, Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB, Clin Cancer Res, 9, 3167",{},{"id":26,"text":3528,"url":26,"identifiers":3529},"Zigler, 2008, Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape, Am J Clin Dermatol, 9, 307, 10.2165\u002F00128071-200809050-00004",{"doi":3530},"10.2165\u002F00128071-200809050-00004",{"id":26,"text":3532,"url":26,"identifiers":3533},"DeNardo, 2009, CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages, Cancer Cell, 16, 91, 10.1016\u002Fj.ccr.2009.06.018",{"doi":3534},"10.1016\u002Fj.ccr.2009.06.018",{"id":26,"text":3536,"url":26,"identifiers":3537},"Ohta, 2005, The high expression of Fractalkine results in a better prognosis for colorectal cancer patients, Int J Oncol, 26, 41",{},{"id":26,"text":3539,"url":26,"identifiers":3540},"Orjalo, 2009, Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6\u002FIL-8 cytokine network, Proc Natl Acad Sci USA, 106, 17031, 10.1073\u002Fpnas.0905299106",{"doi":3541},"10.1073\u002Fpnas.0905299106",{"id":26,"text":3543,"url":26,"identifiers":3544},"Popivanova, 2009, Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice, Cancer Res, 69, 7884, 10.1158\u002F0008-5472.CAN-09-1451",{"doi":3545},"10.1158\u002F0008-5472.CAN-09-1451",{"id":3547,"createTime":3548,"updateTime":3548,"relativeEntities":3549,"slug":3550,"properties":3551,"entityType":788,"verifyStatus":25,"verifyTime":3548,"verifyNote":790,"syncStatus":28,"languages":3564,"translateLanguages":26,"viewCount":36,"primaryUrl":3565,"fullTextUrl":26,"authors":3566,"publicationType":880,"publisherRelationship":3588,"citationCount":3617,"citationInfo":3618,"publishDate":3620,"publishYear":3621,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3622,"isForceReanalyzing":1290},"cef1ce32-0010-4d18-bdc0-4b9b7a504529","2024-10-05T04:59:53.975+00:00",[],"Keratinocyte-Growth-Factor-A-Unique-Player-in-Epithelial-Repair-Processes",{"mag":3552,"keywords":3554,"openalex":3555,"abstract":3557,"title":3558,"pm":3560,"doi":3562},{"VOID":3553},"2080716137",{},{"VOID":3556},"W2080716137",{},{"EN":3559},"Keratinocyte Growth Factor: A Unique Player in Epithelial Repair Processes",{"VOID":3561},"9754709",{"VOID":3563},"10.1016\u002Fs1359-6101(98)00010-0",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610198000100",[3567],{"id":3568,"sortIndex":36,"researcher":26,"roles":3569,"affiliations":3570,"properties":3581},"0df0f54d-1123-44ee-810c-ce1cbe8ed3e3",[],[3571],{"id":3572,"sortIndex":36,"affiliation":3573,"properties":26},"ec9f6036-8919-453d-a9e1-6f358a603e86",{"id":3574,"createTime":3575,"updateTime":3575,"relativeEntities":3576,"slug":3577,"properties":3578,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7d589911-353b-4e54-bc5b-a549a05795ef","2024-10-05T04:59:53.989+00:00",[],"Max-Planck-Institut-f%C3%BCr-Biochemie-Martinsried-Germany-werner-biochem-mpg-de",{"title":3579},{"EN":3580},"Max-Planck-Institut für Biochemie, Martinsried, Germany. werner@biochem.mpg.de",{"openalex":3582,"orcid":3584,"title":3586},{"VOID":3583},"A5077079745",{"VOID":3585},"https:\u002F\u002Forcid.org\u002F0000-0001-7397-8710",{"EN":3587},"Sabine Werner",{"url":26,"publisher":3589,"properties":3611},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3590,"slug":663,"properties":3591,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":3594,"manageAffiliations":3595,"indexDatabases":3596,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":3592,"title":3593},{"VOID":666},{"EN":668},[],[],[3597,3604],{"id":747,"indexDatabase":3598,"url":762,"indexYears":26,"academicFieldIds":3603,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":3599,"label":3600,"description":3601,"key":758,"publicationTags":3602,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":3605,"url":738,"indexYears":739,"academicFieldIds":3610,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":3606,"label":3607,"description":3608,"key":735,"publicationTags":3609,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":3612,"pages":3614,"issue":3616},{"VOID":3613},"9",{"VOID":3615},"153-165",{"VOID":2271},342,{"total":3617,"publishYear":26,"statisticByYear":3619},{"2012":103,"2013":51,"2014":336,"2015":52,"2016":158,"2017":162,"2018":298,"2019":59,"2020":135,"2021":135,"2022":52,"2023":162,"2024":135},"1998-05-01",1998,[3623,3627,3631,3635,3639,3643,3646,3650,3654,3658,3662,3666,3670,3674,3678,3682,3686,3690,3694,3698,3702,3706,3710,3713,3717,3720,3724,3728,3732,3736,3740,3744,3748,3752,3755,3758,3762,3766,3770,3773,3777,3781,3785,3788,3792,3796,3800,3804,3808,3811,3815,3819,3822,3826,3830,3834,3838,3842,3846,3850,3853,3857,3860,3864,3867,3871,3875,3879,3883,3887,3891,3895,3899,3903,3907,3911,3915,3919,3922,3926,3930,3933,3936,3940,3944,3948,3951,3955,3959,3963,3966,3969,3973,3977,3980,3983,3987,3990,3993,3997,4001,4005,4009,4013,4017,4021],{"id":26,"text":3624,"url":26,"identifiers":3625},"Jaye M, Howk R, Burgess W et al. Human endothelial cell growth factor: cloning, nucleotide sequence and chromosome localization. Science 1986, 233, 541–545.",{"doi":3626},"10.1126\u002Fscience.3523756",{"id":26,"text":3628,"url":26,"identifiers":3629},"Abraham JA, Whang JL, Tumolo A et al. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J 1986, 5, 2523–2528.",{"doi":3630},"10.1002\u002Fj.1460-2075.1986.tb04530.x",{"id":26,"text":3632,"url":26,"identifiers":3633},"Moore R, Casey G, Brookes S, Dixon M, Peters G, Dickson D. Sequence, topography and protein coding potential for mouse int-2: A putative oncogene activated by mouse mammary tumour virus. EMBO J 1986, 5, 919–926.",{"doi":3634},"10.1002\u002Fj.1460-2075.1986.tb04304.x",{"id":26,"text":3636,"url":26,"identifiers":3637},"Delli-Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M, Basilico C. An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 1987, 50, 729–737.",{"doi":3638},"10.1016\u002F0092-8674(87)90331-X",{"id":26,"text":3640,"url":26,"identifiers":3641},"Zhan X, Bates B, Hu X, Goldfarb M. The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol 1988, 8, 3487–3495.",{"doi":3642},"10.1128\u002FMCB.8.8.3487",{"id":26,"text":3644,"url":26,"identifiers":3645},"Marics I, Adelaide J, Raybaud F et al. Characterization of the HST-related FGF-6 gene, a new member of the fibroblast growth factor gene family. Oncogene 1989, 4, 335–340.",{},{"id":26,"text":3647,"url":26,"identifiers":3648},"Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U.S.A. 1989, 86, 802–806.",{"doi":3649},"10.1073\u002Fpnas.86.3.802",{"id":26,"text":3651,"url":26,"identifiers":3652},"Tanaka A, Miyamoto K, Minamino N et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci U.S.A. 1992, 89, 8928–8932.",{"doi":3653},"10.1073\u002Fpnas.89.19.8928",{"id":26,"text":3655,"url":26,"identifiers":3656},"Miyamoto M, Naruo K-I, Seko C, Matsumoto S, Kondo T, Kurokawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 1993, 13, 4251–4259.",{"doi":3657},"10.1128\u002FMCB.13.7.4251",{"id":26,"text":3659,"url":26,"identifiers":3660},"Yamasaki M, Miyake A, Tagashira S, Itoh N. Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J Biol Chem 1996, 271, 15918–15921.",{"doi":3661},"10.1074\u002Fjbc.271.27.15918",{"id":26,"text":3663,"url":26,"identifiers":3664},"Smallwood PM, Munoz-Sanjuan I, Tong P et al. Fibroblast growth factor (FGF) homologous factors: New members of the FGF family implicated in nervous system development. Proc Natl Acad Sci U.S.A. 1996, 93, 9850–9857.",{"doi":3665},"10.1073\u002Fpnas.93.18.9850",{"id":26,"text":3667,"url":26,"identifiers":3668},"Mcwhirter JR, Goulding M, Weiner JA, Chun J, Murre C. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-PBX1. Development 1997, 124, 3221–3232.",{"doi":3669},"10.1242\u002Fdev.124.17.3221",{"id":26,"text":3671,"url":26,"identifiers":3672},"Miyake A, Konishi M, Martin FH et al. Structure and expression of a novel member, FGF-16, of the fibroblast growth factor family. Biochem Biophys Res Commun 1988, 243, 148–152.",{"doi":3673},"10.1006\u002Fbbrc.1998.8073",{"id":26,"text":3675,"url":26,"identifiers":3676},"Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992, 59, 115–165.",{"doi":3677},"10.1016\u002FS0065-230X(08)60305-X",{"id":26,"text":3679,"url":26,"identifiers":3680},"Morrison RS, Sharma A, deVellis J, Bradshaw RA. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci U.S.A. 1986, 83, 7537–7541.",{"doi":3681},"10.1073\u002Fpnas.83.19.7537",{"id":26,"text":3683,"url":26,"identifiers":3684},"Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci U.S.A. 1986, 83, 3012–3016.",{"doi":3685},"10.1073\u002Fpnas.83.9.3012",{"id":26,"text":3687,"url":26,"identifiers":3688},"Folkman J, Klagsburn M. Angiogenic factors. Science 1987, 235, 442–447.",{"doi":3689},"10.1126\u002Fscience.2432664",{"id":26,"text":3691,"url":26,"identifiers":3692},"Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cells. Science 1989, 145, 752–755.",{"doi":3693},"10.1126\u002Fscience.2475908",{"id":26,"text":3695,"url":26,"identifiers":3696},"Burrus LW, Zuber ME, Lueddecke BA, Olwin BB. Identification of a cysteine-rich receptor for fibroblast growth factors. Mol Cell Biol 1992, 12, 5600–5609.",{"doi":3697},"10.1128\u002FMCB.12.12.5600",{"id":26,"text":3699,"url":26,"identifiers":3700},"Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993, 60, 1–41.",{"doi":3701},"10.1016\u002FS0065-230X(08)60821-0",{"id":26,"text":3703,"url":26,"identifiers":3704},"Ornitz DM, Xu JS, Colvin JS et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996, 271, 15292–15297.",{"doi":3705},"10.1074\u002Fjbc.271.25.15292",{"id":26,"text":3707,"url":26,"identifiers":3708},"Werner S, Duan D-SR, deVries C, Peters KG, Johnson DE, Wiliams LT. Differential splicing in the extracellular region of FGF receptor 1 generates receptor variants with different ligand binding specificities. Mol Cell Biol 1992, 12, 82–88.",{"doi":3709},"10.1128\u002FMCB.12.1.82",{"id":26,"text":3711,"url":26,"identifiers":3712},"Miki, 1992, Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U.S.A., 89, 246",{},{"id":26,"text":3714,"url":26,"identifiers":3715},"Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM. Fibroblast growth factor receptor 3: Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF\\FGF-1. J Biol Chem 1994, 269, 11620–11627.",{"doi":3716},"10.1016\u002FS0021-9258(19)78170-8",{"id":26,"text":3718,"url":26,"identifiers":3719},"Ron, 1993, Structure\\function analysis of amino-terminal truncation mutants. J Biol Chem, 268, 2984",{},{"id":26,"text":3721,"url":26,"identifiers":3722},"Smola H, Thiekötter, Fusenig NE. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 1993, 122, 417–429.",{"doi":3723},"10.1083\u002Fjcb.122.2.417",{"id":26,"text":3725,"url":26,"identifiers":3726},"Winkles JA, Alberts GF, Chedid M, Taylor WG, Demartino S, Rubin JS. Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries. J Cell Physiol 1997, 173, 380–386.",{"doi":3727},"10.1002\u002F(SICI)1097-4652(199712)173:3\u003C380::AID-JCP10>3.0.CO;2-G",{"id":26,"text":3729,"url":26,"identifiers":3730},"Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial γδT cells. Science 1994, 266, 1253–1255.",{"doi":3731},"10.1126\u002Fscience.7973709",{"id":26,"text":3733,"url":26,"identifiers":3734},"Finch PW, Lengel C, Chedid M. Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J Biol Chem 1995, 270, 11230–11237.",{"doi":3735},"10.1074\u002Fjbc.270.19.11230",{"id":26,"text":3737,"url":26,"identifiers":3738},"Rubin JS, Bottaro DP, Chedid M et al. Keratinocyte growth factor. Cell Biol Internat 1995, 19, 399–411.",{"doi":3739},"10.1006\u002Fcbir.1995.1085",{"id":26,"text":3741,"url":26,"identifiers":3742},"Guo L, Yu Q-C, Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J 1993, 12, 973–986.",{"doi":3743},"10.1002\u002Fj.1460-2075.1993.tb05738.x",{"id":26,"text":3745,"url":26,"identifiers":3746},"Housley RM, Morris CF, Boyle W et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994, 94, 1764–1777.",{"doi":3747},"10.1172\u002FJCI117524",{"id":26,"text":3749,"url":26,"identifiers":3750},"Yi ES, Shabaik AS, Lacey DL et al. Keratinocyte growth factor causes proliferation of urothelium in vivo. J Urol 1995, 154, 1566–1570.",{"doi":3751},"10.1016\u002FS0022-5347(01)66930-1",{"id":26,"text":3753,"url":26,"identifiers":3754},"Ulich TR, Yi ES, Cardiff R et al. Keratinocyte growth factor is a growth factor for mammary epithelium in vivo: the mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor. Am J Pathol 1994, 144, 862–868.",{},{"id":26,"text":3756,"url":26,"identifiers":3757},"Nguyen HQ, Danilenko DM, Bucay N et al. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene 1996, 12, 2109–2119.",{},{"id":26,"text":3759,"url":26,"identifiers":3760},"Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda M, Williams LT. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U.S.A. 1992, 89, 6896–6900.",{"doi":3761},"10.1073\u002Fpnas.89.15.6896",{"id":26,"text":3763,"url":26,"identifiers":3764},"Mason YJ, Fuller-Pace F, Smith R, Dickson C. FGF-7 (Keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech Dev 1994, 45, 15–30.",{"doi":3765},"10.1016\u002F0925-4773(94)90050-7",{"id":26,"text":3767,"url":26,"identifiers":3768},"Finch PW, Cunha GR, Rubin JS, Wong J, Ron D. Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dynamics 1995, 203, 223–240.",{"doi":3769},"10.1002\u002Faja.1002030210",{"id":26,"text":3771,"url":26,"identifiers":3772},"Danilenko DM, Ring BD, Yanagihara D et al. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Am J Pathol 1995, 147, 145–154.",{},{"id":26,"text":3774,"url":26,"identifiers":3775},"Rosenquist TA, Martin GR. Fibroblast growth factor signalling in the hair growth cycle: Expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle. Dev Dyn 1996, 205, 379–386.",{"doi":3776},"10.1002\u002F(SICI)1097-0177(199604)205:4\u003C379::AID-AJA2>3.0.CO;2-F",{"id":26,"text":3778,"url":26,"identifiers":3779},"Orr-Urtreger A, Bedford MT, Burakova T et al. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993, 158, 475–486.",{"doi":3780},"10.1006\u002Fdbio.1993.1205",{"id":26,"text":3782,"url":26,"identifiers":3783},"Werner S, Weinberg W, Liao X et al. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J 1993, 12, 2635–2643.",{"doi":3784},"10.1002\u002Fj.1460-2075.1993.tb05924.x",{"id":26,"text":3786,"url":26,"identifiers":3787},"Werner S, Smola H, Liao X et al. The function of KGF in epithelial morphogenesis and wound reepithelialization. Science 1994, 266, 819–822.",{"doi":2353},{"id":26,"text":3789,"url":26,"identifiers":3790},"Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U.S.A. 1989, 86, 1563–1567.",{"doi":3791},"10.1073\u002Fpnas.86.5.1563",{"id":26,"text":3793,"url":26,"identifiers":3794},"Honegger AM, Schmidt A, Ullrich A, Schlessinger J. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Mol Cell Biol 1990, 10, 4035–4044.",{"doi":3795},"10.1128\u002FMCB.10.8.4035",{"id":26,"text":3797,"url":26,"identifiers":3798},"Kashles O, Yarden Y, Fischer R, Ullrich A, Schlessinger J. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Moll Cell Biol 1991, 11, 1454–1463.",{"doi":3799},"10.1128\u002FMCB.11.3.1454",{"id":26,"text":3801,"url":26,"identifiers":3802},"Ueno H, Colbert H, Escobedo JA, Williams LT. Inhibition of PDGF β-receptor by co-expression of a truncated receptor. Science 1991, 252, 844–848.",{"doi":3803},"10.1126\u002Fscience.1851331",{"id":26,"text":3805,"url":26,"identifiers":3806},"Ueno H, Gunn M, Dell K, Tseng A, Williams LT. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J Biol Chem 1992, 267, 1470–1476.",{"doi":3807},"10.1016\u002FS0021-9258(18)45969-8",{"id":26,"text":3809,"url":26,"identifiers":3810},"Ueno, 1993, Inhibition of receptor function by ligand-dependent formation of heterodimers between PDGF alpha- and beta-receptors. J Biol Chem, 268, 22814",{},{"id":26,"text":3812,"url":26,"identifiers":3813},"Guo L, Degenstein L, Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes & Dev 1996, 10, 165–175.",{"doi":3814},"10.1101\u002Fgad.10.2.165",{"id":26,"text":3816,"url":26,"identifiers":3817},"Beer H-D, Florence C, Dammeier J, McGuire L, Werner S, Duan DR. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene 1997, 15, 2211–2218.",{"doi":3818},"10.1038\u002Fsj.onc.1201383",{"id":26,"text":3820,"url":26,"identifiers":3821},"Clark RAF. Cutaneous wound repair. In Goldsmith LA ed. Physiology, Biochemistry, and Molecular Biology of the skin. Oxford University Press, New York, 1991, 576–601.",{},{"id":26,"text":3823,"url":26,"identifiers":3824},"Marchese C, Chedid M, Dirsch OR et al. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 1995, 182, 1369–1376.",{"doi":3825},"10.1084\u002Fjem.182.5.1369",{"id":26,"text":3827,"url":26,"identifiers":3828},"Werner S, Breeden M, Hübner G, Greenhalgh DG, Longaker MT. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. J Invest Dermatol 1994, 103, 469–473.",{"doi":3829},"10.1111\u002F1523-1747.ep12395564",{"id":26,"text":3831,"url":26,"identifiers":3832},"Brauchle M, Fässler R, Werner S. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Invest Dermatol 1995, 105, 579–584.",{"doi":3833},"10.1111\u002F1523-1747.ep12323521",{"id":26,"text":3835,"url":26,"identifiers":3836},"Tsuboi R, Sato C, Kurita Y, Ron D, Rubin JS, Ogawa H. Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes. J Invest Dermatol 1993, 101, 49–53.",{"doi":3837},"10.1111\u002F1523-1747.ep12358892",{"id":26,"text":3839,"url":26,"identifiers":3840},"Putnins EE, Firth JD, Uitto V-J. Keratinocyte growth factor stimulation of gelatinase (matrix metalloproteinase-9) and plasminogen activator in histiotypic epithelial cell culture. J Invest Dermatol 1995, 104, 989–994.",{"doi":3841},"10.1111\u002F1523-1747.ep12606233",{"id":26,"text":3843,"url":26,"identifiers":3844},"Staiano-Coico L, Krueger JG, Rubin JS et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 1993, 178, 865–878.",{"doi":3845},"10.1084\u002Fjem.178.3.865",{"id":26,"text":3847,"url":26,"identifiers":3848},"Pierce GF, Yanagihara D, Klopchin K et al. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 1994, 179, 831–840.",{"doi":3849},"10.1084\u002Fjem.179.3.831",{"id":26,"text":3851,"url":26,"identifiers":3852},"Danilenko DM, Ring BD, Tarpley JE et al. Growth factors in porcine full and partial thickness burn repair—differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor. Am J Pathol 1995, 147, 1261–1277.",{},{"id":26,"text":3854,"url":26,"identifiers":3855},"Wu L-C, Pierce GF, Galiano RD, Mustoe TA. Keratinocyte growth factor induces granulation tissue in ischemic dermal wounds — importance of epithelial — mesenchymal cell interactions. Arch Surg 1996, 131, 660–666.",{"doi":3856},"10.1001\u002Farchsurg.1996.01430180086018",{"id":26,"text":3858,"url":26,"identifiers":3859},"Marchese, 1990, Differentiation response distinguishes KGF from EGF family. J Cell Physiol, 144, 326",{},{"id":26,"text":3861,"url":26,"identifiers":3862},"Latkowski JAM, Freedberg IM, Blumenberg M. Keratinocyte growth factor and keratin gene expression. J Dermatol Sci 1995, 9, 36–44.",{"doi":3863},"10.1016\u002F0923-1811(94)00350-N",{"id":26,"text":3865,"url":26,"identifiers":3866},"Brauchle M, Angermeyer K, Hübner G, Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines. Oncogene 1994, 9, 3199–3204.",{},{"id":26,"text":3868,"url":26,"identifiers":3869},"Chedid M, Rubin JS, Csaky KG, Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 1994, 269, 10753–10757.",{"doi":3870},"10.1016\u002FS0021-9258(17)34123-6",{"id":26,"text":3872,"url":26,"identifiers":3873},"Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 1987, 329, 630–632.",{"doi":3874},"10.1038\u002F329630a0",{"id":26,"text":3876,"url":26,"identifiers":3877},"Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping. Science 1988, 241, 708–712.",{"doi":3878},"10.1126\u002Fscience.3041594",{"id":26,"text":3880,"url":26,"identifiers":3881},"Lord PCW, Wilmoth LMG, Mizel SB, McCall CA. Expression of interleukin 1α and 1β genes by human blood polymorphonuclear leukocytes. J Clin Invest 1991, 87, 1312–1321.",{"doi":3882},"10.1172\u002FJCI115134",{"id":26,"text":3884,"url":26,"identifiers":3885},"Dinarello CA. Interleukin-1. In Thompson WA ed. The Cytokine Handbook 2nd edn. Academic Press, London, 1994, 31–56.",{"doi":3886},"10.1016\u002FS1054-3589(08)60429-9",{"id":26,"text":3888,"url":26,"identifiers":3889},"Quayle JA, Adams S, Bucknall RC, Edwards SW. Cytokine expression by inflammatory neutrophils. FEMS Immunol & Med Microbiol 1994, 8, 233–240.",{"doi":3890},"10.1111\u002Fj.1574-695X.1994.tb00448.x",{"id":26,"text":3892,"url":26,"identifiers":3893},"Tang A, Gilchrest BA. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J Dermatol Sci 1996, 11, 41–50.",{"doi":3894},"10.1016\u002F0923-1811(95)00418-1",{"id":26,"text":3896,"url":26,"identifiers":3897},"Weng J, Mohan RR, Li Q, Wilson SE. IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: Interleukin-1β expression in the cornea. Cornea 1997, 16, 465–471.",{"doi":3898},"10.1097\u002F00003226-199707000-00015",{"id":26,"text":3900,"url":26,"identifiers":3901},"Maas-Szabowski N, Fusenig NE. Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 1996, 107, 849–855.",{"doi":3902},"10.1111\u002F1523-1747.ep12331158",{"id":26,"text":3904,"url":26,"identifiers":3905},"Hübner G, Brauchle M, Smola H, Madlener M, Fässler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996, 8, 548–556.",{"doi":3906},"10.1006\u002Fcyto.1996.0074",{"id":26,"text":3908,"url":26,"identifiers":3909},"Akira S, Isshiki H, Sugita T et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of the C\\EBP family. EMBO J 1990, 9, 1897–1906.",{"doi":3910},"10.1002\u002Fj.1460-2075.1990.tb08316.x",{"id":26,"text":3912,"url":26,"identifiers":3913},"Chedid M, Hoyle JR, Csaky KG, Rubin JS. Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts. Endocrinol 1996, 137, 2232–2237.",{"doi":3914},"10.1210\u002Fen.137.6.2232",{"id":26,"text":3916,"url":26,"identifiers":3917},"Reed BR, Clark RAF. Cutaneous tissue repair: practical implications of current knowledge. II. J Am Acad Dermatol 1985, 13, 919–941.",{"doi":3918},"10.1016\u002FS0190-9622(85)70242-3",{"id":26,"text":3920,"url":26,"identifiers":3921},"Wahl SM. Glucocorticoids and wound healing. In Schleimer RP, Claman HN, Oronsky A. eds. Anti-Inflammatory Steroid Action. Basic and Clinical Aspects. Academic Press, New York, 1989, 280–302.",{},{"id":26,"text":3923,"url":26,"identifiers":3924},"Baskin LS, Sutherland RS, Thomson AA et al. Growth factors in bladder wound healing. J Urol 1997, 157, 2388–2395.",{"doi":3925},"10.1016\u002FS0022-5347(01)64786-4",{"id":26,"text":3927,"url":26,"identifiers":3928},"Ichimura T, Finch PW, Zhang G, Kan M, Stevens JL. Induction of FGF-7 after kidney damage: a possible paracrine mechanism for tubule repair. Am J Physiol 1996, 271, F967–F976.",{"doi":3929},"10.1152\u002Fajprenal.1996.271.5.F967",{"id":26,"text":3931,"url":26,"identifiers":3932},"Finch PW, Murphy F, Cardinale I, Krueger JG. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 1997, 151, 1619–1628.",{},{"id":26,"text":3934,"url":26,"identifiers":3935},"Brauchle M, Madlener M, Wagner AD et al. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol 1996, 149, 521–529.",{},{"id":26,"text":3937,"url":26,"identifiers":3938},"Finch PW, Pricolo V, Wu A, Finkelstein SD. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterol 1996, 110, 441–451.",{"doi":3939},"10.1053\u002Fgast.1996.v110.pm8566591",{"id":26,"text":3941,"url":26,"identifiers":3942},"Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991, 325, 928–937.",{"doi":3943},"10.1056\u002FNEJM199109263251306",{"id":26,"text":3945,"url":26,"identifiers":3946},"Sartor R. Pathogenesis and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res 1991, 10, 465–471.",{"doi":3947},"10.1007\u002FBF02919743",{"id":26,"text":3949,"url":26,"identifiers":3950},"Bajaj-Elliott, 1997, Increased mRNA transcripts in ulcerative colitis compared with Crohn’s disease in biopsies and isolated mucosal myofibroblasts. Am J Pathol, 151, 1469",{},{"id":26,"text":3952,"url":26,"identifiers":3953},"Dignass AU, Tsunekawa S, Podolsky K. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterol 1994, 106, 1254–1262.",{"doi":3954},"10.1016\u002F0016-5085(94)90017-5",{"id":26,"text":3956,"url":26,"identifiers":3957},"Zeeh JM, Procaccino F, Hoffmann P et al. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterol 1996, 110, 1077–1083.",{"doi":3958},"10.1053\u002Fgast.1996.v110.pm8612996",{"id":26,"text":3960,"url":26,"identifiers":3961},"Khan WB, Shui CX, Ning SC, Knox SJ. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Rad Res 1997, 148, 248–253.",{"doi":3962},"10.2307\u002F3579609",{"id":26,"text":3964,"url":26,"identifiers":3965},"Farrell CL, Bready JV, Rex KL et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998, 58, 933–939.",{},{"id":26,"text":3967,"url":26,"identifiers":3968},"Ulich TR, Whitcomb L, Tang W et al. Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis. Cancer Res 1997, 57, 472–475.",{},{"id":26,"text":3970,"url":26,"identifiers":3971},"Panos RJ, Bak PM, Simonet WS, Rubin JS, Smith LJ. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest 1995, 96, 2026–2033.",{"doi":3972},"10.1172\u002FJCI118250",{"id":26,"text":3974,"url":26,"identifiers":3975},"Yano T, Deterding RR, Simonet WS, Shannon JM, Mason RJ. Keratinocyte growth factor reduces lung damage due to acid installation in rats. Am J Respir Cell Mol Biol 1996, 15, 433–442.",{"doi":3976},"10.1165\u002Fajrcmb.15.4.8879176",{"id":26,"text":3978,"url":26,"identifiers":3979},"Deterding RR, Havill AM, Yano T et al. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc Ass Amer Phys 1996, 109, 254–268.",{},{"id":26,"text":3981,"url":26,"identifiers":3982},"Yi ES, Williams ST, Lee H et al. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Physiol 1996, 149, 1963–1970.",{},{"id":26,"text":3984,"url":26,"identifiers":3985},"Mason CM, Guery BPH, Summer WR, Nelson S. Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats. Crit Care Med 1996, 24, 925–931.",{"doi":3986},"10.1097\u002F00003246-199606000-00009",{"id":26,"text":3988,"url":26,"identifiers":3989},"Panos RJ. Cytokines and alveolar type II cells. In Cytokines of the lung: lung biology in health and disease. Decker M, ed. 1993, 377–383.",{},{"id":26,"text":3991,"url":26,"identifiers":3992},"Adamson IYR, Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988, 130, 377–383.",{},{"id":26,"text":3994,"url":26,"identifiers":3995},"Panos RJ, Rubin JS, Aaronson SA, Mason RJ. Keratinocyte growth factor and hepatocyte growth factor\\ scattor factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest 1993, 92, 969–977.",{"doi":3996},"10.1172\u002FJCI116673",{"id":26,"text":3998,"url":26,"identifiers":3999},"Sugahara K, Rubin JS, Mason RJ, Aronson EL, Shannon JM. Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture. Am J Physiol 1995, 269, L344–L350.",{"doi":4000},"10.1152\u002Fajplung.1995.269.3.L344",{"id":26,"text":4002,"url":26,"identifiers":4003},"Borok Z, Danto SI, Dimen LL, Zhang X-L, Lubman RL. Na+-K+-ATPase expression in alveolar epithelial cells: upregulation of active ion transport by KGF. Am J Physiol 1998, 274, L149–L158.",{"doi":4004},"10.1152\u002Fajplung.1998.274.1.L149",{"id":26,"text":4006,"url":26,"identifiers":4007},"Guery RPH, Mason CM, Dobard EP, Beaucaire G, Summer WR, Nelson S. Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs. Am J Resp Crit Care Med 155, 1777–1784.",{"doi":4008},"10.1164\u002Fajrccm.155.5.9154891",{"id":26,"text":4010,"url":26,"identifiers":4011},"Waters CM, Savla U, Panos RJ. KGF prevents hydrogen peroxide-induced increases in airway epithelial cell permeability. Am J Physiol 1977, 272, L681–L689.",{"doi":4012},"10.1152\u002Fajplung.1997.272.4.L681",{"id":26,"text":4014,"url":26,"identifiers":4015},"Takeoka M, Ward WF, Pollack H, Kamp DW, Panos RJ. KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 1997, 16, L1174–L1180.",{"doi":4016},"10.1152\u002Fajplung.1997.272.6.L1174",{"id":26,"text":4018,"url":26,"identifiers":4019},"Frank S, Munz B, Werner S. The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene. Oncogene 1997, 14, 915–921.",{"doi":4020},"10.1038\u002Fsj.onc.1200905",{"id":26,"text":4022,"url":26,"identifiers":4023},"Munz B, Frank S, Hübner G, Olsen E, Werner S. A novel type of glutathione peroxidase: expression and regulation during wound repair. Biochem J 1997, 326, 579–585.",{"doi":4024},"10.1042\u002Fbj3260579",{"id":4026,"createTime":4027,"updateTime":4027,"relativeEntities":4028,"slug":4029,"properties":4030,"entityType":788,"verifyStatus":25,"verifyTime":4027,"verifyNote":790,"syncStatus":28,"languages":4043,"translateLanguages":26,"viewCount":36,"primaryUrl":4044,"fullTextUrl":26,"authors":4045,"publicationType":880,"publisherRelationship":4175,"citationCount":4204,"citationInfo":4205,"publishDate":4207,"publishYear":4208,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":4209,"isForceReanalyzing":1290},"3dd1ae55-cbef-49fa-b586-02407b339bd6","2025-02-09T21:35:32.462+00:00",[],"Smad3-is-key-to-TGF-%CE%B2-mediated-epithelial-to-mesenchymal-transition-fibrosis-tumor-suppression-and-metastasis",{"mag":4031,"keywords":4033,"openalex":4034,"abstract":4036,"title":4037,"pm":4039,"doi":4041},{"VOID":4032},"1996211554",{},{"VOID":4035},"W1996211554",{},{"EN":4038},"Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis",{"VOID":4040},"16290023",{"VOID":4042},"10.1016\u002Fj.cytogfr.2005.09.008",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610105001127",[4046,4066,4083,4100,4115,4137,4154],{"id":4047,"sortIndex":135,"researcher":26,"roles":4048,"affiliations":4049,"properties":4061},"304e37d3-4309-45aa-ae1e-56ae2499fd89",[],[4050],{"id":4051,"sortIndex":36,"affiliation":4052,"properties":26},"5a6d4f66-447f-4412-b79d-ccf480da6ef1",{"id":4053,"createTime":4054,"updateTime":4055,"relativeEntities":4056,"slug":4057,"properties":4058,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cab92b2b-4a9e-4cec-9a24-a16fe3cfea1e","2024-01-10T21:04:14.401+00:00","2025-02-09T21:35:32.480+00:00",[],"Laboratory-of-Cell-Regulation-and-Carcinogenesis-National-Cancer-Institute-Bethesda-MD-20892-5055-USA",{"title":4059},{"VI":4060},"Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, MD 20892-5055, USA",{"openalex":4062,"title":4064},{"VOID":4063},"A5110043042",{"EN":4065},"Kathleen C. Flanders",{"id":4067,"sortIndex":59,"researcher":26,"roles":4068,"affiliations":4069,"properties":4076},"80c564bc-fa4f-42f3-a108-57c5e40f5bc1",[],[4070],{"id":4071,"sortIndex":36,"affiliation":4072,"properties":26},"d742f63d-b815-4e64-b81e-01ccf452c344",{"id":4053,"createTime":4054,"updateTime":4055,"relativeEntities":4073,"slug":4057,"properties":4074,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4075},{"VI":4060},{"openalex":4077,"orcid":4079,"title":4081},{"VOID":4078},"A5083452456",{"VOID":4080},"https:\u002F\u002Forcid.org\u002F0000-0002-2850-5399",{"EN":4082},"Christina H. Stuelten",{"id":4084,"sortIndex":115,"researcher":26,"roles":4085,"affiliations":4086,"properties":4093},"ea318b05-77a9-47fe-9aec-58938692a6f8",[],[4087],{"id":4088,"sortIndex":36,"affiliation":4089,"properties":26},"b338af2c-f75d-487a-af01-b044908c2dca",{"id":4053,"createTime":4054,"updateTime":4055,"relativeEntities":4090,"slug":4057,"properties":4091,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4092},{"VI":4060},{"openalex":4094,"orcid":4096,"title":4098},{"VOID":4095},"A5100439061",{"VOID":4097},"https:\u002F\u002Forcid.org\u002F0009-0003-0125-5371",{"EN":4099},"Tian Fang",{"id":4101,"sortIndex":36,"researcher":26,"roles":4102,"affiliations":4103,"properties":4110},"82099e6a-70b6-4c97-aad9-fae3d4982cf2",[],[4104],{"id":4105,"sortIndex":36,"affiliation":4106,"properties":26},"669d119d-e740-4f66-9c62-7ee5016c7da7",{"id":4053,"createTime":4054,"updateTime":4055,"relativeEntities":4107,"slug":4057,"properties":4108,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4109},{"VI":4060},{"openalex":4111,"title":4113},{"VOID":4112},"A5000090253",{"EN":4114},"Andrea Roberts",{"id":4116,"sortIndex":162,"researcher":26,"roles":4117,"affiliations":4118,"properties":4130},"8fac2d2c-d426-48ae-9a77-d9ebf24b6071",[],[4119],{"id":4120,"sortIndex":36,"affiliation":4121,"properties":26},"14220d45-6930-4eed-a24d-b2f52939fb89",{"id":4122,"createTime":4123,"updateTime":4124,"relativeEntities":4125,"slug":4126,"properties":4127,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1b9c37b2-b42e-45aa-8733-e5a1a5d1bd69","2024-02-13T15:28:45.892+00:00","2025-02-09T21:35:32.531+00:00",[],"Department-of-Ophthalmology-Wakayama-Medical-University-811-1-Kimiidera-Wakayama-641-0012-Japan",{"title":4128},{"VI":4129},"Department of Ophthalmology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan",{"openalex":4131,"orcid":4133,"title":4135},{"VOID":4132},"A5060322837",{"VOID":4134},"https:\u002F\u002Forcid.org\u002F0000-0003-1584-9552",{"EN":4136},"Shizuya Saika",{"id":4138,"sortIndex":114,"researcher":26,"roles":4139,"affiliations":4140,"properties":4147},"464fe3d1-5e1c-415f-a0cf-311e37005364",[],[4141],{"id":4142,"sortIndex":36,"affiliation":4143,"properties":26},"48ba6f01-c27b-4fd3-ab86-8c20e895e626",{"id":4053,"createTime":4054,"updateTime":4055,"relativeEntities":4144,"slug":4057,"properties":4145,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4146},{"VI":4060},{"openalex":4148,"orcid":4150,"title":4152},{"VOID":4149},"A5028025833",{"VOID":4151},"https:\u002F\u002Forcid.org\u002F0000-0001-8923-0643",{"EN":4153},"Stacey DaCosta Byfield",{"id":4155,"sortIndex":111,"researcher":26,"roles":4156,"affiliations":4157,"properties":4168},"76684609-d21f-4929-baf5-564cd70af520",[],[4158],{"id":4159,"sortIndex":36,"affiliation":4160,"properties":26},"6731622c-5014-4108-bf43-191ae0e547c9",{"id":4161,"createTime":4162,"updateTime":4162,"relativeEntities":4163,"slug":4164,"properties":4165,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8822fc61-0508-4a25-99b0-ac5516fd3d0b","2025-02-09T21:35:32.519+00:00",[],"Department-of-Pathology-Wakayama-Medical-University-811-1-Kimiidera-Wakayama-641-0012-Japan",{"title":4166},{"EN":4167},"Department of Pathology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan",{"openalex":4169,"orcid":4171,"title":4173},{"VOID":4170},"A5081852407",{"VOID":4172},"https:\u002F\u002Forcid.org\u002F0000-0002-2637-1219",{"EN":4174},"Akira Ooshima",{"url":26,"publisher":4176,"properties":4198},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":4177,"slug":663,"properties":4178,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":4181,"manageAffiliations":4182,"indexDatabases":4183,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":4179,"title":4180},{"VOID":666},{"EN":668},[],[],[4184,4191],{"id":747,"indexDatabase":4185,"url":762,"indexYears":26,"academicFieldIds":4190,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":4186,"label":4187,"description":4188,"key":758,"publicationTags":4189,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":4192,"url":738,"indexYears":739,"academicFieldIds":4197,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":4193,"label":4194,"description":4195,"key":735,"publicationTags":4196,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":4199,"pages":4201,"issue":4203},{"VOID":4200},"17",{"VOID":4202},"19-27",{"VOID":1360},336,{"total":4204,"publishYear":26,"statisticByYear":4206},{"2012":173,"2013":234,"2014":124,"2015":516,"2016":242,"2017":53,"2018":51,"2019":234,"2020":237,"2021":173,"2022":53,"2023":116,"2024":356},"2006-02-01",2006,[],{"id":4211,"createTime":4212,"updateTime":4212,"relativeEntities":4213,"slug":4214,"properties":4215,"entityType":788,"verifyStatus":25,"verifyTime":4212,"verifyNote":790,"syncStatus":28,"languages":4228,"translateLanguages":26,"viewCount":36,"primaryUrl":4229,"fullTextUrl":26,"authors":4230,"publicationType":880,"publisherRelationship":4308,"citationCount":4337,"citationInfo":4338,"publishDate":4340,"publishYear":4341,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":4342,"isForceReanalyzing":1290},"011d3bac-c335-434e-a5e9-0e0be0041b48","2024-10-03T13:30:02.769+00:00",[],"Interferon-alpha-in-tumor-immunity-and-immunotherapy",{"mag":4216,"keywords":4218,"openalex":4219,"abstract":4221,"title":4222,"pm":4224,"doi":4226},{"VOID":4217},"2017449430",{},{"VOID":4220},"W2017449430",{},{"EN":4223},"Interferon-alpha in tumor immunity and immunotherapy",{"VOID":4225},"11900988",{"VOID":4227},"10.1016\u002Fs1359-6101(01)00022-3",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610101000223",[4231,4253,4270,4291],{"id":4232,"sortIndex":114,"researcher":26,"roles":4233,"affiliations":4234,"properties":4246},"143edafc-ec2d-4613-abe2-c34921027687",[],[4235],{"id":4236,"sortIndex":36,"affiliation":4237,"properties":26},"e279d046-5a5a-4262-9e97-38a62957684e",{"id":4238,"createTime":4239,"updateTime":4240,"relativeEntities":4241,"slug":4242,"properties":4243,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0e71fdeb-8527-487c-a811-7e8a1d0b9baf","2023-12-06T08:51:48.816+00:00","2024-10-03T13:30:02.792+00:00",[],"Laboratory-of-Virology-Istituto-Superiore-di-Sanit%C3%A0-Viale-Regina-Elena-299-00161-Rome-Italy",{"title":4244},{"VI":4245},"Laboratory of Virology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy",{"openalex":4247,"orcid":4249,"title":4251},{"VOID":4248},"A5004812966",{"VOID":4250},"https:\u002F\u002Forcid.org\u002F0000-0001-9023-2072",{"EN":4252},"Enrico Proietti",{"id":4254,"sortIndex":115,"researcher":26,"roles":4255,"affiliations":4256,"properties":4263},"d59e91c5-017b-48ad-8dac-bd6591ca0cdc",[],[4257],{"id":4258,"sortIndex":36,"affiliation":4259,"properties":26},"c3853724-d6cc-4281-961d-dc5f1e40db45",{"id":4238,"createTime":4239,"updateTime":4240,"relativeEntities":4260,"slug":4242,"properties":4261,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4262},{"VI":4245},{"openalex":4264,"orcid":4266,"title":4268},{"VOID":4265},"A5047393976",{"VOID":4267},"https:\u002F\u002Forcid.org\u002F0000-0002-6979-0149",{"EN":4269},"Maria Ferrantini",{"id":4271,"sortIndex":59,"researcher":26,"roles":4272,"affiliations":4273,"properties":4284},"4d527802-4053-4fbf-9db4-45638c9fb04a",[],[4274],{"id":4275,"sortIndex":36,"affiliation":4276,"properties":26},"5599b8d2-365d-4862-a2ce-a34cacf4d0cf",{"id":4277,"createTime":4278,"updateTime":4278,"relativeEntities":4279,"slug":4280,"properties":4281,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cb72c4bc-5485-4d5d-9724-9d6f3af704e0","2024-10-03T13:30:02.833+00:00",[],"Department-of-Medicine-University-of-Pittsburgh-School-of-Medicine-200-Lothrop-Street-Pittsburgh-PA-15213-2582-USA",{"title":4282},{"EN":4283},"Department of Medicine, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15213-2582, USA",{"openalex":4285,"orcid":4287,"title":4289},{"VOID":4286},"A5007239425",{"VOID":4288},"https:\u002F\u002Forcid.org\u002F0000-0002-3570-4476",{"EN":4290},"John M. Kirkwood",{"id":4292,"sortIndex":36,"researcher":26,"roles":4293,"affiliations":4294,"properties":4301},"03e02646-e8b3-4bd0-9d15-65a78615dcc2",[],[4295],{"id":4296,"sortIndex":36,"affiliation":4297,"properties":26},"5e45fa65-aadd-4f69-a025-0a040dd8dd87",{"id":4238,"createTime":4239,"updateTime":4240,"relativeEntities":4298,"slug":4242,"properties":4299,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4300},{"VI":4245},{"openalex":4302,"orcid":4304,"title":4306},{"VOID":4303},"A5009678390",{"VOID":4305},"https:\u002F\u002Forcid.org\u002F0000-0002-3082-3169",{"EN":4307},"Filippo Belardelli",{"url":26,"publisher":4309,"properties":4331},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":4310,"slug":663,"properties":4311,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":4314,"manageAffiliations":4315,"indexDatabases":4316,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":4312,"title":4313},{"VOID":666},{"EN":668},[],[],[4317,4324],{"id":747,"indexDatabase":4318,"url":762,"indexYears":26,"academicFieldIds":4323,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":4319,"label":4320,"description":4321,"key":758,"publicationTags":4322,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":4325,"url":738,"indexYears":739,"academicFieldIds":4330,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":4326,"label":4327,"description":4328,"key":735,"publicationTags":4329,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":4332,"pages":4334,"issue":4336},{"VOID":4333},"13",{"VOID":4335},"119-134",{"VOID":2271},331,{"total":4337,"publishYear":26,"statisticByYear":4339},{"2012":356,"2013":298,"2014":103,"2015":103,"2016":103,"2017":158,"2018":162,"2019":53,"2020":51,"2021":298,"2022":103,"2023":50,"2024":356},"2002-04-01",2002,[4343,4347,4350,4354,4358,4362,4366,4370,4374,4378,4382,4386,4390,4393,4397,4401,4405,4409,4413,4417,4420,4424,4427,4431,4435,4439,4443,4447,4451,4455,4459,4463,4467,4471,4475,4479,4483,4487,4491,4495,4499,4503,4507,4511,4515,4519,4523,4527,4531,4535,4539,4543,4547,4551,4554,4557,4561,4565,4569,4573,4577,4580,4584,4588,4591,4594,4598,4602,4606,4610,4613,4617,4621,4625,4629,4633,4637,4641,4645,4649,4653,4657,4661,4665,4669,4672,4675,4678,4682,4686,4690,4693,4697,4701,4705,4709,4713,4717,4721,4725,4729,4733,4737,4741,4745],{"id":26,"text":4344,"url":26,"identifiers":4345},"Gutterman, 1994, Cytokine therapeutics: lessons from interferon-alpha, Proc. Natl. Acad. Sci. U.S.A., 91, 1198, 10.1073\u002Fpnas.91.4.1198",{"doi":4346},"10.1073\u002Fpnas.91.4.1198",{"id":26,"text":4348,"url":26,"identifiers":4349},"Pfeffer LM, Dinarello CA, Herberman RB, et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 1998;58:2489–99.",{},{"id":26,"text":4351,"url":26,"identifiers":4352},"Belardelli, 1995, Role of interferons and other cytokines in the regulation of the immune response, APMIS, 103, 161, 10.1111\u002Fj.1699-0463.1995.tb01092.x",{"doi":4353},"10.1111\u002Fj.1699-0463.1995.tb01092.x",{"id":26,"text":4355,"url":26,"identifiers":4356},"Mogensen, 1999, Type I IFN receptor: structure, function, and evolution of a family business, J Interferon Cytokine Res., 19, 1069, 10.1089\u002F107999099313019",{"doi":4357},"10.1089\u002F107999099313019",{"id":26,"text":4359,"url":26,"identifiers":4360},"Belardelli, 1996, The neglected role of type I interferon in the T cell response: implications for its clinical use, Immunol. Today, 17, 369, 10.1016\u002F0167-5699(96)10027-X",{"doi":4361},"10.1016\u002F0167-5699(96)10027-X",{"id":26,"text":4363,"url":26,"identifiers":4364},"Ferrantini, 2000, Gene Therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications, Semin. Cancer Biol., 10, 145, 10.1006\u002Fscbi.2000.0333",{"doi":4365},"10.1006\u002Fscbi.2000.0333",{"id":26,"text":4367,"url":26,"identifiers":4368},"Wu JC, Yang X-F, McLaughlin S, et al. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest 2000;106:705–14.",{"doi":4369},"10.1172\u002FJCI10196",{"id":26,"text":4371,"url":26,"identifiers":4372},"Molldrem JJ, Lee PP, Wang C, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000;6:1018–23.",{"doi":4373},"10.1038\u002F79526",{"id":26,"text":4375,"url":26,"identifiers":4376},"Balch CM, Buzaid AC, Atkins MB, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000;88:1484–91.",{"doi":4377},"10.1002\u002F(SICI)1097-0142(20000315)88:6\u003C1484::AID-CNCR29>3.0.CO;2-D",{"id":26,"text":4379,"url":26,"identifiers":4380},"Balch CM, Soong S, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients. Validation of the American joint committee on cancer melanoma staging system. J Clin Oncol 2001;19:3622–34.",{"doi":4381},"10.1200\u002FJCO.2001.19.16.3622",{"id":26,"text":4383,"url":26,"identifiers":4384},"Livingston PO, Wong GYC, Adluri S, et al. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol 1994;12:1036–44.",{"doi":4385},"10.1200\u002FJCO.1994.12.5.1036",{"id":26,"text":4387,"url":26,"identifiers":4388},"Kirkwood, 1996, Interferon-alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684, J. Clin. Oncol., 14, 7, 10.1200\u002FJCO.1996.14.1.7",{"doi":4389},"10.1200\u002FJCO.1996.14.1.7",{"id":26,"text":4391,"url":26,"identifiers":4392},"Kirkwood, 2001, Pooled-analysis of four ECOG\u002Fintergroup trials of high-dose interferon-alpha-2b (HDI) in 1916 patients with high-risk resected cutaneous melanoma, Proc. ASCO, 20, 350a",{},{"id":26,"text":4394,"url":26,"identifiers":4395},"Creagan ET, Dalton RJ, Ahmann DL, et al. Randomized, surgical adjuvant clinical trial of recombinant interferon-alpha-2a in selected patients with malignant melanoma. J Clin Oncol 1995;13:2776–83.",{"doi":4396},"10.1200\u002FJCO.1995.13.11.2776",{"id":26,"text":4398,"url":26,"identifiers":4399},"Kirkwood JM, Ibrahim JG, Sondak VK, et al. High- and low-dose interferon-alpha-2b in high-risk melanoma: first analysis of intergroup trial E1690\u002FS9111\u002FC9190. J Clin Oncol 2000;18:2444–58.",{"doi":4400},"10.1200\u002FJCO.2000.18.12.2444",{"id":26,"text":4402,"url":26,"identifiers":4403},"Kirkwood JM, Ibrahim J, Lawson DH, et al. High-dose interferon-alpha-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the multicenter ECOG phase II trial: E2696. J Clin Oncol 2001;19:1430–6.",{"doi":4404},"10.1200\u002FJCO.2001.19.5.1430",{"id":26,"text":4406,"url":26,"identifiers":4407},"Morton DL, Foshag LJ, Hoon DS, et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 1992;216:463–82.",{"doi":4408},"10.1097\u002F00000658-199210000-00010",{"id":26,"text":4410,"url":26,"identifiers":4411},"Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759–67.",{"doi":4412},"10.1097\u002F00000658-199412000-00009",{"id":26,"text":4414,"url":26,"identifiers":4415},"Ross, 1993, Selective lymphadenectomy: emerging role of lymphatic mapping and sentinel node biopsy in the management of early stage melanoma, Semin. Surg. Oncol., 9, 219, 10.1002\u002Fj.1098-2388.1993.tb00011.x",{"doi":4416},"10.1002\u002Fj.1098-2388.1993.tb00011.x",{"id":26,"text":4418,"url":26,"identifiers":4419},"Cascinelli, 1995, Evaluation of efficacy of adjuvant rIFN-α2a in melanoma patients with regional node metastases, Proc. ASCO, 14, A1296",{},{"id":26,"text":4421,"url":26,"identifiers":4422},"Pehamberger H, Soyer P, Steiner A, et al. Adjuvant interferon-alpha-2a treatment in resected primary stage II cutaneous melanoma. J Clin Oncol 1998;16:1425–9.",{"doi":4423},"10.1200\u002FJCO.1998.16.4.1425",{"id":26,"text":4425,"url":26,"identifiers":4426},"Kirkwood JM. Interferon-alpha and -beta: clinical applications: melanoma. In: Rosenberg SA, editor. Principles and practice of the biologic therapy of cancer. Lippincott, Philadelphia: Williams & Wilkins, 2000. p. 224–51.",{},{"id":26,"text":4428,"url":26,"identifiers":4429},"Romagnani, 1992, Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?, Immunol. Today, 13, 379, 10.1016\u002F0167-5699(92)90083-J",{"doi":4430},"10.1016\u002F0167-5699(92)90083-J",{"id":26,"text":4432,"url":26,"identifiers":4433},"Rogge L, Barberis-Maino L, Biffi M, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825–31.",{"doi":4434},"10.1084\u002Fjem.185.5.825",{"id":26,"text":4436,"url":26,"identifiers":4437},"von Hoegen, 1995, Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes, Immunol. Lett., 47, 157, 10.1016\u002F0165-2478(95)00065-4",{"doi":4438},"10.1016\u002F0165-2478(95)00065-4",{"id":26,"text":4440,"url":26,"identifiers":4441},"Tüting T, Wilson CC, Martin DM, et al. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-α. J Immunol 1998;160:1139–47.",{"doi":4442},"10.4049\u002Fjimmunol.160.3.1139",{"id":26,"text":4444,"url":26,"identifiers":4445},"Wilson, 1999, HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines, J. Immunol., 162, 3070, 10.4049\u002Fjimmunol.162.5.3070",{"doi":4446},"10.4049\u002Fjimmunol.162.5.3070",{"id":26,"text":4448,"url":26,"identifiers":4449},"Hirohishi, 2000, IFN-α-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs, J. Immunol., 164, 567, 10.4049\u002Fjimmunol.164.2.567",{"doi":4450},"10.4049\u002Fjimmunol.164.2.567",{"id":26,"text":4452,"url":26,"identifiers":4453},"Palmer, 2000, Interpheron-alpha (IFN-α) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumor cultures (MLTC), Clin. Exp. Immunol., 119, 412, 10.1046\u002Fj.1365-2249.2000.01159.x",{"doi":4454},"10.1046\u002Fj.1365-2249.2000.01159.x",{"id":26,"text":4456,"url":26,"identifiers":4457},"Tough, 1996, Induction of bystander T cell proliferation by viruses and type I interferon in vivo, Science, 272, 1947, 10.1126\u002Fscience.272.5270.1947",{"doi":4458},"10.1126\u002Fscience.272.5270.1947",{"id":26,"text":4460,"url":26,"identifiers":4461},"Sun, 1998, Type I interferon-mediated stimulation of T cells by CpG DNA, J. Exp. Med., 188, 2335, 10.1084\u002Fjem.188.12.2335",{"doi":4462},"10.1084\u002Fjem.188.12.2335",{"id":26,"text":4464,"url":26,"identifiers":4465},"Marrack, 1999, Type I interferons keep activated T cells alive, J. Exp. Med., 189, 521, 10.1084\u002Fjem.189.3.521",{"doi":4466},"10.1084\u002Fjem.189.3.521",{"id":26,"text":4468,"url":26,"identifiers":4469},"Matikainen, 1999, Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells, Blood, 93, 1980, 10.1182\u002Fblood.V93.6.1980.406k20_1980_1991",{"doi":4470},"10.1182\u002Fblood.V93.6.1980.406k20_1980_1991",{"id":26,"text":4472,"url":26,"identifiers":4473},"Steinman, 1991, The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol., 9, 271, 10.1146\u002Fannurev.iy.09.040191.001415",{"doi":4474},"10.1146\u002Fannurev.iy.09.040191.001415",{"id":26,"text":4476,"url":26,"identifiers":4477},"Cella, 1997, Origin, maturation, and antigen-presenting function of dendritic cells, Curr. Opin. Immunol., 9, 10, 10.1016\u002FS0952-7915(97)80153-7",{"doi":4478},"10.1016\u002FS0952-7915(97)80153-7",{"id":26,"text":4480,"url":26,"identifiers":4481},"Paquette RL, Hsu NC, Kiertscher SM, et al. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol 1998;64:358–67.",{"doi":4482},"10.1002\u002Fjlb.64.3.358",{"id":26,"text":4484,"url":26,"identifiers":4485},"Luft T, Pang KC, Thomas E, et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998;161:1947–53.",{"doi":4486},"10.4049\u002Fjimmunol.161.4.1947",{"id":26,"text":4488,"url":26,"identifiers":4489},"Radvanyi, 1999, Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells, Scand. J. Immunol., 50, 499, 10.1046\u002Fj.1365-3083.1999.00625.x",{"doi":4490},"10.1046\u002Fj.1365-3083.1999.00625.x",{"id":26,"text":4492,"url":26,"identifiers":4493},"Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-scid mice. J Exp Med 2000;191:1777–88.",{"doi":4494},"10.1084\u002Fjem.191.10.1777",{"id":26,"text":4496,"url":26,"identifiers":4497},"Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type I interferon-producing cells in human blood. Science 1999;284:1835–7.",{"doi":4498},"10.1126\u002Fscience.284.5421.1835",{"id":26,"text":4500,"url":26,"identifiers":4501},"Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919–23.",{"doi":4502},"10.1038\u002F11360",{"id":26,"text":4504,"url":26,"identifiers":4505},"Le Bon, 2001, Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo, Immunity, 14, 461, 10.1016\u002FS1074-7613(01)00126-1",{"doi":4506},"10.1016\u002FS1074-7613(01)00126-1",{"id":26,"text":4508,"url":26,"identifiers":4509},"Belardelli, 1982, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells I, Int. J. Cancer, 30, 813, 10.1002\u002Fijc.2910300621",{"doi":4510},"10.1002\u002Fijc.2910300621",{"id":26,"text":4512,"url":26,"identifiers":4513},"Belardelli, 1982, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms, Int. J. Cancer, 31, 821, 10.1002\u002Fijc.2910300622",{"doi":4514},"10.1002\u002Fijc.2910300622",{"id":26,"text":4516,"url":26,"identifiers":4517},"Belardelli, 1983, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumor implanted subcutaneously, Int. J. Cancer, 31, 649, 10.1002\u002Fijc.2910310518",{"doi":4518},"10.1002\u002Fijc.2910310518",{"id":26,"text":4520,"url":26,"identifiers":4521},"Gresser, 1986, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. IV. Definition of optimal treatment regimens, Int. J. Cancer, 38, 251, 10.1002\u002Fijc.2910380216",{"doi":4522},"10.1002\u002Fijc.2910380216",{"id":26,"text":4524,"url":26,"identifiers":4525},"Gresser, 1987, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases, Int. J. Cancer, 39, 789, 10.1002\u002Fijc.2910390623",{"doi":4526},"10.1002\u002Fijc.2910390623",{"id":26,"text":4528,"url":26,"identifiers":4529},"Gresser I, Maury C, Woodrow D, et al. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells. Int J Cancer 1988;1:135–42.",{"doi":4530},"10.1002\u002Fijc.2910410124",{"id":26,"text":4532,"url":26,"identifiers":4533},"Gresser, 1990, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases, Int. J. Cancer, 46, 468, 10.1002\u002Fijc.2910460324",{"doi":4534},"10.1002\u002Fijc.2910460324",{"id":26,"text":4536,"url":26,"identifiers":4537},"Gresser I, Carnaud C, Maury C, et al. Host humoral and cellular mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon-alpha\u002Fbeta treatment in mice. J Exp Med 1991;73:1193–203.",{"doi":4538},"10.1084\u002Fjem.173.5.1193",{"id":26,"text":4540,"url":26,"identifiers":4541},"Gresser, 1972, Mechanism of the antitumor effect of interferon in mice, Nature, 239, 167, 10.1038\u002F239167a0",{"doi":4542},"10.1038\u002F239167a0",{"id":26,"text":4544,"url":26,"identifiers":4545},"Kaido, 1993, Sensitized T lymphocytes render DBA\u002F2 beige mice responsive to IFN-α\u002Fβ therapy of Friend erythroleukemia visceral metastases, Int. J. Cancer, 54, 475, 10.1002\u002Fijc.2910540320",{"doi":4546},"10.1002\u002Fijc.2910540320",{"id":26,"text":4548,"url":26,"identifiers":4549},"Kaido, 1994, Successful immunotherapy of the highly metastatic murine ESb lymphoma with sensitized CD8+ T cells and IFN-α\u002Fβ, Int. J. Cancer, 57, 538, 10.1002\u002Fijc.2910570417",{"doi":4550},"10.1002\u002Fijc.2910570417",{"id":26,"text":4552,"url":26,"identifiers":4553},"Kaido, 1995, Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha\u002Fbeta and adoptively transferred immune cells in the inhibition of visceral ESb metastases, Cancer Res., 55, 6133",{},{"id":26,"text":4555,"url":26,"identifiers":4556},"Belardelli F, Ferrantini M, Santini SM, et al. The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after injection of tumor cells expressing IFN-α into syngeneic mice. Cancer Res 1998;58:5795–802.",{},{"id":26,"text":4558,"url":26,"identifiers":4559},"Belardelli, 1984, Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus, Proc. Natl. Acad. Sci. U.S.A., 81, 602, 10.1073\u002Fpnas.81.2.602",{"doi":4560},"10.1073\u002Fpnas.81.2.602",{"id":26,"text":4562,"url":26,"identifiers":4563},"Gresser, 1983, Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors, J. Exp. Med., 158, 2095, 10.1084\u002Fjem.158.6.2095",{"doi":4564},"10.1084\u002Fjem.158.6.2095",{"id":26,"text":4566,"url":26,"identifiers":4567},"Hagmann, 1999, Elusive interferon-alpha producers nailed down, Science, 284, 1746, 10.1126\u002Fscience.284.5421.1746",{"doi":4568},"10.1126\u002Fscience.284.5421.1746",{"id":26,"text":4570,"url":26,"identifiers":4571},"Proietti E, Greco G, Garrone B, et al. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. J Clin Invest 1998;101:429–41.",{"doi":4572},"10.1172\u002FJCI1348",{"id":26,"text":4574,"url":26,"identifiers":4575},"Schiavoni G, Mattei F, Di Pucchio T, et al. Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. Blood 2000;95:2024–30.",{"doi":4576},"10.1182\u002Fblood.V95.6.2024",{"id":26,"text":4578,"url":26,"identifiers":4579},"Simons, 1998, Ex vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology, Semin. Oncol., 25, 661",{},{"id":26,"text":4581,"url":26,"identifiers":4582},"Musiani P, Modesti A, Giovarelli M, et al. Cytokines, tumor-cell death, and immunogenicity: a question of choice. Immunol Today 1997;18:32–6.",{"doi":4583},"10.1016\u002FS0167-5699(97)80012-6",{"id":26,"text":4585,"url":26,"identifiers":4586},"Pardoll, 1998, Cancer vaccines, Nat. Med., 4, 525, 10.1038\u002Fnm0598supp-525",{"doi":4587},"10.1038\u002Fnm0598supp-525",{"id":26,"text":4589,"url":26,"identifiers":4590},"Ferrantini M, Proietti E, Santodonato L, et al. Alpha1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Cancer Res 1993;53:1107–12.",{},{"id":26,"text":4592,"url":26,"identifiers":4593},"Gabriele L, Kaido T, Woodrow D, et al. The local and systemic response of mice to interferon-alpha1 transfected Friend leukemia cells. Am J Pathol 1995;147:445–60.",{},{"id":26,"text":4595,"url":26,"identifiers":4596},"Ferrantini M, Giovarelli M, Modesti A, et al. IFN-α1 gene expression into a metastatic murine adenocarcinoma (TS\u002FA) results in CD8+T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-γ producing TS\u002FA cells. J Immunol 1994;153:4604–15.",{"doi":4597},"10.4049\u002Fjimmunol.153.10.4604",{"id":26,"text":4599,"url":26,"identifiers":4600},"Rozera C, Carlei D, Lollini PL, et al. Interferon-beta (IFN-β) gene transfer into TS\u002FA adenocarcinoma cells and comparison with IFN-α. Differential effects on tumorigenicity and host response. Am J Pathol 1999;154:1211–22.",{"doi":4601},"10.1016\u002FS0002-9440(10)65373-4",{"id":26,"text":4603,"url":26,"identifiers":4604},"Tüting T, Gambotto A, Baar J, et al. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models. Gene Ther 1997;4:1053–60.",{"doi":4605},"10.1038\u002Fsj.gt.3300509",{"id":26,"text":4607,"url":26,"identifiers":4608},"Kaido T, Bandu MT, Maury C, et al. IFN-α1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA\u002F2 mice and decreases their tumorigenicity in syngeneic C57BL\u002F6 mice. Int J Cancer 1995;60:1–9.",{"doi":4609},"10.1002\u002Fijc.2910600216",{"id":26,"text":4611,"url":26,"identifiers":4612},"Sarkar, 1995, Injection of irradiated melanoma genetically modified to secrete IFN-α causes regression of an established tumor, Int. J. Oncol., 7, 17",{},{"id":26,"text":4614,"url":26,"identifiers":4615},"Rozera C, Mecchia M, Gresser I, et al. Murine IFN-α1 gene transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to IFN-α\u002Fβ therapy. Cancer Gene Ther 1999;6:246–53.",{"doi":4616},"10.1038\u002Fsj.cgt.7700051",{"id":26,"text":4618,"url":26,"identifiers":4619},"Gresser I. The effect of interferon on experimental tumor metastases. In: Schirrmacher V, Schwartz-Albeiz R, editors. Cancer metastasis. Berlin: Springer, 1989. p. 171–80.",{"doi":4620},"10.1007\u002F978-3-642-74236-1_21",{"id":26,"text":4622,"url":26,"identifiers":4623},"Rossi I, Nicoletti G, Landuzzi L, et al. Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene transduced tumor cells. Clin Exp Metastasis 1998;16:123–8.",{"doi":4624},"10.1023\u002FA:1021980818017",{"id":26,"text":4626,"url":26,"identifiers":4627},"Santodonato L, Ferrantini M, Gabriele L, et al. Cure of mice with established metastatic Friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha1 and herpes simplex thymidine kinase followed by ganciclovir. Hum Gene Ther 1996;7:1–10.",{"doi":4628},"10.1089\u002Fhum.1996.7.1-1",{"id":26,"text":4630,"url":26,"identifiers":4631},"Santodonato L, D’Agostino G, Santini SM, et al. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-α and HSVtk: perspectives for the generation of cancer vaccines. Gene Ther 1997;4:1246–55.",{"doi":4632},"10.1038\u002Fsj.gt.3300518",{"id":26,"text":4634,"url":26,"identifiers":4635},"Wang, 1999, In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha, J. Neuropathol. Exp. Neurol., 58, 847, 10.1097\u002F00005072-199908000-00007",{"doi":4636},"10.1097\u002F00005072-199908000-00007",{"id":26,"text":4638,"url":26,"identifiers":4639},"Sabaawy HME, Ikehara S, Adachi Y, et al. Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer. Int J Oncol 1999;14:1143–51.",{"doi":4640},"10.3892\u002Fijo.14.6.1143",{"id":26,"text":4642,"url":26,"identifiers":4643},"Cao, 1995, Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon-alpha gene therapy in combination with adoptive chemoimmunotherapy, J. Cancer Res. Clin. Oncol., 121, 457, 10.1007\u002FBF01218361",{"doi":4644},"10.1007\u002FBF01218361",{"id":26,"text":4646,"url":26,"identifiers":4647},"Wang, 1996, Treatment of leukemia with fibroblast-mediated interferon-alpha gene therapy alone or in combination with doxorubicin, Leuk. Res., 20, 379, 10.1016\u002F0145-2126(95)00139-5",{"doi":4648},"10.1016\u002F0145-2126(95)00139-5",{"id":26,"text":4650,"url":26,"identifiers":4651},"Mecchia M, Matarrese P, Malorni W, et al. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-α. Gene Ther 2000;7:167–79.",{"doi":4652},"10.1038\u002Fsj.gt.3301059",{"id":26,"text":4654,"url":26,"identifiers":4655},"Hiroishi, 1999, IFN-α gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models, Gene. Ther., 6, 1988, 10.1038\u002Fsj.gt.3301034",{"doi":4656},"10.1038\u002Fsj.gt.3301034",{"id":26,"text":4658,"url":26,"identifiers":4659},"Coleman M, Muller S, Quezada A, et al. Nonviral interferon-alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response. Hum Gene Ther 1998;9:2223–30.",{"doi":4660},"10.1089\u002Fhum.1998.9.15-2223",{"id":26,"text":4662,"url":26,"identifiers":4663},"Horton, 1999, A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon-alpha, Proc. Natl. Acad. Sci. U.S.A., 96, 1553, 10.1073\u002Fpnas.96.4.1553",{"doi":4664},"10.1073\u002Fpnas.96.4.1553",{"id":26,"text":4666,"url":26,"identifiers":4667},"Santodonato L, Ferrantini M, Palombo F, et al. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-α in mice injected with metastatic IFN-resistant tumor cells. Cancer Gene Ther 2001;8:63–72.",{"doi":4668},"10.1038\u002Fsj.cgt.7700274",{"id":26,"text":4670,"url":26,"identifiers":4671},"Ernstoff, 1983, Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha-2) in phase I–II trials, J. Biol. Response Mod., 2, 540",{},{"id":26,"text":4673,"url":26,"identifiers":4674},"Hersey P, Coates A, Rallings M, et al. Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma. J Biol Response Mod 1996;5:236–49.",{},{"id":26,"text":4676,"url":26,"identifiers":4677},"Rhodes, 1983, Increased expression of human monocyte HLA-DR antigen and Fc-gamma receptors in response to human interferon in vivo, Clin. Exp. Immunol., 53, 739",{},{"id":26,"text":4679,"url":26,"identifiers":4680},"Kosmidis PA, Baxevanis CN, Tsavaris N, et al. The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon-alpha-2b. J Clin Oncol 1992;10:1153–7.",{"doi":4681},"10.1200\u002FJCO.1992.10.7.1153",{"id":26,"text":4683,"url":26,"identifiers":4684},"Tsavaris, 1996, The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon-alpha-2b, Cancer Immunol. Immunother., 43, 94, 10.1007\u002Fs002620050308",{"doi":4685},"10.1007\u002Fs002620050308",{"id":26,"text":4687,"url":26,"identifiers":4688},"Agarwala, 1994, Interferons in the therapy of solid tumors, Oncology, 51, 129, 10.1159\u002F000227327",{"doi":4689},"10.1159\u002F000227327",{"id":26,"text":4691,"url":26,"identifiers":4692},"Mihm, 1996, Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response, Lab. Invest., 74, 43",{},{"id":26,"text":4694,"url":26,"identifiers":4695},"Hakansson, 1996, Tumor-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon-alpha treatment, Br. J. Cancer, 74, 670, 10.1038\u002Fbjc.1996.420",{"doi":4696},"10.1038\u002Fbjc.1996.420",{"id":26,"text":4698,"url":26,"identifiers":4699},"Hakansson, 1998, Effect of IFN-α on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma, J. Interferon Cytokine Res., 18, 33, 10.1089\u002Fjir.1998.18.33",{"doi":4700},"10.1089\u002Fjir.1998.18.33",{"id":26,"text":4702,"url":26,"identifiers":4703},"Zarour HM, Kirkwood JM, Kierstead LS, et al. Melan-A\u002FMART-1(51–73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells. Proc Natl Acad Sci USA 2000;97:400–5.",{"doi":4704},"10.1073\u002Fpnas.97.1.400",{"id":26,"text":4706,"url":26,"identifiers":4707},"Rowley, 1990, The Philadelphia chromosome translocation: a paradigm for understanding leukemia, Cancer, 65, 2178, 10.1002\u002F1097-0142(19900515)65:10\u003C2178::AID-CNCR2820651004>3.0.CO;2-#",{"doi":4708},"10.1002\u002F1097-0142(19900515)65:10\u003C2178::AID-CNCR2820651004>3.0.CO;2-#",{"id":26,"text":4710,"url":26,"identifiers":4711},"Faderl, 1999, Chronic myelogenous leukemia: biology and therapy, Ann. Int. Med., 131, 207, 10.7326\u002F0003-4819-131-3-199908030-00008",{"doi":4712},"10.7326\u002F0003-4819-131-3-199908030-00008",{"id":26,"text":4714,"url":26,"identifiers":4715},"Fujii, 2000, Role of interferon-alpha and clonally expanded T cells in the immunotherapy of chronic myelogenous leukemia, Leuk. Lymphoma, 38, 21, 10.3109\u002F10428190009060316",{"doi":4716},"10.3109\u002F10428190009060316",{"id":26,"text":4718,"url":26,"identifiers":4719},"Wang C, Al-Omar HM, Radvanyi L, et al. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T -cells stimulatory activity by IFN-α. Exp Hematol 1999;27:1176–84.",{"doi":4720},"10.1016\u002FS0301-472X(99)00055-7",{"id":26,"text":4722,"url":26,"identifiers":4723},"Chen, 2000, Interferon-alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia, Br. J. Haematol., 111, 596, 10.1046\u002Fj.1365-2141.2000.02361.x",{"doi":4724},"10.1046\u002Fj.1365-2141.2000.02361.x",{"id":26,"text":4726,"url":26,"identifiers":4727},"Cortes, 1998, GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia, Leukemia, 12, 860, 10.1038\u002Fsj.leu.2401033",{"doi":4728},"10.1038\u002Fsj.leu.2401033",{"id":26,"text":4730,"url":26,"identifiers":4731},"Albert, 1998, Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, 392, 86, 10.1038\u002F32183",{"doi":4732},"10.1038\u002F32183",{"id":26,"text":4734,"url":26,"identifiers":4735},"Finkelman, 1991, Regulation by interferon α of immunoglobulin isotype selection and lymphokine production in mice, J Exp Med, 174, 1179, 10.1084\u002Fjem.174.5.1179",{"doi":4736},"10.1084\u002Fjem.174.5.1179",{"id":26,"text":4738,"url":26,"identifiers":4739},"Chen, 1986, Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro, Proc Natl Acad Sci USA, 83, 4887, 10.1073\u002Fpnas.83.13.4887",{"doi":4740},"10.1073\u002Fpnas.83.13.4887",{"id":26,"text":4742,"url":26,"identifiers":4743},"Muller, 1994, Functional role of type I and type II interferons in antiviral defense, Science, 264, 1918, 10.1126\u002Fscience.8009221",{"doi":4744},"10.1126\u002Fscience.8009221",{"id":26,"text":4746,"url":26,"identifiers":4747},"Vieillard, 1997, Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th-1 type cytokine production and improves the proliferative response to recall antigens, Proc Natl Acad Sci USA, 94, 11595, 10.1073\u002Fpnas.94.21.11595",{"doi":4748},"10.1073\u002Fpnas.94.21.11595",{"id":4750,"createTime":4751,"updateTime":4751,"relativeEntities":4752,"slug":4753,"properties":4754,"entityType":788,"verifyStatus":25,"verifyTime":4767,"verifyNote":790,"syncStatus":28,"languages":4768,"translateLanguages":26,"viewCount":36,"primaryUrl":4769,"fullTextUrl":26,"authors":4770,"publicationType":880,"publisherRelationship":4809,"citationCount":4838,"citationInfo":4839,"publishDate":4841,"publishYear":4208,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":4842,"isForceReanalyzing":1290},"e3126ca8-b2be-431c-9534-c5cef06a35f9","2024-09-17T18:03:51.060+00:00",[],"Interleukin-22-A-novel-T-and-NK-cell-derived-cytokine-that-regulates-the-biology-of-tissue-cells",{"mag":4755,"keywords":4757,"openalex":4758,"abstract":4760,"title":4761,"pm":4763,"doi":4765},{"VOID":4756},"2038539820",{},{"VOID":4759},"W2038539820",{},{"EN":4762},"Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells",{"VOID":4764},"17030002",{"VOID":4766},"10.1016\u002Fj.cytogfr.2006.09.001","2024-09-17T18:03:51.059+00:00",[102],"https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1359610106000505",[4771,4792],{"id":4772,"sortIndex":115,"researcher":26,"roles":4773,"affiliations":4774,"properties":4785},"a094813e-c59d-478d-b8cf-66f667d5e631",[],[4775],{"id":4776,"sortIndex":36,"affiliation":4777,"properties":26},"a233b449-28d4-4768-9223-3a5c8ab65692",{"id":4778,"createTime":4779,"updateTime":4779,"relativeEntities":4780,"slug":4781,"properties":4782,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"775d0792-d934-4c38-b55e-28e31ad0e025","2024-09-17T18:03:51.071+00:00",[],"Interdisciplinary-group-of-Molecular-Immunopathology-Dermatology-Medical-Immunology-University-Hospital-Charit%C3%A9-Campus-Charit%C3%A9-Mitte-Charit%C3%A9platz-1-D-10117-Berlin-Germany-",{"title":4783},{"EN":4784},"Interdisciplinary group of Molecular Immunopathology, Dermatology\u002FMedical Immunology, University Hospital Charité, Campus Charité Mitte, Charitéplatz 1, D-10117 Berlin, Germany.",{"openalex":4786,"orcid":4788,"title":4790},{"VOID":4787},"A5079084283",{"VOID":4789},"https:\u002F\u002Forcid.org\u002F0000-0002-0198-940X",{"EN":4791},"Robert Sabat",{"id":4793,"sortIndex":36,"researcher":26,"roles":4794,"affiliations":4795,"properties":4802},"5f89863e-6d89-4ddc-8d72-d294098c4109",[],[4796],{"id":4797,"sortIndex":36,"affiliation":4798,"properties":26},"9441dcb3-5548-4a8c-869a-500e86fe919e",{"id":4778,"createTime":4779,"updateTime":4779,"relativeEntities":4799,"slug":4781,"properties":4800,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":4801},{"EN":4784},{"openalex":4803,"orcid":4805,"title":4807},{"VOID":4804},"A5057872727",{"VOID":4806},"https:\u002F\u002Forcid.org\u002F0000-0002-7689-4130",{"EN":4808},"Kerstin Wolk",{"url":26,"publisher":4810,"properties":4832},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":4811,"slug":663,"properties":4812,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"subjectFields":4815,"manageAffiliations":4816,"indexDatabases":4817,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":4813,"title":4814},{"VOID":666},{"EN":668},[],[],[4818,4825],{"id":747,"indexDatabase":4819,"url":762,"indexYears":26,"academicFieldIds":4824,"indexDatabaseRanking":26},{"id":749,"createTime":750,"updateTime":751,"relativeEntities":4820,"label":4821,"description":4822,"key":758,"publicationTags":4823,"standard":26},[],{"EN":754,"VI":754},{"VI":756,"EN":757},[760,761],[764,765],{"id":725,"indexDatabase":4826,"url":738,"indexYears":739,"academicFieldIds":4831,"indexDatabaseRanking":745},{"id":727,"createTime":728,"updateTime":729,"relativeEntities":4827,"label":4828,"description":4829,"key":735,"publicationTags":4830,"standard":26},[],{"EN":732,"VI":732},{"EN":732,"VI":734},[737],[741,742,743,744],{"volume":4833,"pages":4834,"issue":4836},{"VOID":4200},{"VOID":4835},"367-380",{"VOID":4837},"5",298,{"total":4838,"publishYear":26,"statisticByYear":4840},{"2012":239,"2013":237,"2014":238,"2015":52,"2016":356,"2017":298,"2018":356,"2019":52,"2020":50,"2021":53,"2022":53,"2023":162,"2024":59},"2006-10-01",[4843,4847,4851,4855,4859,4863,4867,4870,4874,4878,4882,4886,4890,4894,4898,4902,4906,4910,4914,4918,4922,4926,4930,4934,4938,4942,4946,4950,4954,4958,4962,4966,4970,4974,4977,4981,4985,4989,4993,4997,5001,5005,5009,5013,5017,5021,5025,5029,5033,5037,5041,5045,5049,5053,5056,5060,5064,5068,5071,5075,5079,5083],{"id":26,"text":4844,"url":26,"identifiers":4845},"Dumoutier, 2000, Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9, J Immunol, 164, 1814, 10.4049\u002Fjimmunol.164.4.1814",{"doi":4846},"10.4049\u002Fjimmunol.164.4.1814",{"id":26,"text":4848,"url":26,"identifiers":4849},"Dumoutier, 2000, Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor, Proc Natl Acad Sci USA, 97, 10144, 10.1073\u002Fpnas.170291697",{"doi":4850},"10.1073\u002Fpnas.170291697",{"id":26,"text":4852,"url":26,"identifiers":4853},"Xie, 2000, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, J Biol Chem, 275, 31335, 10.1074\u002Fjbc.M005304200",{"doi":4854},"10.1074\u002Fjbc.M005304200",{"id":26,"text":4856,"url":26,"identifiers":4857},"Blumberg, 2001, Interleukin 20: discovery, receptor identification, and role in epidermal function, Cell, 104, 9, 10.1016\u002FS0092-8674(01)00187-8",{"doi":4858},"10.1016\u002FS0092-8674(01)00187-8",{"id":26,"text":4860,"url":26,"identifiers":4861},"Gallagher, 2000, Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10), Genes Immun, 1, 442, 10.1038\u002Fsj.gene.6363714",{"doi":4862},"10.1038\u002Fsj.gene.6363714",{"id":26,"text":4864,"url":26,"identifiers":4865},"Knappe, 2000, Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri, J Virol, 74, 3881, 10.1128\u002FJVI.74.8.3881-3887.2000",{"doi":4866},"10.1128\u002FJVI.74.8.3881-3887.2000",{"id":26,"text":4868,"url":26,"identifiers":4869},"Jiang, 1995, Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression, Oncogene, 11, 2477",{},{"id":26,"text":4871,"url":26,"identifiers":4872},"Volk, 2001, IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets, Trends Immunol, 22, 414, 10.1016\u002FS1471-4906(01)01985-8",{"doi":4873},"10.1016\u002FS1471-4906(01)01985-8",{"id":26,"text":4875,"url":26,"identifiers":4876},"Kotenko, 2003, IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex, Nat Immunol, 4, 69, 10.1038\u002Fni875",{"doi":4877},"10.1038\u002Fni875",{"id":26,"text":4879,"url":26,"identifiers":4880},"Sheppard, 2003, IL-28, IL-29 and their class II cytokine receptor IL-28R, Nat Immunol, 4, 63, 10.1038\u002Fni873",{"doi":4881},"10.1038\u002Fni873",{"id":26,"text":4883,"url":26,"identifiers":4884},"Donnelly, 2004, The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain, J Leukoc Biol, 76, 314, 10.1189\u002Fjlb.0204117",{"doi":4885},"10.1189\u002Fjlb.0204117",{"id":26,"text":4887,"url":26,"identifiers":4888},"Langer, 2004, The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions, Cytokine Growth Factor Rev, 15, 33, 10.1016\u002Fj.cytogfr.2003.10.001",{"doi":4889},"10.1016\u002Fj.cytogfr.2003.10.001",{"id":26,"text":4891,"url":26,"identifiers":4892},"Pestka, 2004, Interleukin-10 and related cytokines and receptors, Annu Rev Immunol, 22, 929, 10.1146\u002Fannurev.immunol.22.012703.104622",{"doi":4893},"10.1146\u002Fannurev.immunol.22.012703.104622",{"id":26,"text":4895,"url":26,"identifiers":4896},"Logsdon, 2002, Comparison of interleukin-22 and interleukin-10 soluble receptor complexes, J Interferon Cytokine Res, 22, 1099, 10.1089\u002F10799900260442520",{"doi":4897},"10.1089\u002F10799900260442520",{"id":26,"text":4899,"url":26,"identifiers":4900},"Reineke, 1999, Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope, J Mol Recognit, 12, 242, 10.1002\u002F(SICI)1099-1352(199907\u002F08)12:4\u003C242::AID-JMR461>3.0.CO;2-1",{"doi":4901},"10.1002\u002F(SICI)1099-1352(199907\u002F08)12:4\u003C242::AID-JMR461>3.0.CO;2-1",{"id":26,"text":4903,"url":26,"identifiers":4904},"Dumoutier, 2000, IL-TIF\u002FIL-22: genomic organization and mapping of the human and mouse genes, Genes Immun, 1, 488, 10.1038\u002Fsj.gene.6363716",{"doi":4905},"10.1038\u002Fsj.gene.6363716",{"id":26,"text":4907,"url":26,"identifiers":4908},"Kotenko, 2002, The family of IL-10-related cytokines and their receptors: related, but to what extent?, Cytokine Growth Factor Rev, 13, 223, 10.1016\u002FS1359-6101(02)00012-6",{"doi":4909},"10.1016\u002FS1359-6101(02)00012-6",{"id":26,"text":4911,"url":26,"identifiers":4912},"Nagem, 2002, Crystal structure of recombinant human interleukin-22, Structure (Camb), 10, 1051, 10.1016\u002FS0969-2126(02)00797-9",{"doi":4913},"10.1016\u002FS0969-2126(02)00797-9",{"id":26,"text":4915,"url":26,"identifiers":4916},"Xu, 2005, Structure of insect-cell-derived IL-22, Acta Crystallogr D Biol Crystallogr, 61, 942, 10.1107\u002FS0907444905009601",{"doi":4917},"10.1107\u002FS0907444905009601",{"id":26,"text":4919,"url":26,"identifiers":4920},"Chang, 2003, Crystal structure of interleukin-19 defines a new subfamily of helical cytokines, J Biol Chem, 278, 3308, 10.1074\u002Fjbc.M208602200",{"doi":4921},"10.1074\u002Fjbc.M208602200",{"id":26,"text":4923,"url":26,"identifiers":4924},"Walter, 1995, Crystal structure of interleukin 10 reveals an interferon gamma-like fold, Biochemistry, 34, 12118, 10.1021\u002Fbi00038a004",{"doi":4925},"10.1021\u002Fbi00038a004",{"id":26,"text":4927,"url":26,"identifiers":4928},"Zdanov, 1995, Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma, Structure, 3, 591, 10.1016\u002FS0969-2126(01)00193-9",{"doi":4929},"10.1016\u002FS0969-2126(01)00193-9",{"id":26,"text":4931,"url":26,"identifiers":4932},"Kotenko, 2001, Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes, J Biol Chem, 276, 2725, 10.1074\u002Fjbc.M007837200",{"doi":4933},"10.1074\u002Fjbc.M007837200",{"id":26,"text":4935,"url":26,"identifiers":4936},"Logsdon, 2004, The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation, J Mol Biol, 342, 503, 10.1016\u002Fj.jmb.2004.07.069",{"doi":4937},"10.1016\u002Fj.jmb.2004.07.069",{"id":26,"text":4939,"url":26,"identifiers":4940},"Wolk, 2002, Cutting edge: immune cells as sources and targets of the IL-10 family members?, J Immunol, 168, 5397, 10.4049\u002Fjimmunol.168.11.5397",{"doi":4941},"10.4049\u002Fjimmunol.168.11.5397",{"id":26,"text":4943,"url":26,"identifiers":4944},"Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016\u002Fj.immuni.2004.07.007",{"doi":4945},"10.1016\u002Fj.immuni.2004.07.007",{"id":26,"text":4947,"url":26,"identifiers":4948},"Wolk, 2006, IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis, Eur J Immunol, 36, 1309, 10.1002\u002Feji.200535503",{"doi":4949},"10.1002\u002Feji.200535503",{"id":26,"text":4951,"url":26,"identifiers":4952},"Wolk, 2005, Is there an interaction between interleukin-10 and interleukin-22?, Genes Immun, 6, 8, 10.1038\u002Fsj.gene.6364144",{"doi":4953},"10.1038\u002Fsj.gene.6364144",{"id":26,"text":4955,"url":26,"identifiers":4956},"Leung, 2003, Atopic dermatitis, Lancet, 361, 151, 10.1016\u002FS0140-6736(03)12193-9",{"doi":4957},"10.1016\u002FS0140-6736(03)12193-9",{"id":26,"text":4959,"url":26,"identifiers":4960},"Andoh, 2005, Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts, Gastroenterology, 129, 969, 10.1053\u002Fj.gastro.2005.06.071",{"doi":4961},"10.1053\u002Fj.gastro.2005.06.071",{"id":26,"text":4963,"url":26,"identifiers":4964},"Ikeuchi, 2005, Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine, Arthritis Rheum, 52, 1037, 10.1002\u002Fart.20965",{"doi":4965},"10.1002\u002Fart.20965",{"id":26,"text":4967,"url":26,"identifiers":4968},"Whittington, 2004, Interleukin-22: a potential immunomodulatory molecule in the lung, Am J Respir Cell Mol Biol, 31, 220, 10.1165\u002Frcmb.2003-0285OC",{"doi":4969},"10.1165\u002Frcmb.2003-0285OC",{"id":26,"text":4971,"url":26,"identifiers":4972},"Kotenko, 1997, Identification and functional characterization of a second chain of the interleukin-10 receptor complex, EMBO J, 16, 5894, 10.1093\u002Femboj\u002F16.19.5894",{"doi":4973},"10.1093\u002Femboj\u002F16.19.5894",{"id":26,"text":4975,"url":26,"identifiers":4976},"Adams RL, Farrah TM, Jelmberg AC, Lok S, Whitemore TE, Patent WO9907848-A1 and U.S. Patent 5,965,704; 1999.",{},{"id":26,"text":4978,"url":26,"identifiers":4979},"Tachiiri, 2003, Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice, Genes Immun, 4, 153, 10.1038\u002Fsj.gene.6363934",{"doi":4980},"10.1038\u002Fsj.gene.6363934",{"id":26,"text":4982,"url":26,"identifiers":4983},"Li, 2004, Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2, Int Immunopharmacol, 4, 693, 10.1016\u002Fj.intimp.2004.01.010",{"doi":4984},"10.1016\u002Fj.intimp.2004.01.010",{"id":26,"text":4986,"url":26,"identifiers":4987},"Josephson, 2001, Crystal structure of the IL-10\u002FIL-10R1 complex reveals a shared receptor binding site, Immunity, 15, 35, 10.1016\u002FS1074-7613(01)00169-8",{"doi":4988},"10.1016\u002FS1074-7613(01)00169-8",{"id":26,"text":4990,"url":26,"identifiers":4991},"Reineke, 1998, Mapping of the interleukin-10\u002Finterleukin-10 receptor combining site, Protein Sci, 7, 951, 10.1002\u002Fpro.5560070412",{"doi":4992},"10.1002\u002Fpro.5560070412",{"id":26,"text":4994,"url":26,"identifiers":4995},"Boniface, 2005, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J Immunol, 174, 3695, 10.4049\u002Fjimmunol.174.6.3695",{"doi":4996},"10.4049\u002Fjimmunol.174.6.3695",{"id":26,"text":4998,"url":26,"identifiers":4999},"Lecart, 2002, IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells, Int Immunol, 14, 1351, 10.1093\u002Fintimm\u002Fdxf096",{"doi":5000},"10.1093\u002Fintimm\u002Fdxf096",{"id":26,"text":5002,"url":26,"identifiers":5003},"Aggarwal, 2001, Acinar cells of the pancreas are a target of interleukin-22, J Interferon Cytokine Res, 21, 1047, 10.1089\u002F107999001317205178",{"doi":5004},"10.1089\u002F107999001317205178",{"id":26,"text":5006,"url":26,"identifiers":5007},"Parrish-Novak, 2002, Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions, J Biol Chem, 277, 47517, 10.1074\u002Fjbc.M205114200",{"doi":5008},"10.1074\u002Fjbc.M205114200",{"id":26,"text":5010,"url":26,"identifiers":5011},"Dumoutier, 2001, Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor\u002FIL-22, J Immunol, 166, 7090, 10.4049\u002Fjimmunol.166.12.7090",{"doi":5012},"10.4049\u002Fjimmunol.166.12.7090",{"id":26,"text":5014,"url":26,"identifiers":5015},"Gruenberg, 2001, A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta, Genes Immun, 2, 329, 10.1038\u002Fsj.gene.6363786",{"doi":5016},"10.1038\u002Fsj.gene.6363786",{"id":26,"text":5018,"url":26,"identifiers":5019},"Kotenko, 2001, Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity, J Immunol, 166, 7096, 10.4049\u002Fjimmunol.166.12.7096",{"doi":5020},"10.4049\u002Fjimmunol.166.12.7096",{"id":26,"text":5022,"url":26,"identifiers":5023},"Wei, 2003, Cloning and characterization of mouse IL-22 binding protein, Genes Immun, 4, 204, 10.1038\u002Fsj.gene.6363947",{"doi":5024},"10.1038\u002Fsj.gene.6363947",{"id":26,"text":5026,"url":26,"identifiers":5027},"Weiss, 2004, Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart, Genes Immun, 5, 330, 10.1038\u002Fsj.gene.6364104",{"doi":5028},"10.1038\u002Fsj.gene.6364104",{"id":26,"text":5030,"url":26,"identifiers":5031},"Xu, 2001, A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist, Proc Natl Acad Sci USA, 98, 9511, 10.1073\u002Fpnas.171303198",{"doi":5032},"10.1073\u002Fpnas.171303198",{"id":26,"text":5034,"url":26,"identifiers":5035},"Dumoutier, 2001, Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types, J Immunol, 167, 3545, 10.4049\u002Fjimmunol.167.7.3545",{"doi":5036},"10.4049\u002Fjimmunol.167.7.3545",{"id":26,"text":5038,"url":26,"identifiers":5039},"Lejeune, 2002, Interleukin-22 (IL-22) activates the JAK\u002FSTAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10, J Biol Chem, 277, 33676, 10.1074\u002Fjbc.M204204200",{"doi":5040},"10.1074\u002Fjbc.M204204200",{"id":26,"text":5042,"url":26,"identifiers":5043},"Oral, 2006, Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26, Eur J Immunol, 36, 380, 10.1002\u002Feji.200425523",{"doi":5044},"10.1002\u002Feji.200425523",{"id":26,"text":5046,"url":26,"identifiers":5047},"Salazar, 2001, Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders, Eur J Clin Invest, 31, 1070, 10.1046\u002Fj.1365-2362.2001.00913.x",{"doi":5048},"10.1046\u002Fj.1365-2362.2001.00913.x",{"id":26,"text":5050,"url":26,"identifiers":5051},"Radaeva, 2004, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, 39, 1332, 10.1002\u002Fhep.20184",{"doi":5052},"10.1002\u002Fhep.20184",{"id":26,"text":5054,"url":26,"identifiers":5055},"Pan, 2004, Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3, Cell Mol Immunol, 1, 43",{},{"id":26,"text":5057,"url":26,"identifiers":5058},"Schroder, 2006, Antimicrobial skin peptides and proteins, Cell Mol Life Sci, 63, 469, 10.1007\u002Fs00018-005-5364-0",{"doi":5059},"10.1007\u002Fs00018-005-5364-0",{"id":26,"text":5061,"url":26,"identifiers":5062},"Powell, 1999, Myofibroblasts. II. Intestinal subepithelial myofibroblasts, Am J Physiol, 277, 10.1152\u002Fajpcell.1999.277.2.C183",{"doi":5063},"10.1152\u002Fajpcell.1999.277.2.C183",{"id":26,"text":5065,"url":26,"identifiers":5066},"Dohi, 2005, Therapeutic potential of follistatin for colonic inflammation in mice, Gastroenterology, 128, 411, 10.1053\u002Fj.gastro.2004.11.063",{"doi":5067},"10.1053\u002Fj.gastro.2004.11.063",{"id":26,"text":5069,"url":26,"identifiers":5070},"Hubner, 1997, Activin A: a novel player and inflammatory marker in inflammatory bowel disease?, Lab Invest, 77, 311",{},{"id":26,"text":5072,"url":26,"identifiers":5073},"Grosfeld, 1999, Interleukin-11: its biology and prospects for clinical use, JPEN J Parenter Enteral Nutr, 23, S67, 10.1177\u002F014860719902300517",{"doi":5074},"10.1177\u002F014860719902300517",{"id":26,"text":5076,"url":26,"identifiers":5077},"Murphy, 1998, Growth factors and the gastrointestinal tract, Nutrition, 14, 771, 10.1016\u002FS0899-9007(98)00081-1",{"doi":5078},"10.1016\u002FS0899-9007(98)00081-1",{"id":26,"text":5080,"url":26,"identifiers":5081},"Kalabis, 2003, Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture, FASEB J, 17, 1115, 10.1096\u002Ffj.02-0852fje",{"doi":5082},"10.1096\u002Ffj.02-0852fje",{"id":26,"text":5084,"url":26,"identifiers":5085},"Nagakawa, 2004, Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts, Scand J Immunol, 60, 449, 10.1111\u002Fj.0300-9475.2004.01504.x",{"doi":5086},"10.1111\u002Fj.0300-9475.2004.01504.x"]